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1 Summary
1 Summary
Bacterial and viral pathogens have evolved a wide range of strategies to invade their
unwilling hosts. Many of them rely on actin-based motility to penetrate and survive
within the host cells, yet in many cases it is not fully understood how and where exactly
they manipulate actin dynamics. Arp2/3-mediated nucleation and branching of actin
depends on nucleation promoting factors that locally recruit and activate the Arp2/3
complex. In particular, Arp2/3 activation and function is regulated by a class of pro-
teins termed type I nucleation promoting factors, which comprise the WAS-superfamily
including the well-known WASp and WAVE proteins as well as WASH, WHAMM, and
JMY that operate in endomembrane traﬃc.
The aim of this study was to elucidate the connection between actin polymerization
on internal membranes and the intracellular lifecycle of pathogenic invaders by sys-
tematically inactivating the respective nucleation promoting factor genes using the
CRISPR/Cas9 technology. Aside from speciﬁc functions in host-pathogen interaction,
this approach was expected to help shedding new light on the cellular functions of
these Arp2/3-activators. Upon somatic gene knockout of actin regulators, I examined
a broad set of cellular and infection processes in murine ﬁbroblasts and human cancer
cells.
To this end, I have generated several independent clones of mouse embryonic ﬁbrob-
lasts (NIH/3T3) as well as human osteosarcoma cells (U-2 OS) by disrupting their
genes of WASH, WHAMM, and JMY, respectively. All cell lines were probed for the
absence of the respective proteins by western blotting. Additionally, NIH/3T3 knock-
outs were genomically sequenced for targeted loci of clones lacking protein expression.
The cellular phenotypes of obtained NIH/3T3 WHAMM knockout cell lines have been
characterized with special emphasis on ER- and Golgi morphology as well as on au-
tophagy. Moreover, I performed transcriptional proﬁling to identify pathways, which
are diﬀerentially regulated dependent on the respective phenotype, followed by exem-
plary evaluation of the aﬀected pathways.
WHAMM knockout signiﬁcantly alters NIH/3T3 morphology. In particular, WHAMM-
deﬁcient cells exhibited enlarged cell size and nuclear area and displayed higher gran-
ularity. In addition, knockout of WHAMM signiﬁcantly aﬀects integrity of the Golgi
apparatus. Microarray analyses revealed a deregulation of genes encoding for enzymes
involved in autophagy, cholesterol biosynthesis as well as of genes crucial for integring-
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1 Summary
mediated adhesion in WHAMM knockout clones. Notably, examination of autophagy
uncovers increased numbers of LC3-, p62-, and LAMP-1-positive vesicles as well as
revealed enlarged omegasomes, autophagosomes, and lysosomes in WHAMM knockout
cells. Lastly, it could be shown that WHAMM ablation decreases the infection rate
of Vesicular stomatitis virus and Herpes simplex virus type 1, suggesting that loss of
WHAMM is involved in viral infection processes.
Preliminary data of NIH/3T3 JMY knockout cells revealed also enlarged cell nuclei as
well as showed a strong increase of LC3- and p62-positive vesicles under nonstarved
conditions. Moreover, JMY knockout cells exhibited a clear inhibition of Vesicular
stomatitis virus release, indicating that JMY is also likely involved in Vesicular stom-
atitis virus infection.
Current experiments are designed to unravel speciﬁc functions of WHAMM and its
relatives in autophagy as well as during Vesicular stomatitis virus and/or Herpes sim-
plex virus type 1 infection in more detail and to explore membrane alterations of for
instance omegasomes by both super-resolution and electron microscopy in WHAMM
KO cells.
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Shaping, locomotion and internal organization of eukaryotic cells are generated and
maintained by a structure called the cytoskeleton, a network of ﬁlaments or ﬁbers. It
is composed of three distinct elements that diﬀer in size and protein composition.
Microtubules are the largest type of ﬁlaments. These long hollow tubes consist of 13
columns of tubulin dimers. Microtubules mainly function in maintenance of cell shape
and a variety of cell migration events such as intracellular organelle transport and chro-
mosome movements in cell division.
The second cytoskeletal subtype are intermediate ﬁlaments. These rope-like ﬁbers are
constructed from a number of diﬀerent ﬁbrous proteins depending on the cell type.
Indeed, intermediate ﬁlaments are not directly involved in cell movements, but possess
a structural role by providing mechanical strength to cells and tissues (e.g. in epithelial
tissue) [1].
The machinery that powers locomotion of eukaryotic cells is built from the actin cy-
toskeleton. Cell locomotion is a fundamental event of multi-cellular life and formation
of dynamic membrane protrusions occurs as lamellipodia, membrane rues or ﬁlopo-
dia [2]. Actin exists as globular monomers termed G-actin, which can polymerize to
ﬁlamentous actin (F-actin) [3]. In addition to cell locomotion, actin is the major cy-
toskeletal ﬁlament exploited by pathogens. Actin rearrangements are a common feature
of most pathogenic internalization events enabling bacteria or viruses to move around
within the cytoplasm or to support cell-to cell spread [4]. The next chapters will focus
on the regulation of actin polymerization by nucleation promoting factors (NPFs), the
potential impact of these proteins on a mechanism termed autophagy and will describe
how pathogens use the host actin cytoskeleton for their own purposes.
2.1 The actin cytoskeleton
Actin, also referred to as microﬁlament system, is the most abundant intracellular
protein observed in eukaryotes [5]. It is a highly conserved ATPase and participates in
diverse processes, including cell migration, endocytosis, vesicle traﬃcking and cytokine-
sis. As mentioned above, actin is found both as monomeric G-actin, and as a polymeric
linear chain of G-actin subunits termed F-actin. F-actin is formed by reversible non-
covalent self-association of monomeric G-actin [3]. The transition between these two
states involves adenosine triphosphate (ATP) hydrolysis and the binding of adenosine
diphosphate (ADP) to actin. G-actin binds ATP via a central grove, a prerequisite
to allow polymerization to F-actin that is constantly occurring within living cells [6].
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In vitro experiments such as viscometry, sedimentation, and ﬂuorescence spectroscopy
monitored the polymerization process showing that actin polymerization proceeds in
three sequential phases (Figure 2.1). In the initial step G-actin aggregates into short,
unstable oligomers. However, the formation of new actin ﬁlaments in cells is kinetically
unfavorable because of the instability of these polymerization intermediates. Once the
oligomer reaches a length of three or four subunits it can form stable complexes of
actin (nuclei). In the second phase, the nuclei rapidly elongate into ﬁlaments by the
addition of actin monomers to both ends of the ﬁlament. In the third phase (steady
state) G-actin monomers exchange with subunits at the ﬁlament ends but there is no
net change in the total mass of ﬁlaments [7].
Figure 2.1: Formation of F-actin. G-actin forms the basic unit for actin ﬁlaments. Generally,
actin polymerization proceeds over three stages: A nucleation phase, an elongation phase and a
steady state phase. A G-actin monomer binds to ATP and interacts with other ATP-bound G-actin
molecules. The formation of a stable trimer (nucleus) occurs that usually consists of three or four
actin monomers. Nucleus formation is essential for the assembly of F-actin. In the third phase, both
ends of the ﬁlament are in a steady state with monomeric ATP-G-actin. Shortly after its integration
into a ﬁlament, subunits hydrolyze ATP to ADP and inorganic phosphate (Pi) is released [8].
F-actin is a double-helical ﬁlament, which arranges head-to-tail to give the ﬁlament a
molecular intrinsic polarity (Figure 2.2). Filamentous actin structures have a fast grow-
ing plus end (barbed end) and a slowly growing minus end (pointed end). The barbed
end displays a cleft where ATP-actin monomers are preferentially incorporated, while
the opposite end possesses an actin subunit with an exposed ATP binding site. The
cycle of actin polymerization and depolymerization is termed actin treadmilling mech-
anism by which ADP exchange for ATP enhances the addition of G-actin monomers
to the barbed end [9]. However, even cells contain a large pool of actin monomers,
spontaneous actin assembly is prohibited in vivo. Actin monomer-binding proteins
such as proﬁlin suppress spontaneous nucleation of new ﬁlaments and the cell requires
nucleation factors to catalyze the de novo assembly of ﬁlaments (Chapter 2.2) [10].
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Figure 2.2: .
F-actin appears as a double-helical ﬁlament. A F-actin ﬁlament grown from
the polymerization of G-actin monomers. Plus = barbed end, minus = pointed end
(https://www.hypermol.com/index.php?cat=c91_FAQs-FAQs.html)(13.09.2018)
2.2 Actin nucleators
The dynamic assembly and disassembly of actin ﬁlaments and the formation of larger
scale ﬁlament structures are controlled by a vast number of regulatory proteins, which
bind to and modify both G- and F-actin [3, 11]. Some of these factors bind to actin
monomers (e.g. thymosin 4 and proﬁlin), thereby suppressing spontaneous actin
polymerization. Therefore the initial step, known as nucleation (Figure 2.1), repre-
sents the rate-limiting step in de novo ﬁlament formation. Once nucleated, ﬁlaments
elongate at their barbed ends at a rate proportional to the concentration of available
actin monomers [12]. To overcome this kinetic hurdle to ﬁlament polymerization, cells
express actin nucleators that can accelerate or bypass this step [3]. These proteins
contain actin-binding sites and either mimic or stabilize the spontaneous formation
of dimeric and then trimeric actin intermediates. A variety of actin nucleators have
been found to date, which include the actin-related protein-2/3 (Arp2/3) complex, the
formins and Spire (Figure 2.3).
The ﬁrst physiologically relevant actin nucleation factor identiﬁed was the Arp2/3 com-
plex [11]. It is a seven-subunit protein complex containing Arp2 and Arp3, and ﬁve
unique polypeptides [3]. Arp2 and Arp3 are closely related to G-actin, which allows
the formation of a "cryptic dimer" similar to an actin dimer that can act as a stable
nucleus for actin polymerization [13]. The Arp2/3 complex alone does not stimulate
actin ﬁlament assembly as it possesses little biochemical activity. Rather, it is acti-
vated by NPF proteins to catalyze the formation of a new (daughter) ﬁlament from the
side of an pre-existing (mother) ﬁlament in a y-branch conﬁguration at a 70° angle [3].
This process is known as dendritic nucleation and is utilized to assemble actin struc-
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tures such as Listeria comet tails, lamellipodia, and focal adhesions. The best studied
Arp2/3 complex activators are the WiskottAldrich Syndrome protein (WASp)/WAVE
family proteins, which enhance conformational changes to enable the Arp2/3 complex
to nucleate actin (Chapter 2.3) [12,13].
Figure 2.3: Paths to actin nucleation. (a) The initial step in actin-ﬁlament assembly requires
the formation of a stable, trimeric complex (nucleus), a process called nucleation. However, sponta-
neous nucleation is kinetically unfavourable due to the instability of actin dimer intermediates. To
overcome the kinetic hurdle for nucleation and to promote the initiation of new ﬁlament assembly,
cells utilize factors that directly nucleate actin (b-d). (b) Arp2/3 complex is activated by binding
to NPFs. It mimics actin dimer or trimer and functions in the initiation of a new actin (daughter)
ﬁlament, forming y-branched networks. (c) Another class of proteins called tandem-monomer-binding
nucleators (e.g. Spire) use actin-monomer-binding WH2 domains to nucleate and polymerize into
long stretches of linear microﬁlaments. (d) Formins generate actin polymerization nuclei by stabi-
lizing actin dimer or trimer through their FH2 domains. In contrast to Arp2/3 complex and Spire,
formins remain processively attached to the growing barbed ends of actin ﬁlaments [3].
The second major class of actin nucleators identiﬁed are the formin proteins, which
generate linear (unbranched) actin ﬁlaments in vitro independently of the Arp2/3 com-
plex and NPFs [11]. They are large, dimeric multi-domain proteins and characterized
by the C-terminal FH1 and FH2 domains [14]. The FH1 domain harbors polyproline
stretches for proﬁlin recruitment and to mediate interactions with domain proteins such
as SH3. The FH2 motif associates with the barbed end and is required for dimerization
as well as actin nucleation [15]. Formins assemble diverse actin structures, including
stress ﬁbers, ﬁlopodia and lamellipodia, cytokinetic actin rings, and actin cables in
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vivo [12, 14]. More recently, it was shown that FMNL2 and FMNL3 contribute to the
velocity of lamellipodium protrusion in vitro, and loss of these proteins reduces lamel-
lipodial width, actin ﬁlament density and -bundling [16].
The third class of nucleators discovered are known as tandem-monomer-binding nucle-
ators. This group comprises proteins such as Spire, Cordon bleu (Cobl), and Leiomodin
(Lmod) [11,12]. Each member possesses tandem repeats of G-actin binding motifs (typ-
ically WH2 domains) [11], which function in nucleation by recruiting actin monomers
to form the polymerization nucleus [17].
2.3 Regulation of Arp2/3 complex by NPFs
The Arp2/3 complex promotes actin nucleation weakly, but it can be activated by
a class of proteins termed NPFs. Most mammalian NPFs are members of the (Class
I) WASp/WAVE family, which comprises ten proteins. WASp was identiﬁed as the
product of the gene mutated in human patients with WiskottAldrich Syndrome and
is restricted to haematopoietic cells. Its closest homolog N-WASp and the more dis-
tant relatives WAVE1-3 (also known as SCAR proteins) are ubiquitously expressed
in other cells and tissues. In the last years, further NPFs called WASp and Scar
homolog (WASH) (also known as WASHC1), WASp homolog associated with actin,
membranes and microtubules (WHAMM) and junction-mediating and regulatory pro-
tein (JMY) have been identiﬁed, but little is known about their biochemical regulation
and cellular function [18]. Moreover, evolutionary investigation of WASp family mem-
bers in other organisms has revealed three other families of WASp proteins known
as WHAMY, WAML (WASp and MIM-like) and WAWH (WASp without WHI do-
main) [19]. All members of this family are diverse in their overall domain organization
but share a WCA (WH2 domain, connector region, acidic region) catalytic module at
the C-terminal region, required for potent activation of Arp2/3-mediated actin nucle-
ation (Figure 2.4) [3, 20]. The WH2 domain is an actin monomer-binding motif and
enables actin polymerization onto the barbed end, whereas the connector and acidic
region mediate binding to Arp2/3. This interaction faciliates a conformational change
of the Arp2/3 complex, which brings Arp2 and Arp3 into proximity. Subsequently, the
WH2 domain presents an actin monomer to Arp2/3, thereby enhancing the formation
of a nucleus required for polymerization of a new actin ﬁlament [3].
A second class of NPFs (Class II) binds actin ﬁlaments instead of actin monomers and
are best represented by Src kinase substrate cortactin [20].
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Figure 2.4: Scheme of Arp2/3 complex activation and recycling. Overview of branching
nucleation depicting the required reaction components (Arp2/3 complex in blue, actin in red, NPFs
indicated with WCA). The Arp2/3 starts in an inactive state. (Step 1) Binding of two WCA domain
facilitates a conformational change in the Arp2/3 complex that leads to complex activation. WCA
motif presents an ATPactin monomer to the complex and/or possibly to the fast growing (barbed)
end of the pre-existing actin ﬁlament. (Step 2) ATP hydrolysis occurs on Arp2 concomitant with or
shortly after nucleation of the new (daughter) ﬁlament and the WCA domain dissociates from the
complex. (Step 3) Phosphate is released from Arp2 and mother as well as daughter ﬁlaments elongate.
(Step 4) The interactions between Arp2/3 complex and the daughter and/or the mother ﬁlament are
weaken (Step 5) leading to branch disassembly and release of the Arp2/3 complex. (Step 6) Nucleotide
exchange on Arp2 occurs and the cycle restarts from step 1 [3].
2.3.1 WASH
The gene encoding for WASH was discovered as one of several subtelomeric genes in
humans [21] and is conserved from simple eukaryotes such as Dictyostelium to humans.
The modular organization of WASH includes N-terminal localization domains WASH
homology domain (WHD) 1 and tubulin-binding WDH2 followed by a proline-rich re-
gion (PP) and the C-terminal WCA unit [18] (Figure 2.5). WASH is intrinsically inac-
tive and functions in a heteropentameric complex (WASH regulatory complex (SHRC))
containing strumpellin, FAM21A, KIAA1033, and CCDC53, which show sequence ho-
mology to components of the WAVE complex [22]. Moreover, both complexes share
similarities in shape and size as determined by electron microscopy [19].
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Figure 2.5: Domain organization of WASH, WHAMM and JMY. The C-terminus of each
NPF is characterized by Arp2/3-binding CA-modules linked N-terminally to diﬀerent numbers of actin
monomer-binding sites (WH2 domains). The divergent N-termini mediate subcellular targeting. [19].
Initial mutation experiments of WASH in Drosophila showed an impairment of oo-
genesis and larval development [21, 23] and deletion of WASH in mice led to early
embryonic lethality [24, 25]. In contrast to the these data, a recent report shows that
homozygous wash mutant ﬂies are viable and fertile [26]. Mutations in the genes of
individual subunits (e.g. strumpellin and KIAA1033) have been linked to intellectual
disability syndromes [27,28], and separate mutations in strumpellin caused hereditary
spastic paraplegia [29].
A number of subcellular and ribonucleic acid (RNA) interference studies in mammalian
cells revealed that WASH associates with endosomes regulating sorting and maturation
steps of endocytic vesicles. WASH inactivation induced endosome tubulation [30, 31],
a collapse of the endolysosomal system [24], and studies in Drosophila exhibited a role
for WASH in integrin receptor recycling and lysosome acidiﬁcation [26].
Experimemts performed in Dictyostelium showed that WASH drives the retrieval of the
vacuolar ATPase from post-lysosomal compartments [32], and regulates the recycling
of membrane components from macropinosomes and phagosomes [33]. Furthermore,
it was demonstrated that WASH is recruited to retromer-enriched endosomal subdo-
mains via an interaction of FAM21 with the retromer subunit VPS35 [34]. A mutation
in VPS35 displayed a reduced interaction of the SHRC with VSP35 and impaired
vesicular traﬃcking from the late endosomes [35, 36]. WASH and the Arp2/3 com-
plex regulate endosome shape and traﬃcking by actin polymerization [31], however,
vesicle scission at WASH-containing endosomes requires also the coordinated action of
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microtubules and the endoplasmic reticulum (ER) [3740]. Other essential but con-
troversial roles of WASH have been recently described in autophagy (Chapter 4.2.2).
These aspects will be further discussed in Chapter 2.5.2.
2.3.2 WHAMM
WHAMM is another actin-binding protein that is expressed in virtually all human
and mouse tissues [18]. It localizes to the cis-Golgi apparatus as well as tubulo-vesicular
membrane transport intermediates and has been described to drive vesicle traﬃc be-
tween the ER and the Golgi (ER-Golgi intermediate compartment (ERGIC)). The
modular organization of WHAMM includes an N-terminal WHAMM membrane inter-
action domain (WMD), a coiled-coil (CC) microtubule-binding domain, a PP sequence,
and a C-terminal WWCA motif involved in regulating actin nucleation (Figure 2.5).
WHAMM is <20% similar to other Class I NPFs, but is roughly 35% identical and
50% similar to JMY, another NPF that controls p53-mediated apoptosis (Chapter
2.3.3) [20]. Recent studies have been shown that G-proteins have the ability to in-
teract with WHAMM. The ﬁrst report displayed that WHAMM acts downstream of
RhoD and is required for RhoD-dependent actin reorganization [41]. The second study
demonstrated that the G-protein Rab1 inhibits WHAMM-mediated actin assembly in
vitro. Active Rab1 recruited WHAMM to tubulovesicular structures through an inter-
action with the WMD [42].
Cryoelectron microscopy unveiled that WHAMM binds to the outer surface of mi-
crotubule protoﬁlaments through an interaction between its CC region and tubulin
heterodimers. Upon microtubule binding, the N-terminal WMD was exposed at the
microtubules periphery, thereby recruiting vesicles, which are remodelled into tubular
structures. In contrast, microtubule binding masked the C-terminal WWCA domain,
thus preventing actin polymerization [43]. Furthermore, recent ﬁndings have identiﬁed
that WHAMM is another NPF involved in autophagy [44,45] (Chapter 2.5.2).
2.3.3 JMY
The last NPF interesting for this study is the multifunctional actin nucleator called
JMY that is most closely related to WHAMM [18]. It was shown that JMY localizes
to lamellipodia in migrating cells, and its loss slowed motility while its overexpres-
sion enhanced cell migration [46]. Moreover, recent data showed that JMY localizes
to vesiculo-tubular structures throughout the cytoplasm and partially interacts with
vesicle-associated membrane protein-associated protein-A (VAP-A), a protein impli-
cated in ER/Golgi vesicle transport [47]. JMY was initially discovered as a p300
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cofactor that facilitates the p53 response by augmenting p53-dependent transcription
and apoptosis [48]. It was found to carry a WCA domain containing a series of WH2
motifs (WWWCA) that promotes in vitro actin nucleation. Moreover, it possesses a
PP and a CC sequence at its N-terminus (Figure 2.5). JMY is a dual function protein
as it nucleates actin ﬁlaments in the presence and absence of Arp2/3 complex [18].
It directly nucleates unbranched actin ﬁlaments but also cooperates and activates the
Arp2/3 complex to polymerize branched actin ﬁlaments [46, 49]. Under basal, non-
stressed conditions, JMY localizes at the leading edge of a cell, but in response to
deoxyribonucleic acid (DNA) damage it accumulates in the nucleus and promotes p53-
dependent apoptosis [46, 50]. This subcellular localization is controlled by a nuclear
localization sequence, which has been found within the tandem WH2 domains [50].
Overexpression experiments exhibited that JMY aﬀects integrity of the Golgi network
by loss from the trans-site and impaired Vesicular stomatitis virus (VSV)-G transport
in HeLa cells [47].
As WASH and WHAMM, recent publications link JMY to autophagy. It enhances
the formation of autophagosomes based on its function as Arp2/3 regulator (Chapter
2.5.2).
2.4 Actin cytoskeleton manipulation by microbial pathogens
Bacteria and viruses comprise a group of highly infectious human pathogens. They
possess unique adaptations that support intracellular lifestyles and have evolved nu-
merous ways to subvert the host molecular signaling machinery. Microbial pathogens
utilize mechanisms that support key infection events including invasion, replication,
immune evasion, and dissemination [51]. To accomplish this, they hijack the cytoskele-
ton and modulate actin dynamics at the plasma membrane or in the cytosol [52].
One example for the stimulation of actin assembly is the manipulation of pathways
governed by Rho-family GTPases [52]. Rac1 and Cdc42 are best known for Arp2/3
complex activation through proteins of the WASp/WAVE family [53]. Microorganisms
modify eukaryotic GTPases, thereby manipulating various cellular pathways to favor
microbial colonization and/or proliferation, which ﬁnally results in parasitizing and
even killing the host cell [54].
Upon contact, pathogens such as Salmonella and Shigella express specialized virulence
proteins known as eﬀector proteins, which can be delivered into the host cell cytoplasm.
These proteins help the bacteria to invade the host through directly or indirectly tar-
geting the Arp2/3 complex by either mimicking NPFs or cellular upstream regulators
of actin polymerization [52, 55]. The delivery of eﬀector proteins from Salmonella
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or Shigella into eukaryotic cells is a key feature of virulence and is conferred by a
type III secretion system. This complex macromolecular machine transfers eﬀector
toxins directly from the bacterium into the host cell cytosol [56]. Salmonella is one
prominent example that comprises several eﬀector proteins. These toxins directly or
indirectly manipulate actin or regulators of the actin polymerization machinery such as
SipA, which promotes actin ﬁlament polymerization as well as prevents depolymeriza-
tion [52,57]. Other bacteria (e.g. Listeria or Yersinia) do not secrete virulence factors
to stimulate their uptake but instead induce host-cell receptors or employ receptors at
the sites of bacterial attachment and invasion [52]. However, Listeria monocytogenes
and Shigella ﬂexneri possess proteins that activate the Arp2/3 complex (i.e. act as
NPFs) to promote intracellular motility, cell-to-cell spread, and rapid dissemination
in the infected host [55]. In contrast to intracellular bacteria, pathogenic E. coli and
Helicobacter pylori subvert actin polymerization from outside to facilitate adherence
(actin pedestal formation). Extracellular pathogens such as enterohemorrhagic E. coli
and enteropathogenic E. coli manipulate the actin cytoskeleton by their translocated
intimin receptor, which mainly supports the bacteria to bind to the epithelial cell sur-
face [58].
A second major type of pathogenic organisms are viruses, which can convert the nor-
mal functions of a cell to optimize its own replication as well as production. They
are capable to reconﬁgure and reorganize the host actin cytoskeleton, thereby aﬀecting
every stage of the viral life cycle: Entry, assembly, and egress [59]. The ﬁrst links be-
tween viral infection and changes of the actin cytoskeleton were described in the early
1970s [6062]. Amongst others, cell lines exhibited diminished microﬁlaments and dis-
rupted stress ﬁbres, which involves actin remodelling mediated by Rho proteins and
Rho-associated protein kinases (ROCKs) [59]. Actin is routinely engaged and exploited
by infective viruses such as Respiratory syncytial virus (RSV), Simian virus 40 (SV40)
and Herpes simplex virus type 1 (HSV-1). Current data suggest that F-actin is crucial
for RSV assembly and budding [63]. The SV40 small tumor antigen induced disor-
ganization of the actin cytoskeleton and loss of tight junctions in epithelial cells [64].
Moreover, it is known that early events (e.g. cell surface attachment) in the herpesvirus
life cycle trigger cytoskeletal rearrangements that promote eﬃcient virus entry. HSV-1
virus particles utilize a phagocytosis-like entry pathway and attachment to ﬁbrob-
lasts activated Cdc42 and RhoA, resulting to ﬁlopodium-like protrusions from the cell
membrane. It was further shown that HSV-1 virus particles preferentially associated
with these protrusions and treatment with actin-depolymerizing drugs blocked HSV-1
internalization [65].
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2.5 Autophagy
Autophagy literally means "self-eating" and is a self-degradative process that hap-
pens inside all eukaryotic cells. It is crucial for balancing intracellular energy stores at
critical times in development and in response to nutrient stress such as amino acid and
fatty acid starvation. Autophagy also plays a prominent role in removing misfolded,
ubiquitylated proteins, clearing damaged organelles (e.g. mitochondria, ER, and per-
oxisomes) as well as in eliminating intracellular pathogens such as bacteria [66]. More-
over, autophagy malfunction is associated with a variety of diseases, including cancer,
certain neurodegenerative disorders, infectious diseases, and metabolic diseases such
as diabetes [67, 68]. There are three main types of autophagy in mammalian cells:
macroautophagy, microautophagy, and Chaperone-mediated autophagy (CMA) (only
occurs in mammalian cells)(Figure 2.6), all of which facilitate proteolytic degradation
of cytosolic components at the lysosome [66, 69]. Microautophagy is characterized
by direct lysosomal engulfment of the cytoplasmic cargo by invagination or protru-
sion/septation of the lysosomal limiting membrane. CMA involves selective degrada-
tion of cytosolic proteins that contain a pentapeptide motif. This motif is recognized
speciﬁcally by the chaperone Hsc70, which transfers protein substrates to the lysoso-
mal membrane. Protein substrates bind to the receptor lysosome-associated membrane
protein 2A (LAMP2A) and translocate into the lysosomal lumen for degradation.
In this work, I will focus on macroautophagy (referred to here as autophagy) that in
contrast to microautophagy and CMA involves sequestration of a cargo and, ﬁnally,
fusion with the lysosome. During this process, cells form a double-membrane seques-
tering compartment (phagophore), which matures into a double-membraned vacuole,
known as autophagosome. The autophagosome ultimately fuses with the lysosome
to form autolysosomes, which supply acid hydrolases resulting in degradation of the
cargo [6770].
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Figure 2.6: Schematic depiction of the three main types of autophagy. Macroautophagy
degrades soluble proteins, damaged organelles, and protein aggregates upon their sequestration into
a de novo-formed double membrane vesicle (termed autophagosome) that fuses with the lysosome
to form a structure known as autolysosome. (B) Microautophagy also degrades soluble proteins and
damaged organelles by direct lysosomal engulfment in small vesicles that are formed from invaginations
or protrusion/septation of the lysosomal membrane. (C) CMA contributes to the selective degradation
of soluble proteins, which are targeted to lysosomes without any type of membrane deformity [71].
2.5.1 Molecular regulation of autophagy in mammalian cells
Autophagy is an evolutionarily conserved pathway and genetic screens in Saccha-
romyces cerevisiae set the basis for studies in mammalian cells. They also led to the
identiﬁcation of more than 30 autophagy-related (ATG) genes, many of which have
known orthologs in higher eukaryotes [69,70].
Autophagy starts with the formation of a double membrane structure termed phagophore
or isolation membrane (Figure 2.7). Various studies have implicated several membrane
sources that make up the phagophore such as ER, mitochondria, the Golgi apparatus,
and the plasma membrane [72].
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Figure 2.7: The process of autophagy in mammalian cells. During starvation, autophagy is
initiated by the Unc-51-like kinase family (ULK1/2) complex and nucleation of the phagophore occurs.
This double membrane structure elongates with the help of the ATG12ATG5-ATG16L1 complex,
the class III phosphatidylinositol 3-kinase (PtdIns3K) complex, LC3-II, and ATG9. The expanding
phagophore closes around its substrate to form an autophagosome and LC3-II is cleaved from the
outer membrane. The autophagosome then fuses with a lysosome to form an autolysosome. The inner
membrane of the autophagosome, along with engulfed compounds, are degraded by acid hydrolases
and exported back into the cytoplasm for reuse by the cell. In some cases, the autophagosome receives
input from the endocytic pathway and may fuse with an endosome. The resulting amphisome fuses
with the lysosome [68].
In yeast, initiation of autophagy begins at a single perivacuolar site termed phagophore
assembly site, whereas in mammalian systems the initiation takes place at multiple
sites througout the cytoplasm [68, 72]. It was shown that ER-subdomains enriched
in phosphatidylinositol 3-phosphate (PI3P), called omegasomes, are a major initia-
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tion site in mammalian cells [70, 73, 74]. Following the induction of autophagy, the
phagophore begins to expand and then closes to an autophagosome [68,70]. Its diam-
eter ranges from 0.4 to 0.9 µm in yeast and 0.5 to 1.5 µm in mammals [68]. The outer
membrane of these double-membrane vesicles will fuse with lysosomes to release their
cargo into the acidic and hydrolytic lumen of these organelles. Exposed to the acidic
environment, the autophagosome inner membrane as well as the autophagic content
(e.g. proteins, lipids, nucleic acids) are degraded and exported back into the cytoplasm
through lysosomal permeases and transporters, where they can be reused in biosyn-
thetic processes or to generate energy [68, 75]. In mammals, the autophagic pathway
intersects with the endocytic pathway when autophagosomes fuse with early or late
endosomes forming amphisomes, which then fuse with lysosomes to generate autolyso-
somes [68]. Important to highlight is that all these events such as autophagosome
maturation, intracellular transport, and fusion with lysosomes and endosomes involves
actin- and microtubule-mediated motility [76]. There are four steps in the autophagic
process: induction, nucleation, expansion, and maturation (see the following).
Induction. Induction of autophagosome formation in mammals is regulated by the
ULK1/2 complex, which consists of ULK1/2-ATG13-RB1CC1/FIP200 [68]. Directly
bound to ATG13 is C12orf44/ATG101 that protects ATG13 from proteasomal degra-
dation [77]. Under nutrient-rich conditions, the key upstream negative regulator of
autophagy termed mammalian target of rapamycin complex 1 (mTORC1) associates
with the complex and inactivates ULK1/2 and ATG13 by phosphorylation. Upon
nutrient starvation, mTORC1 is released from the complex, resulting in partial de-
phosphorylation of its substrates and induction of autophagy [68,78].
Nucleation. The next step following the initiation of autophagy is the recruitment
of the ATG14-containing class III PtdIns3K complex that phosphorylates phospha-
tidylinositol to generate PI3P, a phospholipid central for membrane traﬃcking pro-
cesses [68,79]. The formation of phagophores requires the class III PtdIns3K complex,
which consists of PIK3C3/VPS34, PIK3R4/p150, and Beclin 1. The complex either
functions in autophagy or in the endocytic pathway by interacting with UVRAG.
The UVRAG-associated PtdIns3K complex was shown to play an essential role in au-
tophagosome formation, but also in later stages of autophagosome development [68].
Elongation. Phagophore expansion requires ubiquitin-like proteins, which are part of
two distinct conjugation systems. The ﬁrst system involves formation of the ATG5,
ATG12 and ATG16L1 complex that associates with the phagophore membrane, but dis-
sociates from fully formed autophagosome [68]. The second ubiquitin-like system cru-
cial for phagophore expansion is the Atg8/microtubule associated protein 1 light-chain
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3 (MAP1LC3) system (hereafter referred to as LC3) that is associated with closure,
hemi-fusion, or transport of the autophagosome during its maturation [80]. Atg8/LC3
is processed by the protease ATG4(B) to expose a C-terminal glycine residue. The
cleaved form of LC3 is referred to as LC3-I and is then phosphatidylethanolamine (PE)-
conjugated by sequential activation of Atg7 (E1-like enzyme), Atg3 (E2-like enzyme),
and the Atg12 complex. The lipid-modiﬁed form of LC3 is called LC3-II, and can be
degraded during autophagy. LC3 itself is a widely used marker to monitor autophagic
ﬂux [68,80]. Although there is only one Atg4 and one Atg8 protein in yeast, there are
four isoforms of ATG4 and several Atg8-like proteins in mammals. The latter are clas-
siﬁed into the MAP1LC3-A/-B/-C, GABARAP, and GABARAP-L1/-L2 subgroups,
however the functional characterization has mostly been focused on LC3 [80]. Another
ATG protein that is required for phagophore elongation is the multi-spanning trans-
membrane protein ATG9. It has a key role in directing membrane sources from donor
organelles such as ER or Golgi for autophagosome formation [81]. Under nutrient-
rich conditions, ATG9 travels to the trans-Golgi network (TGN) and the endosomal
system. Upon nutrient starvation, ATG9 localizes with autophagosomal marker (e.g.
LC3) [68,82].
Autophagosome completion and fusion. Once the phagophore is fully expanded,
it is sealed to form an autophagosome, which traﬃcs to and fuses either directly with
a lysosome or with components of the endocytic pathway, such as endosomes or mul-
tivesicular bodies [76].
2.5.2 NPFs and their role during autophagy
It was demonstrated that the actin cytoskeleton is necessary during early events of
autophagsome formation and reports on WASH, WHAMM, and JMY conﬁrmed a link
between the Arp2/3 complex and mammalian autophagy [19,83].
The pentameric WASH complex colocalizes with autophagic markers such as Atg5,
LC3-II and p62, and data revealed a role of WASH in the early stages of autophagy [76].
However, its role in autophagy appears controversial. In the ﬁrst report, WASH-
complex deﬁciency causes early embryonic lethality at embryonic day 7.5 and mutant
mice exhibited extensive autophagy. WASH suppressed Beclin 1 ubiquitination by
Ambra1, an event required for the activation of VPS34 [25]. A follow-up study iden-
tiﬁed that the E3 ligase RNF2 associates with AMBRA1 leading to its ubiquitination
and degradation with the help of WASH [84]. A more recent report showed that loss
of WASH function in Drosophila also leads to a dramatic increase of autophagy [26].
Interestingly, another study revealed that WASH functions to promote autophagy.
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Short interfering RNA (siRNA)-mediated silencing of WASH causes an accumulation
of ATG9A at the Golgi apparatus and a mild, but statistically signiﬁcant decrease
of LC3-positive structures in nutrient-starved cells, indicating an impaired ATG9A
traﬃcking, which is required for autophagosome biogenesis [36]. Future investigations
should clarify whether WASH is a positive or negative regulator of autophagy.
The two related NPFs, WHAMM and JMY, were also described in autophagosome bio-
genesis [44,85]. WHAMM colocalizes with autophagy markers (i.e. LC3, DFCP1, and
p62) and additionally to Arp2/3 complex-enriched actin comet tails. Gene silencing of
WHAMM resulted in fewer actin comet tails, and reduced the number of autophago-
somes. Deleting the ﬁrst 169 amino acids impaired autophagosome localization and led
to the assumption that WHAMM interacts with the phagophore membrane through
its N-terminal region [44]. Recently, WHAMM has also been implicated in an inherited
disorder called Galloway-Mowat syndrome (GMS). Patient cells harbor mutations in
the wdr73 as well as the closely linked whamm gene and exhibit cytoskeletal irreg-
ularities and defects in autophagosome biogenesis. Reexpression of wild type (WT)
WHAMM restored defects in autophagy in patient cells. In addition, the study showed
that WHAMM is recruited to nascent autophagosomes by binding to PI3P, a key player
in membrane dynamics and traﬃcking regulation [45,86].
JMY was shown to enhance the formation of elongated membranes containing LC3,
suggesting a participation in the autophagy maturation process. As observed for
WHAMM, removal of the ﬁrst amino acids (119) of JMY caused a loss of autophago-
some localization. It has been discovered that JMY harbors an LC3-interacting re-
gion (LIR) within its N-terminus, which targets the protein to LC3-containing au-
tophagosome. Mutation of the LIR resulted in lack of autophagosomal localization of
JMY and prevented its colocalization with foci of F-actin. Gene silencing by siRNA
or mutations that abrogate JMY´s ability to activate Arp2/3 resulted in decreased
LC3-II levels and reduced the number of autophagosomes [85].
2.6 CRISPR/Cas9 gene editing
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9
was originally discovered in bacteria and archaea as an adaptive immune system as
a way of protecting against viruses and plasmid DNA. It uses RNA-guided nucleases
to cleave these foreign genetic elements. Short DNA sequences from invaders are in-
corporated at CRISPR loci within the bacterial genome and serve as "memory" of pre-
vious infection (Figure 2.8). Re-infection triggers the complementary mature CRISPR
RNA (crRNA) to ﬁnd a matching sequence, providing RNA-guided Cas nuclease the
speciﬁcity to form a double-strand break at speciﬁc foreign nucleic acids [87].
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Figure 2.8: The three major phases of CRISPR/Cas immune systems. The key steps
of CRISPR/Cas immunity comprise adaptation, expression and interference. 1.) Adaptation: Cas
proteins excise the new spacer derived from foreign DNA and insert it into the CRISPR locus. 2.)
Expression: The CRISPR sequence is transcribed and processed into multiple short crRNA molecules,
each harboring a single spacer sequence and part of the adjoining repeat sequence. 3.) Interference:
The crRNAs are assembled and associate with and guide bacterial molecular machinery to a matching
target sequence of either invading element or their transcripts. The molecular machinery cuts up and
destroys the invading DNA [87,88].
Three types (I-III) of CRISPR have been identiﬁed in bacterial and archaea hosts,
wherein each system comprises a cluster of Cas genes, noncoding RNAs and direct re-
peats (repetitive elements). These repeats are interspaced by short variable sequences
(protospacer) derived from exogenous DNA targets, and together they constitute the
crRNA array. Within the DNA target, each protospacer is associated with a proto-
spacer adjacent motif (PAM), which varies depending on the speciﬁc CRISPR system.
Through this PAM sequence, the Cas9 select its target sites directly 3´of the tar-
get sequence. The CRISPR/Cas9 technology facilitates targeted DNA double strand
breaks at speciﬁc loci of interest and stimulates genome editing via non-homologous
end joining (NHEJ) or homology directed repair (HDR). NHEJ leaves scars in form
of insertion or deletion (indel) mutations that might occur within a coding exon lead-
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ing to frameshift mutations and premature stop codons. HDR is an alternative major
DNA repair pathway and can be leveraged to generate precise, deﬁned modiﬁcations
at a target locus [89].
2.7 Project aims
The actin cytoskeleton is a critical target of many bacteria and viruses at multi-
ple stages of infection. A large number of pathogens utilize actin-based motility to
spread within and between mammalian host cells. This is frequently associated with
hijacking of the Arp2/3 complex, but requires Arp2/3 complex activators, namely
NPFs. Finally, actin cytoskeleton dynamics also appear to play essential roles in au-
tophagy. Autophagy, however, can act as anti-pathogen defense or be utilized by
selected pathogens to promote infection.
Hence, I wanted to elucidate the functional roles of the three most recently identiﬁed
Arp2/3 complex activators (NPFs), which have all been implicated in endomembrane
traﬃc and/or autophagy. Genetic inactivation of these proteins was approached by
generating somatic knockouts (KOs) in tissue cultured cells using the CRISPR/Cas9
technology. On basis of preliminary phenotypic observations and expression proﬁling, I
ﬁnally selected subprojects to uncover the relevance of selected actin regulators during
homeostasis, autophagy, and infection with selected pathogens.
Together, this thesis had the following aims:
1. Establish CRISPR/Cas9 technology-mediated gene inactivation of the NPFs
WASH, WHAMM, and JMY in murine NIH/3T3 ﬁbroblasts as well as in human
U-2 OS cells.
2. Characterize cellular phenotypes of obtained KO cell lines with special em-
phasis on ER- and Golgi morphology as well as on autophagy.
3. Perform transcription proﬁling to identify pathways, which are diﬀerentially
regulated dependent on the respective genotypes.
4. Perform infection assays with selected viruses in WT versus KO cells and
identify provisional alterations of the viral life cycle in the host.
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3.1 Chemicals and buﬀers
3.1.1 Chemicals and reagents
Chemicals, reagents, and solvents were purchased from AppliChem, Invitrogen, J.T.
Baker, Biochrom, Calbiochem, Merck Millipore, New England Biolabs, Promega, Qia-
gen, Roche, Roth, Serva, Sigma-Aldrich and Thermo Fisher Scientiﬁc. The analytical
purity was per analysis. Special equipment, consumables, and chemicals are listed in
the corresponding paragraphs.
3.1.2 Buﬀers
All buﬀers were prepared with deionized water and, if suitable, autoclaved prior
to use. Deionized water was puriﬁed by a Milli-Q-System (Merck Millipore). Heat-
sensitive components were sterile-ﬁltered and added to the autoclaved medium. Buﬀers
not listed below (Table 3.1), are listed in the corresponding method description.
Table 3.1: Buﬀers
Name Components
Amplex lysis buﬀer I 50mM Tris
2mM CaCl2
80mM NaCl
1% (v/v) Triton X-100
Amplex lysis buﬀer II 100mM Tris
2mM CaCl2
100mM NaCl
1% (v/v) NP-40
Buﬀer A, pH 7.5 50mM Tris
150mM NaCl
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5mM MgCl2
1mM DTT
Elution buﬀer 50mM Tris, pH 8.0
10mM reduced glutathione
Flow cytometry buﬀer Phosphate buﬀered saline (PBS), 1x
2% (v/v) FBS
2mM EDTA
DNA lysis buﬀer 100mM Tris, pH 8.5
5mM EDTA, pH 8
0.2% (w/v) SDS
200mM NaCl
NP-40 lysis buﬀer 50mM Tris-HCl, pH 8
100mM NaCl
2mM MgCl
1% (v/v) Nonidet P-40
100mM NaF
1mM Na3VO4
1x Protease inhibitor cocktail
10% (v/v) Glycerol
PBS, 1x, pH 7.4 137.9mM NaCl
2.7mM KCl
8mM Na2HPO4
1.5mM KH2PO4
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Resolving buﬀer 1.5M Tris, pH 8.8
0.4% (w/v) SDS
SDS loading buﬀer, 8x 1.5M Tris-HCl, pH 6.8
16% (w/v) SDS
0.5% (w/v) Bromophenol blue
33% (v/v) ß -Mercaptoethanol
SDS running buﬀer, 1x 25mM Tris, pH 6.8
192mM Glycine
0.1% (w/v) SDS
Stacking buﬀer 0.5M Tris, pH 6.8
0.5% (w/v) SDS
Tris-acetate EDTA (TAE) buﬀer, 1x 40mM Tris base
20mM Acetate
1mM EDTA
Tris-buﬀered saline with Tween (TBS-T)-20 20mM Tris-HCl, pH 7.6
1x 137mM NaCl
0.1% (v/v) Tween-20
Tris lysis buﬀer 50mM Tris, pH 7.5
150mM NaCl
1mM EDTA
1% (v/v) Triton X-100
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3.2 Bacterial culture
3.2.1 Bacterial strains
The following bacterial strains were used in this study (Table 3.2). Liquid bacterial
cultures were grown in Lysogeny broth (LB) medium at 37C with agitation (Infors).
Table 3.2: Bacterial strains
Bacterial strain Source Application
Escherichia coli (E. coli) Melanie Brinkmann Transformation
DH5 HZI, Braunschweig
E. coli TOP10 Ingo Schmitz Transformation
HZI, Braunschweig
E. coli BL21 (DE3) Susanne Häußler Transformation
HZI, Braunschweig Protein puriﬁcation
E. coli Rosetta Novagen Protein puriﬁcation
(Chloramphenicol (Cm) resistance)
3.2.2 Bacterial media and antibiotics
All media were prepared with deionized water and autoclaved prior to use. Respec-
tive antibiotics were added from sterile ﬁltered stock solutions after the medium had
cooled down below 50°C.
Table 3.3: Bacterial media and antibiotics
Name Concentration/Component
LB medium 10 g/L bacto-tryptone
5 g/L bacto-yeast extract
10 g/L NaCl
LB agar plates 0.4% (w/v) agar in LB medium
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Ampicillin (Amp) 100 µg/mL
Kanamycin (Kana) 50 µg/mL
Cm 25 µg/mL
Gentamycin (Gm) 10 µg/mL
3.3 Molecular biological methods
Molecular biological standard methods were performed according to Maniatis et al.
[90], if not stated otherwise. (Restriction) Enzymes and the appropriated buﬀer were
obtained from Epicentre, New England Biolabs, Promega, Roche and Thermo Fisher
Scientiﬁc.
3.3.1 Oligonucleotides
All oligonucleotides used in this study were purchased from Eurogentec. Oligonu-
cleotides were diluted in deionized water and stored as 100 µM stock solutions at -20°C.
Single guided ribonucleic acid (sgRNA) molecules were designed with the help of the
online tools crispr.mit.edu and crispr.cos.uni-heidelberg.de to target the gene of interest
(Table 3.4).
Table 3.4: sgRNAs applied for gene editing
Target Organism Exon Sequence
WASH Mouse 2 top GCGACGAGAGGAGGCAATCC
bottom GGATTGCCTCCTCTCGTCGC
WHAMM Mouse 1 top GTGGCTGGGTTCCGCTGCGTG
bottom CACGCAGCGGAACCCAGCCAC
JMY Mouse 1 top GGAGACACTCGAGTCCGACT
bottom AGTCGGACTCGAGTGTCTCC
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WASH Human 4 top TCTTCACGGGCGCCCAGGAC
bottom GTCCTGGGCGCCCGTGAAGA
5 top GTGTGCGTGAGCACCAAGCC
bottom GGCTTGGTGCTCACGCACAC
WHAMM Human 2 top AGAGGAAGATGAAGCATACC
bottom GGTATGCTTCATCTTCCTCT
3 top GGATGACCTAGGTCCTAGAA
bottom TTCTAGGACCTAGGTCATCC
JMY Human 2 top GCTTCTGGACTTGTATCAGA
bottom TCTGATACAAGTCCAGAAGC
4 top GAAATTTGGTAAAGCATCAT
bottom ATGATGCTTTACCAAATTTC
Moreover, oligonucleotides were designed ﬂanking the region of interest in order to
verify gene modiﬁcations (Table 3.5).
Primer used in quantitative polymerase chain reaction (qPCR) are listed in Table 3.6.
Table 3.5: Primer sequences for sgRNA validation
Target Organism Sequence Product size
WASH Mouse fw ATAGGCAGAGGGGTGAGTGT 330 bp
rv ACACTGGGCATTAGTTGGGT
WHAMM Mouse fw TAACCAACTCCAGACAGCCTC 272 bp
rv TCGTGACAGGTGACGGCGAA
JMY Mouse fw GAACCGCTCCTCTGTCTCTG 330 bp
rv ATTGTCTCTTCTGAGAGCCGC
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WASH Human fw GTTCTCCAGTGCCAAGTACC 281 bp
rv GGTTCTCGGTGGTGTTGAAG
WHAMM Human fw GCTGCGCCAGGTTATTCAAG 409 bp
rv CAACCTGGGAATTGCTGTGG
JMY Human fw TGACCGAGCAGGAAATCGAC 343 bp
rv CTCATGTCTCGGAATGGCTG
fw GAAGATGCTGATTGGCAGCG 255 bp
rv GTGCATGTTTCCGCTGTTCC
Table 3.6: Primer sequences applied in qPCR
Target Organism Sequence
DHCR7 Mouse fw GTACCACCCTGTGCAGCTC
rv GGTCCTTCTGATGGTTGGTCAT
SOAT-1 Mouse fw TTATGAAGGAAGTTGGGTGCCA
rv AATGGAGAAGGTTGTGAGTGCA
3.3.2 Plasmid constructs
Plasmids used in this thesis are shown in Table 3.7.
Table 3.7: Plasmid constructs
Vector Resistance Characteristics Reference
pSpCas9(BB)-2A-GFP
(pX458)
Amp Cas9 from S.
pyogenes with
2A-enhanced green
ﬂuorescent pro-
tein (EGFP)
Addgene
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Cloning backbone
for sgRNA
pGEX-6P-3 Amp Provides
Glutathione S-
transferase (GST)
fusion
Pharmacia
pX458-WASH-2-Mouse Amp Encodes sequence
for KO of murine
WASH, Exon2 (see
Table 3.4)
This dissertation
pX458-WASH-4-Human Amp Encodes sequence
for KO of human
WASH, Exon4 (see
Table 3.4)
This dissertation
pX458-WASH-5-Human Amp Encodes sequence
for KO of human
WASH, Exon5 (see
Table 3.4)
This dissertation
pX458-WHAMM-1-Mouse Amp Encodes sequence
for KO of murine
WHAMM, Exon1
(see Table 3.4)
This dissertation
pX458-WHAMM-2-Human Amp Encodes sequence
for KO of human
WHAMM, Exon2
(see Table 3.4)
This dissertation
pX458-WHAMM-3-Human Amp Encodes sequence
for KO of human
WHAMM, Exon3
(see Table 3.4)
This dissertation
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pX458-JMY-1-Mouse Amp Encodes sequence
for KO of murine
JMY, Exon1 (see
Table 3.4)
This dissertation
pX458-JMY-2-Human Amp Encodes sequence
for KO of human
JMY, Exon2 (see
Table 3.4)
This dissertation
pX458-JMY-4-Human Amp Encodes sequence
for KO of human
JMY, Exon4 (see
Table 3.4)
This dissertation
pGEX-6P-3-
WHAMMAA696 809
Amp Encodes GFP-
fused human
WHAMM
This dissertation
pGEX-6P-1-JMYAA824 983 Kana Encodes GFP-
fused VVVCA
domain of murine
JMY
Jan Hänisch, HZI
pEGFP-C2-DFCP1 Kana Encodes GFP-
fused DFCP1
Axe, Babraham In-
stitute [91]
EGFP-C1-ERGIC53 Kana Encodes GFP-
fused ERGIC
Ben-Tekaya [92]
EGFP-C1-VAP-A Kana Encodes GFP-
fused VAP-A
Kai Schlüter, Uni-
versity Münster
3.3.3 Experimental design of sgRNAs and cloning into pX458
Genome editing of murine NIH/3T3 ﬁbroblasts and human U2-OS cells was per-
formed with the CRISPR/Cas9 technology. Selected DNA target sequences were pro-
vided to a CRISPR design tool (CRISPR.mit.edu or CCTop). These online softwares
oﬀer the sequences necessary for designing the sgRNA constructs (20 bp), assay target
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modiﬁcation eﬃciency and assess cleavage at potential oﬀ-target sites [89]. To gener-
ate pX458(sgRNA), a pair of annealed oligonucleotides (Table 3.4) was cloned into the
expression plasmid pX458. This plasmid allows the simultanous expression of sgRNA,
SpCas9 and contains EGFP as a selection marker.
First, the top and bottom strands of oligonucleotides of the diﬀerent sgRNAs were
phosphorylated and annealed according to the following protocol:
100 µM sgRNA top
100 µM sgRNA bottom
1L T4 ligation buﬀer, 10x
1 µL T4 Polynucleotide kinase (10,000U/mL)
ad 10 µL ddH2O
The reaction mixture was incubated in a thermocycler (Biometra, TGradient) using
the following parameters:
37°C for 30min
95°C for 5min
Ramp down to 25°C at 5°C/min
Phosphorylated and annealed oligonuleotides were diluted 1:200 and cloned into pX458:
100 ng pX458
2 µL diluted oligo duplex
2 µL Tango buﬀer, 10x
1 µL Dithiothreitol (DTT), 10mM
1 µL ATP, 10mM
1 µL FastDigest BbsI
0.5 µL T4 DNA ligase (400,000U/mL)
ad 20 µL ddH2O
The reaction mixture was incubated in a thermocycler using the following parameters:
Cycles 1-6, 37°C for 5min, 21°C for 5min
The ligation reaction was then treated with PlasmidSafe to digest any residual lin-
earized DNA:
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11 µL Ligation reaction
1.5 µL PlasmidSafe buﬀer, 10x
1.5 µL ATP, 10mM
1 µL PlasmidSafe exonuclease (10,000U/mL)
ad 15 µL ddH2O
PlasmidSafe reaction was incubated at 37°C for 30min, followed by 70°C for 30min
and stored at -20°C, if necessary.
In order to verify successful cloning from sgRNA into pX458, a double digestion with
FastDigest restriction enzymes BbsI and EcoRV was performed for 20min at 37°C and
checked by agarose gel electrophoresis (Chapter 3.3.4).
1g DNA
2 µL FastDigest buﬀer, 10x
0.5 µL FastDigest BbsI
1 µL FastDigest EcoRV
ad 20 µL ddH2O
3.3.4 Agarose gel electrophoresis
DNA samples were analyzed via agarose gel electrophoresis. The samples were loaded
into pre-cast wells in the gel and a voltage of 120V was applied (Biorad PowerPac Basic
Electrophoresis Power Supply). Due to its negatively charged phosphate backbone,
DNA migrates to the positively charged anode. Depending on the fragment size, 1-2%
(w/v) agarose was dissolved in 1x TAE buﬀer using a microwave. After cooling down
to approximately 50°C, the gel was supplemented with Midori Green, which binds
to DNA, but less aggressively than ethidium bromide. The DNA sample was mixed
with 6x Orange DNA loading dye. Quick-Load® 100 bp and/or 1 kb DNA ladder were
loaded as molecular weight standards to estimate fragment sizes. The detection was
carried out under UV light using Intas GelJet Imager.
3.3.5 Cloning of egfp-whamm into the pGEX-6P-3 vector
In order to produce high levels of WHAMM, EGFP-WHAMMAA696 809 was cloned
into pGEX-6P-3, a bacterial vector expressing GST fusion proteins. In the ﬁrst step,
egfp-whamm was digested with two restriction enzymes for 1 h at 37°C:
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5 µg DNA
2 µL FastDigest buﬀer, 10x
1 µL FastDigest Eco72I
1 µL FastDigest NotI
ad 20 µL ddH2O
The reaction was stopped by heat inactivation for 5min at 80°C and obtained whamm
fragment was analyzed on 2% agarose (Chapter 3.3.4). DNA was cleaned from the
agarose gel with NucleoSpin® Gel kit (Table 3.12) as recommended by the manufac-
turer.
Furthermore, pGEX-6P-3 was digested with SmaI for 1 h at 25°C and NotI for 1 h at
37°C:
1 µg DNA
2 µL FastDigest buﬀer, 10x
1 µL FastDigest SmaI
1 µL FastDigest NotI
ad 30 µL ddH2O
The reaction was stopped by heat inactivation for 5min at 80°C. To avoid undesired
religation of the linearized vector, desphosphorylation was applied for 15min at 37°C:
30 µL DNA
10 µL Antarctic phosphatase reaction buﬀer, 10x
1 µL Antarctic phosphatase (5,000U/mL)
ad 100 µL ddH2O
The reaction was stopped by heat inactivation for 5min at 70°C and linearized pGEX-
6P-3 was analyzed on a 1% (w/v) agarose gel (Chapter 3.3.4). DNA was cleaned as
previously described.
Subsequently, WHAMMAA696 809 was ligated into linearized pGEX-6P-3 resulting in
pGEX-6P-3-WHAMMAA696 809. Ligations were performed overnight at 14°C according
to the following protocol:
0.3 µg plasmid DNA
0.9 µg insert DNA
1 µL Ligation buﬀer, 10x
1 µL T4 DNA ligase (400,000U/mL)
ad 20 µL ddH2O
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pGEX-6P-3-WHAMMAA696 809 was transformed into competent E. coli to allow pro-
tein expression as described in chapter 3.5.3.
3.3.6 Transformation of plasmid DNA into E. coli
Chemically competent E. coli strains (DH5, TOP10 or BL21 (DE3)) were thawed
on ice and mixed with 100 ng DNA. The suspension was incubated on ice for 10min
to allow DNA attachment followed by a heat shock at 42°C for 1min (Thermomixer,
Eppendorf®Model 5436) to induce DNA uptake. Transformed bacteria were incubated
on ice as previously and supplemented with 1mL LB medium. The cell suspension was
incubated at 37°C for 1 h while shaking in order to develop antibiotic resistance. Af-
terwards, bacteria were spun down for 10 s at (Heraeus Biofuge pico), an appropriate
amount of LB medium was removed and the bacterial pellet was resuspended in the
remaining medium. Bacteria were transferred onto pre-warmed LB agar plates with
the appropriate antibiotic for selection and were incubated overnight at 37°C (Incuba-
tor Heraeus instruments).
TOPO® Cloning ligation reaction was transformed into electrocompetent E. coli DH5.
Bacteria were thawed on ice, ligation reaction was added and the suspension was incu-
bated for 2min. Bacteria were given into a 0.2 cm GenePulser electroporation cuvette
(Biorad) followed by electroporation with GenePulser® II (Biorad). Default setting
applied for electroporation was: 25 µF, R = 
 and V = 2.3 kV. Immediately after the
electrical pulse, 1mL LB medium was added and the cell suspension was incubated
at 37°C for 1 h while shaking. Bacteria were spun down and 900 µL of LB medium
were removed. The pellet was resuspended in the remaining 100 µL, spread on LB agar
plates containing kana and incubated overnight at 37°C.
3.3.7 Isolation of plasmid DNA from E. coli
Plasmid DNA was isolated using a kit from Macherey & Nagel (Table 3.12) following
the manufacturer´s instructions. DNA concentration and purity was determined by
DeNovix Spectrophotometer.
3.3.8 Genomic DNA isolation
Single colony-derived strains were expanded and cultivated to 90% conﬂuency. Stan-
dard trypsinization was performed and cells were lysed adding 200 µL DNA lysis buﬀer
containing 0.5mg /mL proteinase K (20mg/mL). Samples were incubated overnight
at 55°C with agitation. Nucleic acid extraction was performed by a standard ethanol
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precipitation procedure. 700 µL 100% ice-cold ethanol were added and samples were
centrifuged at 16,000 xg at 4°C for 30min (Thermo Fisher Scientiﬁc, Fresco 21). The
supernatant was removed and samples were washed with 400 µL 70% ice-cold ethanol.
Samples were dried at 45°C for 20min. Subsequently, 100 µL deionized water were
added and DNA was dissolved at 4°C overnight. Next day, DNA concentration and
purity was determined as previously.
3.3.9 PCR
Ampliﬁcation of murine genes by PCR
Isolated genomic DNA from NIH/3T3 KO cells was used as template in a PCR. PCR
reactions were carried out in 50 µL volume in PCR strips (Kisker, G003-SF) and re-
action cycles were performed in a thermocycler (PeqStar). Ampliﬁcation of DNA was
performed using GoTaq G2 ﬂexi DNA polymerase. Primer employed in PCR reactions
are listed in Table 3.5. Reaction set ups and temperature programs for murine genes
are listed in Table 3.8 and Table 3.9, respectively. Taq DNA polymerase exhibits 5´-3´
exonuclease activity and allows an DNA extension of 1 kb/60 s. To overcome ampliﬁca-
tion failure and low DNA yield, the PCR-enhancing agent Dimethylsulfoxide (DMSO)
was applied. It is used as an additive to aid PCR ampliﬁcation of GC rich targets.
PCR products were analyzed via agarose gel electrophoresis (Chapter 3.3.4). To avoid
any residual enzyme activity, appropriate PCR products were either puriﬁed from re-
action mixtures with PCR clean-up kit or from agarose gels (Table 3.12) as previously
described following the manufacturer´s recommendations.
To screen and identify gene mutations in the DNA of potential NIH/3T3 KO cells,
puriﬁed PCR products were cloned into a sticky end TOPO vector for 5 min at room
temperature according to the following protocol:
2 µL DNA
1 µL salt
0.5 µL pCR4-TOPO® vector
2.5 µL ddH2O
DNA was ﬁnally transformed into electrocompetent bacteria as described in chapter
3.3.6.
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Table 3.8: PCR reaction mixtures of murine WASH, WHAMM and JMY
Component Final concentration
DNA template 1 ng/µL
5x Colorless GoTaq® Reaction Buﬀer 1x
Forward primer, 10 µM 0.2 µM
Reverse primer, 10µM 0.2 µM
MgCl2, 25mM 2mM
Deoxyribonucleotide triphosphates (dNTPs), 10mM 0.2mM
DMSO 3%
Polymerase, 5U/µL 0.05U/µL
Sterile deionized H2O ad 50 µL
Table 3.9: PCR cycling program of murine 1WASH, 2WHAMM and 3JMY
Step Purpose Condition
1 Initial denaturation 95°C for 120 s
2 Denaturation 95°C for 30 s
3 Primer annealing 160.7°C for 30 s
265.7°C for 30 s
367°C for 30 s
4 DNA elongation 1;372°C for 40 s
268°C for 40 s
5 Repetion steps 2-4 35x
6 Final DNA elongation 1;372°C for 5min
268°C for 5min
7 Stop of reaction 4°C (Hold)
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Ampliﬁcation of human genes by PCR
Inspection of human U-2 OS cells was performed with complementary DNA (cDNA)
as template in a PCR. Therefore, RNA was isolated and used to generate cDNA by a
reverse transcription PCR (Chapter 3.3.10). PCR reactions were carried out as previ-
ously described. Primer employed in PCR reactions are listed in Table 3.5. Reaction
set ups and temperature programs for human genes are listed in Table 3.10 and Table
3.11, respectively.
Table 3.10: PCR reaction mixtures of human WASH, WHAMM and JMY
Component Final concentration
cDNA template 1 ng/µL
5x Colorless GoTaq® Reaction Buﬀer 1x
Forward primer, 10 µM 0.2 µM
Reverse primer, 10µM 0.2 µM
dNTPs, 10mM 0.2mM
Polymerase, 5U/µL 0.05U/µL
Sterile deionized H2O ad 50 µL
Table 3.11: PCR cycling program of human 1WASH, 2WHAMM and 3JMY
Step Purpose Condition
1 Initial denaturation 95°C for 120 s
2 Denaturation 95°C for 30 s
3 Primer annealing 1;2;362°C for 30 s
4 DNA elongation 72°C for 40 s
5 Repetion steps 2-4 35x
6 Final DNA elongation 72°C for 5min
7 Stop of reaction 4°C (Hold)
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3.3.10 RNA extraction, cDNA synthesis and qPCR
For successful validation of human KOs by conventional PCR, 5x105 cells were seeded
onto 6-well plates and grown for 24 h. RNA was isolated using RNeasy Mini kit (Ta-
ble 3.12) according to the manufacturer´s recommended protocol. RNA was applied
as template in a reverse transcription reaction to synthesize cDNA using transcriptor
ﬁrst strand cDNA synthesis kit (Table 3.12) following the manufacturer´s instruc-
tions. cDNA served as template in a PCR reaction (Chapter 3.3.9). RNA isolation,
cDNA synthesis, and PCR were performed with the help of Annette Otto (HZI, Braun-
schweig).
For qPCR, cells were seeded and total RNA was isolated using NucleoSpin RNA Plus
kit (Table 3.12) according to the manufacturer´s recommended protocol. cDNA synthe-
sis and qPCR were performed simultaneously using SensiFASTTM SYBR® No-ROX
One-Step Kit (Table 3.12) according to the manufacturer´s recommended protocol.
Reactions were carried out in a Rotor-Gene Q lightcycler (Qiagen). RNA isolation,
cDNA synthesis, and qPCR were performed with the help of Silvia Prettin.
3.3.11 DNA sequencing
Sequence validation was accomplished by Euroﬁns MWG Operon. Screening of
pX458(sgRNA) was performed using crCHECK1 primer (GCACCGACTCGGTGC-
CAC) to identify positive clones. DNA samples from TOPO cloning reactions were
analyzed using M13 forward primer (GTAAAACGACGGCCAG). Result analysis was
performed with SnapGene® Viewer software 2.6.2.
3.3.12 DNA microarray hybridization and analysis
Microarray analyses using AﬀymetrixTM genechips were performed by Robert Gef-
fers (HZI, Braunschweig). 3x106 cells were seeded onto 6-well plates and grown for
24 h. RNA isolation was performed using RNeasy Mini kit (Table 3.12) according to
the manufacturer´s recommended protocol. Quality and integrity of total RNA iso-
lated from NIH/3T3 WT and KO cells was controlled on Agilent 2100 Bioanalyzer
(Agilent Technologies). 500 ng of total RNA was used for biotin labeling according to
the 3´ IVT Express Kit (Aﬀymetrix). 7.5 µg of biotinylated cRNA was fragmented and
placed in a hybridization cocktail containing four biotinylated hybridization controls
(BioB, BioC, BioD, and Cre). Samples were hybridized to an identical lot of Aﬀymetrix
GeneChip MOE 430 2.0 for murine samples for 16 h at 45°C. Steps for washing and
SA-PE staining were processed on the ﬂuidics station 450 using the mini euk2v3 FS450
protocol (Aﬀymetrix). Image analysis was performed on a GCS3000 Scanner equipped
with GCOS1.2 Software Suite (Aﬀymetrix).
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3.3.13 Kits
Kits used in this thesis are shown in Table 3.12.
Table 3.12: Kits
Product Supplier
NucleoSpin® Plasmid Quick Pure Macherey & Nagel
NucleoSpin® Gel Macherey & Nagel
PCR clean-up Macherey & Nagel
TOPO® TA Cloning® Invitrogen
RNeasy Mini Qiagen
NucleoSpin RNA Plus Macherey & Nagel
Transcriptor ﬁrst strand cDNA synthesis kit Roche
SensiFASTTM SYBR® Bioline
No-ROX One-Step Kit
Pierce BCA Protein Assay Kit Thermo Fisher Scientic
AmplexTM Red Cholesterol Assay Kit Thermo Fisher Scientic
3.4 Cell culture
3.4.1 Reagents and plasticware
Cell culture media and additives were purchased from Corning, Thermo Fisher Sci-
entic, Sigma and PAA, if not stated otherwise. Hank´s Balanced Salt Solution (HBSS)
starvation medium was purchased from Biochrom. Fetal bovine serum (FBS) (Lot:
054M3396) was sterile ﬁltered using bottel top ﬁlters and stored at 4°C. Plasticware
was from Corning.
3.4.2 Cell lines and culture conditions
Mouse embryonic ﬁbroblast cells (NIH/3T3, ATCC CRL-1658) and human osteosar-
coma cells (U2-OS cells, DSMZ ACC 785) were maintained on sterile 10 cm cell culture
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dishes in DMEM (4.5 g/L glucose) supplemented with 10% (v/v) FBS, 1mM sodium
pyruvate, 1x non-essential amino acids and 2mM L-glutamine at 37°C in a humidiﬁed
7.5% CO2-atmosphere. For starvation and autophagic ﬂux analyses, cells were incu-
bated in complete culture medium for 24 h and either starved in HBSS or starved in
HBSS and treated with 100 nm Baﬁlomycin A1 (BafA1)(Cayman Chemical) for the
indicated time points. To assess cholesterol levels, cells were incubated in complete
culture medium or serum free culture medium supplemented with 1% (v/v) Insulin-
Transferrin-Selenium-G (ITS-G) for 24 h.
For passaging, cultures were washed once with PBS and incubated in trypsin/EDTA
solution at 37°C until cell detachment. The reaction was stopped by adding complete
culture medium and cells were subcultured at dilutions suitable for further cultivation.
3.4.3 Cell thawing and freezing
For recultivation, cells were rapidly thawed in a 37°C water bath, slowly transferred
to a 5mL tube containing complete culture medium and centrifuged at 115 xg for 5min
at 4°C (Eppendorf 5804R). The supernatant was discarded and cells were resuspended
in complete culture medium and plated onto 10 cm cell culture dishes.
For longterm storage, cells were trypsinized and centrifuged as previously. Cell pellets
were resuspended in chilled freezing medium (70% DMEM (4.5 g/L glucose) containing
20% (v/v) FBS and 10% (v/v) DMSO) and transferred into cryogenic storage vials.
Cells were frozen overnight at -70°C in a cell freezing container (Biocision) and stored
in liquid nitrogen.
3.4.4 Transfection and generation of mutant eukaryotic cells
Transfections were performed using X-tremeGENETM9 following the manufacturer´s
recommended protocol. For transfection of cells in 10 cm dishes, the mixture was scaled
up accordingly. Opti-MEM I Reduced Serum Medium was used as transfection reagent.
The protocol given below was performed to transfect cells grown in 6-well plates.
1 µg DNA
100 µL Opti-MEM
3 µL X-tremeGENETM 9
The transfection mixture was incubated for 30min at room temperature and ﬁnally
added to the cells. Transfection eﬃciency was monitored with EVOS® FL Cell Imag-
ing System 24 h post-transfection. Cells were grown to conﬂuence and subsequently
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inspected by ﬂow cytometry in order to sort single, GFP-positive cells. Therefore, cells
were dissociated and spun down at 115 xg for 5min at room temperature. The medium
was aspirated and cells were resuspended in 500 µL PBS. Flow cytometry was carried
out by Lothar Gröbe (HZI, Braunschweig) and performed with Aria II instrument (BD
Biosciences) using FACSDiva (Version 6.1). Non-transfected WT NIH/3T3 ﬁbroblasts
and U-2 OS cells, respectively, served as negative controls. Afterwards, sorted cells
were maintained in cell culture medium supplemented with 30% conditioned medium
and 10µM Y-27632 ROCK inhibitor (Biosciences). A second approach to isolate single
cells from a cell population was serial dilution since cell types vary in their response to
ﬂow cytometry and do not survive the process itself or the subsequent outgrowth.
3.4.5 Flow cytometry
To analyze cell size and cell granularity of NIH/3T3 WHAMM KOs, subconﬂuent
cells were harvested and ﬁxed with ice-cold 70% (v/v) ethanol at 4°C for 30min. Cells
were spun down at 115 xg for 5min, washed with PBS and centrifuged as previously.
Cell pellet was washed again with PBS and centrifuged as previously. Supernatant
was discarded and cells were collected in PBS containing 50 µg/mL RNase (Qiagen)
and 20µg/mL propidium iodide (Biolegend) and incubated at 37°C for 15min. Sub-
sequently, cells were analyzed by ﬂow cytometry using a LSR-II SORP ﬂow cytome-
ter (BD Biosciences) operated by FACSDiva software (Version 6.1) carried out by
Stephanie Stahnke (HZI, Braunschweig). Forward and side-scatter proﬁles were ob-
tained and at least 10,000 events were recorded per sample. Data was analyzed using
FlowJo® software (Version 10).
Moreover, ﬂow cytometry has been used to assess autophagic ﬂux in NIH/3T3 WT as
well as WHAMM KO cells by measuring LC3 and LAMP1 signal. 8x103 cells were
seeded in a 96-well plate (round bottom) and grown for 24 h. Cells were starved for the
indicated time points with HBSS, harvested and washed with ﬂow cytometry buﬀer.
Subsequently, cells were centrifuged at 259 xg for 5min, supernatant was discarded and
live/dead staining solution (1:1000, Thermo Fisher Scientiﬁc) was added for 20min at
4°C. Cells were washed and centrifuged, supernatant was discarded and cells were
ﬁxed in 4% (w/v) paraformaldehyde (PFA) in PBS for 20min at room temperature.
Cells were washed with ﬂow cytometry buﬀer, centrifuged, and stained with the re-
spective primary antibody (Table 3.14) diluted in ﬂow cytometry buﬀer containing
0.1% (w/v) saponin for 20min at room temperature. Note that usage of saponin is
highly recommended as it selectively extracts cytosolic LC3-I, while lipidated LC3-II
is membrane-bound and insoluble. Otherwise, one can barely discriminate between
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nonautophagosome-associated LC3-I and autophagosome-associated LC3-II [93]. Af-
terwards, cells were washed, centrifuged, and stained with the apropriate secondary
antibody (Table 3.15) diluted in ﬂow cytometry buﬀer containing 0.1% (w/v) saponin.
Cells were washed and centrifuged as previously. Subsequently, samples were resus-
pended in ﬂow cytometry buﬀer and ﬂow cytometry was carried out as described. At
least 1,000 events were recorded per sample.
3.5 Protein biochemistry
3.5.1 SDS-PAGE
SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate protein
samples according to their molecular weight as described by Laemmli et al. (1970).
Standard preparation of protein extracts from cultured cells
Conﬂuent adherent tissue culture cells were incubated on ice for 10min, washed three
times with ice-cold PBS followed by addition of NP-40 lysis buﬀer. Cells were scratched,
transferred into pre-chilled Eppendorf tubes and kept on ice for 20min. Next, cells were
centrifuged at 18,800 xg for 15min at 4°C. The supernatant was transferred and pro-
tein concentration was determined with PierceTM BCA Protein Assay kit (Table 3.12)
following the manufacturer´s instructions. Lysate samples with equal amounts of total
protein were mixed with appropriate amounts of 8x SDS sample buﬀer and boiled for
5min at 95°C.
Preparation of protein extracts from cultured cells to assess autophagy
To analyze autophagy in established NIH/3T3 KO cells, 2.2x105 cells were plated in a
6 cm dish and grown for 24 h. Next day, cells were washed once with HBSS and incu-
bated with HBSS for the indicated time points. Samples were placed on ice, washed
three times with ice-cold PBS and Tris lysis buﬀer was added. Cells were harvested,
centrifuged and protein concentration was determined as previously described.
After preparation of protein extracts, samples were separated on SDS-PAGE, which
consists of a top layer (stacking gel) and a bottom layer (resolving gel) (Formula Table
3.13). To determine the protein size, a mixture of proteins having deﬁned molecular
weights was loaded along the samples (PageRulerTM Prestained Protein Ladder, Bi-
oLabs Broad Range Color Prestained Protein Standard or Spectra Multicolor Broad
Range Protein Ladder). Electrophoresis was carried out at constant voltage (80V)
at room temperature. After electrophoresis was completed, proteins were transferred
from the gel onto a Polyvinylidene diﬂuoride (PVDF) membrane (Merck Millipore)
(Chapter 3.6.4).
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Preparation of protein extracts from cultured cells to determine cholesterol
levels
To quantify cholesterol in established NIH/3T3 WHAMM KO cells, 2x105 cells were
plated in a 6-well plate and grown for 24 h in complete culture medium or in serum
free culture medium supplemented with ITS-G. Next day, cells were incubated on ice
for 5min, washed two times with ice-cold PBS and lysed in Amplex lysis buﬀer I and
II, respectively. Subsequently, protein samples were snap frozen two times in liquid
nitrogen and used in Amplex® Red Cholesterol Assay kit (Table 3.12) following the
manufacturer´s instructions. Fluorescence was detected using Tecan inﬁnite 200 Pro
microplate reader (excitation/emission of 530/590 nm).
Table 3.13: Formula of stacking and resolving gel
Component Stacking gel Resolving gel
7.5% 10% 12.5% 15%
H2O 4mL 7.8mL 6.6mL 5.24mL 3.9mL
1.5M Tris/0.4% SDS pH 8.8 - 4mL
0.5M Tris/0.4% SDS pH 6.8 0.9mL -
*Acrylamide solution 0.9mL 4mL 5.34mL 6.66mL 8mL
TEMED 8 µL 16 µL
25% APS 32 µL 64 µL
*30% Acryalamide/0.8% N,N´-Methylenbisacrylamide
3.5.2 Coomassie blue and Ponceau S staining
Coomassie blue was used to visualize proteins on polyacrylamide gels. The gel was
incubated with Coomassie stain and heated in a microwave on 50% power for 10 to
30 s (until the Coomassie solution boils). Afterwards, the gel was incubated with the
Coomassie stain for 5 to 10min on a rocking table. Destaining of the gel was performed
by replacing Coomassie stain with distilled water followed by microwave heating for 10
to 30 s.
To check for successful protein transfer, the PVDF membrane was stained with Pon-
ceau S. Therefore, the membrane was washed with distilled water and incubated with
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Ponceau S for 5min. Destaining of the membrane was done by washing extensively in
water until the protein bands were well-deﬁned.
Coomassie solution
0.1% Coomassie brilliant blue G-250
10% Ethanol
5% Aluminium sulfate
2% Phosphoric acid
ddH2O
Ponceau S
0.5% Ponceau S
1% Acetic acid
ddH2O
3.5.3 Expression of recombinant proteins in E. coli
In order to express recombinant WHAMM or JMY, pGEX-6P-3-WHAMMAA696 809
and pGEX-6P-1-JMYAA824 983 were transformed into E. coli BL21 (DE3) and E. coli
Rosetta, respectively (Chapter 3.3.6). Both pGEX-6P-3 and pGEX-6P-1 provide GST
fusion. E. coli cells harbouring the recombinant plasmid were inoculated into 100mL
LB medium containing the appropriate antibiotic(s) (Table 3.2 and Table 3.7) and
cultured overnight at 37°C with agitation. Starter cultures were diluted 1:10 in 1 L
fresh medium containing the appropriate antibiotic(s) and were grown at 37°C un-
til an optical density (OD) value of 0.8 at 600 nm was reached. Isopropyl-beta-D-
thiogalactopyranoside was added to a ﬁnal concentration of 1mM and cultures were
further grown for 4 h (BL21 (DE3)) or 3 h (Rosetta) at 37°C with agitation. Cells
were harvested by centrifugation (6,000 rounds per minute (rpm) for 15min at 4°C
in an AvantiTM J-25 Beckman centrifuge with JA10 rotor). The pellet was washed
with ice-cold buﬀer A containing 1mM DTT and centrifuged as previously. Cells were
resuspended in cold buﬀer A containing 1mM DTT, 1µL Benzonase for degradation
of DNA, 1 pill Mini-complete protease inhibitor cocktail to inhibit protease activity
and a tip of a spatula of lysozyme. Cells were disrupted on ice by gentle sonication
(3 cycles, 45 s, Branson Soniﬁer 250) and centrifuged (16,500 rpm for 30 min at 4°C).
Glutathione Sepharose® 4B slurry (GE Healthcare) was equilibrated with buﬀer A
containing 1mM DTT and 1mL was mixed with the supernatant for 1 h at 4°C on
a rotary wheel. pGEX-6P-3-WHAMMAA696 809 and pGEX-6P-1-JMYAA824 983 were
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puriﬁed using a PD10 plastic column cartidge (sepharose column from Amersham Bio-
sciences). Beads were washed ten times with buﬀer A containing 1mM DTT and
the GST tagged proteins were eluted with elution buﬀer (0.5mL elution buﬀer/1mL
Glutathione Sepharose® 4B slurry). The total protein amount was quantiﬁed photo-
metrically by measuring the OD at 280 nm. The expression and purity of the protein
was assessed by SDS-PAGE applying samples from every step of the procedure.
3.6 Immunological methods
3.6.1 Primary antibodies
Primary antibodies applied for immunoblotting (WB), immunoﬂuorescence (IF), or
ﬂow cytometry (FC) are listed in Table 3.14.
Table 3.14: Primary antibodies
Target mc/pc Species Application Source
Actin pc rabbit WB 1:1,000 Sigma, A2066
ATG9A mc rabbit WB 1:1,000 Abcam, 108338
IF 1:100
Calnexin pc rabbit IF 1:100 Abcam, 75801
EEA1 mc rabbit IF 1:100 Cell Signaling, C45B10
GAPDH mc mouse WB 1:10,000 CalBiochem, 1001
Giantin pc rabbit IF 1:500 BioLegend®, PRB-114C
JMY pc rabbit WB 1:500 This dissertation
LAMP1 mc rat *IF 1:200 Abcam, 25245
FC 1:500
LC3A/B pc rabbit WB 1:2,000 Cell Signaling, 4108
LC3B pc rabbit *IF 1:500 Novus, 600-1384
FC 1:1,000
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mTOR mc rabbit WB 1:1,000 Abcam, 7c10
Paxillin mc rabbit WB 1:500 Abcam, Y113
IF 1:100
p62 mc mouse WB 1:5,000 Abcam, 56416
*IF 1:500
p-mTOR mc rabbit WB 1:1,000 Abcam , D9C2
Tubulin mc rat WB 1:10,000 J. Wehland, HZI, Braunschweig
YL 1/2
Tubulin mc mouse IF 1:500 Sigma, T 6793
Ubiquitin mc mouse WB 1:2,000 Cell Signaling, 3936
Vinculin mc mouse WB 1:5,000 Sigma, V-9131
IF 1:250
WASH pc rabbit WB 1:800 A. Gautreau, Ecole Polytechnique
Paris, France
WHAMM pc rabbit WB 1:500 Abcam, 122572
mc = monoclonal, pc = polyclonal, *Fixative: Methanol
3.6.2 Secondary antibodies
Secondary antibodies applied for immunoblotting (WB), immunoﬂuorescence (IF) or
ﬂow cytometry (FC) are listed in Table 3.15. All secondary antibodies listed in Table
3.15 are speciﬁc for both heavy and light chains of IgG. Phalloidin conjugates used in
immunoﬂuorescence are listed in Table 3.15.
Table 3.15: Secondary antibodies and phalloidin conjugates.
Name Description Coupled to Application Source
A4C goat anti-mouse IgG Horseradish WB 1:5,000 Dianova
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peroxidase (HRP)
B4C goat anti-rabbit IgG HRP WB 1:5,000 Dianova
C4C goat anti-rat IgG HRP WB 1:5,000 Dianova
A12C goat anti-mouse IgG Alexa FluorTM 488 IF 1:400 Invitrogen
A13C goat anti-mouse IgG Alexa FluorTM 594 IF 1:400 Invitrogen
B12C goat anti-rabbit IgG Alexa FluorTM 488 IF 1:400 Invitrogen
B13C goat anti-rabbit IgG Alexa FluorTM 594 IF 1:400 Invitrogen
FC 1:1,000
C12C goat anti-rat IgG Alexa FluorTM 488 IF 1:400 Invitrogen
FC 1:1,000
PH12 - Alexa FluorTM 488 IF 1:200 Invitrogen
PH13 - Alexa FluorTM 594 IF 1:200 Invitrogen
PH20 - ATTO 594 IF 1:200 ATTO TEC
3.6.3 Generation of polyclonal WHAMM and JMY antibodies
For generation of WHAMM and JMY antibodies, WHAMMAA696 809 and JMYAA824 983
were expressed in E. coli BL21 (DE3) and Rosetta, respectively (Chapter 3.5.3). Gen-
eration of antisera against the proteins was carried out by Prof. Jan Faix (MHH,
Hanover).
3.6.4 Western blotting
After protein separation via SDS-PAGE (Chapter 3.5.1), Western blotting was ap-
plied to detect speciﬁc proteins in cell lysate samples. Proteins were transferred with
Pierce G2 Fast Blotter (Thermo Fisher Scientiﬁc) employing the semi-dry technique.
The PVDF membrane was activated by soaking in pure methanol and afterwards equi-
librated in Pierce 1-Step transfer buﬀer. Whatman ﬁlter paper and SDS gels were
incubated in transfer buﬀer for 10min. The activated and washed PVDF membrane
was placed beneath the gel for transferring the proteins. Both sides were surrounded
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with Whatman ﬁlter paper and western blotting was performed. Depending on the
molecular weight, proteins <100 kDa were transferred up to 15min, whereas larger
proteins (>100 kDa) up to 20min. Protein transfer was performed at a maximum of
25V and at a constant current of 2.5A. Subsequently, the membrane was incubated
in methanol and completely dried before blocking. Successful protein transfer was in-
vestigated by Ponceau S staining (Chapter 3.5.2). To prevent nonspeciﬁc binding of
the antibody, the membrane was incubated in blocking solution for 1 h on a shaker at
room temperature.
Blocking solution I (applied for LC3 and p62 antibodies)
5% (w/v) Skim milk powder in 1x TBS-T
Blocking solution II
10% (v/v) FBS in 1x TBS-T
Next, the membrane was incubated with the primary antibody diluted in the respec-
tive blocking solution at 4°C overnight on a shaker. The membrane was washed three
times in 1x TBS-T for 20min and incubated with a HRP coupled secondary antibody
diluted in the respective blocking solution for 1 h at room temperature. Afterwards,
the membrane was washed as previously and protein detection was conducted using
Lumi-Light Western blotting substrate (Roche). Protein bands were visualized via a
chemiluminescence reaction, which results from the oxidation of luminol by the per-
oxidase linked to the secondary antibody. Resulting luminescence was detected with
Intas ECL Chemocam Imager at diﬀerent exposure times.
3.6.5 Immunoﬂuorescence
Preparation of coverslips
Coverslips (12mm or 15mm Ø from Thermo Fisher Scientic; 18mm Ø from Marien-
feld) were washed in a solution of 60% (v/v) ethanol and 40% (v/v) HCl for 30min on
a shaker. Washing solution was removed and coverslips were rinsed extensively with
distilled water. Afterwards, coverslips were air dried separately on Whatman ﬁlter
paper and ﬁnally sterilized by autoclavation (121°C, 30min).
Coating of coverslips
Before cell seeding, coverslips were coated with 25 µg/mL ﬁbronectin (Roche) in PBS
for 1 h at room temperature. Fibronectin is a excellular matrix protein, which im-
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proves cell adhesion on the glass surface. Coating solution was removed by washing
three times with PBS followed by cell seeding. Fibronectin was stored as 1mg/mL
solution in 2M urea.
Fixation and staining of samples
In general, 22.5x103 cells were plated onto coated coverslips and cultured for 24 h fol-
lowed by ﬁxation.
For Brefeldin A (BFA) treatment, 3x104 cells were seeded into 12-well plates and grown
for 24 h. BFA (2.5 µg/mL) was added and cells were incubated at 37°C for 35min. For
regeneration studies, cells were removed from the treatment medium and washed free
of BFA with fresh culture medium for time points as indicated in the ﬁgure.
To compare and quantiﬁy F-actin intensities between NIH/3T3 WT and WHAMM
KO cells, 4x104 cells were seeded into 12-well plates and grown for 24 h. Media
was discarded and either WT or WHAMM KO cells were incubated with 7.5 µM/mL
CellTrackerTM Green CMFDA (Thermo Fisher Scientiﬁc) in Opti-MEM at 37°C for
30min. Half of the WT and the respective KO clone plate was seeded onto coated
coverslips and ﬁxation was performed after cell detachment.
To study autophagy, cells were either starved with HBSS or starved with HBSS and
treated with BafA1 prior to ﬁxation.
In this study, both PFA and methanol ﬁxation procedures were performed. Therefore,
cells were placed on a styrofoam and cell culture medium was discarded. Next, cells
were ﬁxed with prewarmed 4% (w/v) PFA in PBS for 20min at room temperature in
order to cross-link proteins. For vinculin stainings, cells were pre-extracted with 0.3%
(v/v) Triton X-100 in 4% (w/v) PFA in PBS for 1min and ﬁxed as previously. Cells
were washed thrice with PBS and permeabilized with 0.2% (v/v) Triton X-100 in PBS
for 1min at room temperature to become permeable for larger structures. Cells were
washed as previously.
In case of methanol ﬁxation, cells were placed on a styrofoam and cell culture medium
was removed. Ice-cold 100% methanol was added for 5min at room temperature and
ﬁnally washed out with PBS by slowly decreasing the methanol concentration. As
methanol is a permeabilization agent, no treatment with 0.2% (v/v) Triton X-100 in
PBS was required.
To avoid nonspeciﬁc binding of the antibody, cells were incubated in blocking solution
(5% (v/v) horse serum in 1% (w/v) BSA in PBS) for 1 h at room temperature with
the cell side down in a humidiﬁed chamber. Cells were then stained with the primary
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antibody diluted in the blocking solution and added to the cells as previously. After-
wards, cells were washed ﬁve times in PBS and incubated with the secondary antibody
diluted in the blocking solution for 1 h at room temperature. If required, the sec-
ondary antibody solution was supplemented with phalloidin (Table 3.15) and/or DAPI
(1:500, Sigma). Phalloidin is a phallotoxin that binds to F-actin, thereby preventing
its depolymerization. DAPI staining was performed to visualize cell nuclei. Cells were
washed two times in PBS and one time in deionized water to remove any salts. Cover-
slips were overturned on a microscope slide covered with ProLong Antifade mounting
medium (Thermo Fisher Scientiﬁc) and stored in the dark at 4°C.
For ﬁlipin staining, cells were PFA-ﬁxated as described, washed thrice with PBS and
incubated with 1mL of 1.5mg/mL (w/v) glycine in PBS for 10min at room temper-
ature. Cells were stained with 0.25mg/mL Filipin (Sigma) in 10% (v/v) FBS in PBS
for 2 h at room temperature. Cells were washed and mounted as previously described.
3.7 Microscopical methods
3.7.1 Epiﬂuorescence microscopy
To localize a certain protein in cells, it can be coupled to ﬂuorochromes as described
by Mies et al. A ﬂuorophore is a ﬂuorescent chemical compound that can be excited
allowing the visualization of biological molecules and structures. For this purpose,
samples were prepared as described in chapter 3.6.5 and imaging was conducted with
the following tools (Tables 3.16 and 3.17).
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Table 3.16: Hardware used for immunoﬂuorescence analyses
Microscope Axiovert 135TV Spinning Disk
Carl Zeiss Microscopy Perkin Elmer
Nikon Ti Eclipse
Light source Mercury lamp Intensilight Nikon C-HGFIE
HXP120 Modular laser system 2.0
Objective Plan Apo 100x/1.4 NA Plan Apo 60x/1.4 NA
Plan Apo 63x/1.4 NA Plan Apo 100x/1.4 NA
Camera Coolsnap HQ2 Orca R2
(Photometrics) EM-CCD
(Hamamatsu)
Acquisition Visi View Volocity
Immersion oil Carl Zeiss or Nikon (Refraction index: 1.518)
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Table 3.17: Hardware used for immunoﬂuorescence analyses
Microscope SIM-E Nikon Ti2 Nikon
Nikon Ti Eclipse
Light source Intensilight Nikon C-HGFIE CoolLED
pE-4000
Objective Plan Fluor 60x/1.4 Plan Apo 60x/1.4 NA
SR Apo TIRF Plan TIRF 100x/1.49 NA
100x/1.49 NA
Camera Orca Flash LT PCOedge (PCO)
(Hamamatsu)
Acquisition NIS-Elements
software
Immersion oil Carl Zeiss or Nikon (Refraction index: 1.518)
Particle analysis using ImageJ
Images acquired by ﬂuorescence microscopy have been analyzed for their number, size
and/or intensity of the respective, stained target. To do so, two diﬀerent approaches
have been utilized in order to make an appropriate particle analysis. Counting LC3 and
p62 spots has been performed by manual thresholding. The monochrome images were
most simply thresholded via the menu command Image-Adjust-Threshold. Finally, the
command Analyze-Analyze particles provided me with information about each single
particle in the image. This procedure turned out to work properly for p62-detection
(Figure 3.1, A). However, the tool illustrated diﬃculties in the selection of LC3 par-
ticles, especially due to non-uniform lighting images (Figure 3.1, B). Moreover, some
LC3 spots could not reliably selected since there was partly a strong nucleus staining
throughout the samples. Examples shown in Figure 3.1, B) were either not taken into
considerations or, depending on the signal intensity, the image has been cropped and
calculations were performed gradually.
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Figure 3.1: Threshold selection of p62-positive as well as LC3-positive particles. Au-
tophagy was induced by HBSS treatment and was studied with autophagy markers p62 (A) and LC3
(B). ImageJ thresholding was used to perform particle analysis of both proteins. (A) Individual p62-
positive structures were precisely detected by the threshold function. (B) Depending on the image,
LC3 particles could not reliably selected due to non-uniform lighting of the sample. Red dots indicate
p62-positive or LC3-positive structures. Scale bar: 10µm.
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In order to analyze the Golgi apparatus with/without BFA treatment, the number of
ATG9-positive and LAMP1-spots as well as the number of focal adhesions, I applied
automatic particle counting using an ImageJ plugin named MosaicSuite. Note that
background subtraction seetings were equal for all measured particles (Remove back-
ground: Yes; Rolling ball window size: 10).
For Golgi analysis the settings were chosen as follows:
Table 3.18: MosaicSuite analysis of Golgi fragments
Settings Value
Segmentation parameters
Regularization (>0) ch1 0.010
Regularization (>0) ch2 0.050
Minimum object intensity channel 1 (0 to 1) 0.150
Minimum object intensity channel 2 (0 to 1) 0.90
Subpixel segmentation No
Exclude Z edge Yes
PSF model (Gaussian approximation)
Standard deviation xy (in pixels) 0.91
Standard deviation z (in pixels) 0.69
Region ﬁlter
Remove region with intensities < 0
Remove region with size < 0 pixels
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For ATG9 and LAMP1-particle analysis the settings were chosen as follows:
Table 3.19: MosaicSuite analysis of ATG9-containing particles as well as LAMP1 spots
Settings Value
Segmentation parameters
Regularization (>0) ch1 0.010
Regularization (>0) ch2 0.050
Minimum object intensity channel 1 (0 to 1) 0.150
Minimum object intensity channel 2 (0 to 1) 0.150
Subpixel segmentation No
Exclude Z edge Yes
PSF model (Gaussian approximation)
Standard deviation xy (in pixels) 1.21
Standard deviation z (in pixels) 0.69
Region ﬁlter
Remove region with intensities < 0
Remove region with size < 2 pixels
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For Vinculin and paxillin analyses the settings were chosen as follows:
Table 3.20: MosaicSuite analysis of vinculin- and paxillin-positive spots
Settings Value
Segmentation parameters
Regularization (>0) ch1 0.010
Regularization (>0) ch2 0.050
Minimum object intensity channel 1 (0 to 1) 0.150
Minimum object intensity channel 2 (0 to 1) 0.68
Subpixel segmentation No
Exclude Z edge Yes
PSF model (Gaussian approximation)
Standard deviation xy (in pixels) 0.71
Standard deviation z (in pixels) 0.69
Region ﬁlter
Remove region with intensities < 0
Remove region with size < 15 pixels
Even though the majority of particles has been properly detected, the MosaicSuite
tool also displayed inaccuracies, independent from the particle of interest. Examples
are shown for the Golgi apparatus (Figure 3.2), ATG9 detection (Figure 3.3), LAMP1
staining (Figure 3.4), Vinculin staining (Figure 3.5), and Paxillin staining (Figure 3.6),
where some particles were falsely detected (e.g. brighter regions were falsely recognized
as positive structures), other were not recognized at all as well as some structures were
incorrectly recognized (e.g. counting three spots instead of two). Since these errors
appeared in both genotypes, they were considered tolerable (for Vinculin see Results,
Figure 4.28).
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Figure 3.2: Counting Golgi fragment by MosaicSuite. The Golgi apparatus was investigated
in both NIH/3T3 WT and WHAMM KO cells. One example is shown for WHAMM#11. Giantin
staining was used to label the position of Golgi. The MosaicSuite tool was applied to count the number
of fragments. Scale bar: 10µm.
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Figure 3.3: Counting ATG9 dots by MosaicSuite. Number and distribution of ATG9 particles
were investigated in both NIH/3T3 WT and WHAMM KO cells. One example is shown for NIH/3T3
WT ﬁbroblasts. ATG9 staining was used to label small single membrane-vesicles. The MosaicSuite
tool was applied to count the number of ATG9-containing spots. Note that the monochromatic image
(upper left) depicts a cropped version. Scale bar: 10µm.
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Figure 3.4: Counting lysosomal structures by MosaicSuite. Number and size of lysosomes
were investigated in both NIH/3T3 WT and WHAMM KO cells. One example is shown for NIH/3T3
WT ﬁbroblasts. LAMP1 staining was used to label the position of lysosomes. The MosaicSuite tool
was applied to count the number of lysosomes. Note that the monochromatic image (upper left)
depicts a cropped version. Scale bar: 10µm.
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Figure 3.5: Counting vinculin-containing focal adhesions by MosaicSuite. Number,
length, and intensity of focal adhesions were investigated in both NIH/3T3 WT and WHAMM KO
cells. One example is shown for WHAMM#2. Vinculin staining was used to visualize focal adhe-
sions. The MosaicSuite tool was applied to count the number of focal adhesions. Note that the
monochromatic image (upper left) depicts a cropped version. Scale bar: 10µm.
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Figure 3.6: Counting paxillin-containing focal adhesions by MosaicSuite. Number, length,
and intensity of focal adhesions were investigated in both NIH/3T3 WT and WHAMM KO cells. One
example is shown for WHAMM#2. Paxillin staining was used to visualize focal adhesions. The
MosaicSuite tool was applied to count the number of focal adhesions. Note that the monochromatic
image (upper left) depicts a cropped version. Scale bar: 10µm.
3.7.2 Live cell imaging
To monitor life cell imaging of EGFP-DFCP1, cells were plated onto 12-well plates
and transiently transfected according to the protocol in chapter 3.4.4. The next day
the transfected cells were transferred onto 35-mm glas bottom dishes (Ibidi) and on
the third day the cells were starved with HBSS for 1, 2, and 4 h. Microscopy was
performed with SIM-E Nikon (Table 3.17). Cells were maintained at 37°C and 7.5 %
CO2 using an OKO Labs full enclosure incubation system. Technical equipment and
software were analogous to the description in chapter 3.7.1.
3.7.3 Superresolution microscopy
For 3D-structured illumination microscopy of EGFP-DFCP1, cells were seeded and
transfected as described in chapter 3.4.4. Data as well as corresponding movies were
acquired on Nikon SIM-E superresolution microscope (Chapter 3.7.1). Reconstructions
were performed with the stack reconstruction tool (Nikon, NIS-Elements).
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3.8 Viral infection studies of NIH/3T3 WHAMM and JMY KO
cells
3.8.1 Analysis of virus-infected cells by ﬂow cytometry
The absolute infection rate of VSV and HSV-1 was determined by ﬂow cytometry.
1.8x105 NIH/3T3 WT and NIH/3T3 KO cells were seeded onto 24-well plates and
grown for 24 h in complete culture medium. Next day, cells were either infected with
VSV-eGFP or HSV-1-eGFP (Kalinke, Twincore) at a multiplicity of infection (MOI) of
5.5 for 1 h at 37°C. The supernatant was removed and cells were cultured in complete
culture medium for 6 h or 12 h. After the indicated time points, medium was discarded
and cells were detached with 1mM EDTA in PBS up to 30min at 4°C. Cells were
carefully removed by pipetting up and down and placed in ﬂow cytometry tubes. Cell
suspension was washed with ﬂow cytometry buﬀer at 300 xg for 6min, supernatant was
discarded and ﬁxation was applied with 3% (w/v) PFA in PBS. Analysis was performed
by ﬂow cytometry using a LSR II ﬂow cytometer (BD bioscience) operated by DIVA
software (Version V8.0.1) carried out by Luca Ghita (Twincore). At least 10,000 events
were recorded per sample. Data was analyzed using FlowJo® software (Version 1).
3.8.2 Plaque assay
The approximate virus titer after infection was determined by plaque assays. 1.8x105
NIH/3T3WT and NIH/3T3 KO cells were seeded onto 24-well plates and grown for 24 h
in complete culture medium. Next day, cells were either infected with VSV or HSV-1
(Kalinke, Twincore) at a MOI of 10 for 24 h at 37°C. Furthermore, 2x105 Vero cells
(Kalinke, Twincore) were seeded onto 24-well plate and grown for 24 h. Supernatant of
infected NIH/3T3 cells was taken oﬀ and used to prepare serial dilutions from 10 3 to
10 8. Vero cells were infected by transferring 50 µL to the subsequent dilution for 1 h at
37°C. Afterwards, the media was discarded and infected cells were overlayed with pre-
warmed 1% (w/v) methyl cellulose (Sigma) in distilled water. In case of VSV infection,
the overlay was discarded after 24 h and samples were stained with 0.1% crystal violet
for 30min at room temperature. HSV-1 infected samples were incubated with the
overlay for 72 h and stained as previously described. Plates were carefully washed with
distilled water, dried and plaques were counted (Plaque forming units (PFU)).
3.8.3 Live cell imaging of EGFP-VSV
For real-time visualization of virus movement, cells were seeded onto 35-mm glas
bottom dishes and grown for 24 h. Next day, cells were infected with VSV-eGFP in
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RPMI containing 30mM HEPES for 1 h at a MOI of 5.5. The dish was placed in
a closed chamber maintained at 37°C and 5% CO2. Infection medium was replaced
with complete culture medium and live cell imaging was performed for 8 hours post
infection (hpi) using the Leica SP8 microscope ﬁtted with a 63Ö lens. For time-lapse
recording of the same sets of cells, images were collected every 30 s for 6 h.
3.9 Data processing and statistical analyses
Brightness and contrast levels were adjusted using ImageJ software (Version: 1.48).
Figures were further processed and assembled with both ImageJ and Inkscape (Ver-
sion: 0.92.3). For statistical analysis of western blot quantiﬁcation, protein levels were
quantitated by densitometry and normalized to the control group. One-Way ANOVA
was used as statistical test for ﬂow cytometry analyses, whereas all other experiments
were analyzed using Two-tailed Student´s t-test (if not stated otherwise). Expression
results of microarray analysis were displayed as binary logarithm. KO values were
normalized to WT results. For statistical analyses, Microsoft Excel 2010, SigmaPlot
Version 14, and GraphPad Prism 5 or 8 were employed.
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4.1 Generation of clonal cell lines lacking WASH, WHAMM or
JMY
The CRISPR/Cas technology oﬀers unprecedented genome editing capability and
was applied in this thesis to elucidate and study the functional roles of WASH,WHAMM,
and JMY. These NPFs are distinct catalytic activators of the Arp2/3 complex, which
is unique in its ability to polymerize branched actin networks in the cell [3]. Interest-
ingly, pathogenic microbes have evolved molecular mechanisms to manipulate Arp2/3-
mediated actin polymerization in order to subvert actin-based motility for their own
purposes (e.g. adhesion to, spreading within, and immune evasion from the host) [4,94].
However, little is known about the role of these actin regulators during infection with in-
vasive pathogens. Additionally, recent publications link the mammalian NPFs WASH,
WHAMM, and JMY to autophagy, an intracellular bulk degradation system used to
remove misfolded, ubiquitylated proteins, damaged organelles as well as intracellular
pathogens such as bacteria [25, 44, 84, 85]. Indeed, Bacteria have developed multiple
mechanisms to avoid, inhibit or subvert the autophagy machinery [95].
To delineate the cellular role of the selected NPFs in these processes, I created so-
matic KOs in mouse embryonic ﬁbroblasts (NIH/3T3) and human osteosarcoma cells
(U-2 OS). I ﬁrst determined an appropriate targeting sequence in WASH, WHAMM,
and JMY using a bioinformatic database (ensembl.org) and focused on the coding re-
gion of the respective exon (Table 3.4). sgRNAs were designed with the help of two
target online predictors (crispr.mit.edu and crispr.cos.uni-heidelberg.de). I have cho-
sen a sgRNA binding in close proximity to the ATG start codon and best provided
oﬀ-target score to speciﬁcally disrupt the protein-coding region. Gene editing by the
CRISPR/Cas9 system was performed by transient transfections of NIH/3T3 and U-2
OS WT cells. Cells were transfected with pSpCas9(BB)-2A-GFP carrying a certain
sgRNA targeting WASH, WHAMM, and JMY. Isolation of clonal cell lines bearing a
KO in the respective locus was achieved by ﬂow cytometry of single GFP-positive cells
into 96-well plates or by single cell dilution.
The generation of the diﬀerent KO cells yielded at least three clones in NIH/3T3 cells
bearing either homozygous or heterozygous mutations (Table 4.1). Note that positions
of premature stop codons are depicted in Figures 4.3 and 6.5.
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Table 4.1: Established NIH/3T3 KO cells (+ = insertion,  = deletion)
Clone Allele 1 Allele 2 Premature stop codon
WASH#19 +T +A No
WASH#20 +A CGACGAG No
WASH#22 +A A, +T No
WHAMM#2 +C Identical to allele 1 Yes
WHAMM#3 +C C Yes
WHAMM#7 +C GTGAGGAC Yes
WHAMM#11 +C Identical to allele 1 Yes
JMY#2 CG AGTCCGACTGGGTG Yes
JMY#5 AC CG Yes
JMY#10 +G C, GAC No
All clones were examined for gene editing by PCR ampliﬁcation of the targeted locus of
genomic DNA followed by sequencing (Figure 4.1, Supplementary data, Figures 6.1  
6.3). At least nine clonal amplicons from each KO cell line were analyzed. Sequencing
data revealed indel mutations (+ = insertion,  = deletion) in the WASH, WHAMM,
and JMY loci (Table 4.1). Consequence of these gene modiﬁcations in WHAMM
and two JMY KO cell lines was a frameshift mutation generating a premature stop
codon resulting in the termination of protein synthesis (Figure 4.3, Supplementary data,
Figure 6.5). In the case of WASH and JMY#10, CRISPR/Cas9 did not introduce an
early stop codon, but resulted in extensive alterations of a certain number of amino
acids that likely led to a misfolding and hence protein degradation (Supplementary
data, Figures 6.4 and 6.5). Sequencing results of WASH#22 and JMY#10 displayed
three diﬀerent alleles which might indicate a mixture of clones or the presence of more
than two alleles. Moreover, all NIH/3T3 KO clones were probed for protein expression
by western blotting and showed a complete lack of the respective protein as compared
to the non-edited control (Figure 4.2 A-C).
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Figure 4.1: Representative DNA alignments of NIH/3T3 WT and WHAMM
KO cells. WHAMM#2 displayed the same two alleles (homozygous mutation), whereas
WHAMM#3 bears two diﬀerent alleles (heterozygous mutation). Sequencing gaps (underlined in
red) in the WHAMM locus indicate indels (pair-wise alignments were done in Clustal Omega
(https://www.ebi.ac.uk/Tools/msa/clustalo)). Upper lane = WT sequence, lower lane = KO se-
quence.
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Figure 4.2: Western blot analyses show absence of expression of WASH, WHAMM
or JMY in NIH/3T3 clones. NIH/3T3 WT cells were transfected with pSpCas9(BB)-2A-GFP
containing a sgRNA targeting the respective NPF. Single clonal strains were obtained by ﬂow cytom-
etry or serial dilution and were sent for sequencing after cell expansion. Cell lysates were harvested
and protein expression was checked by western blotting. GAPDH or Tubulin was used as loading
control. (A-C) Representative images of western blots. Western blot analysis revealed eﬃcient loss
of WASH (A), WHAMM (B) or JMY (C) proteins in murine ﬁbroblasts. Data are representative of
three independent experiments. Individual clones are designated by numbers.
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Figure 4.3: Protein alignments of NIH/3T3 WT and WHAMM KO cells. In this study,
I established NIH/3T3 cells deﬁcient in whamm. Four clonal cell lines were generated by using one
sgRNA targeting the coding region of whamm, which produced indels that abolished WHAMM pro-
tein expression. Amino acids labeled in red indicate positions that diﬀer from the WT sequence.
Protein sequence alignments show positions of premature stop codons (designated by stars) due to
the introduced frameshifts.
Targeting NPF genes in human cells proved to be more complicated. First, I per-
formed the experiments with one sgRNA per candidate in MDA-MB-231 and A549
cells (data not shown). However, western blotting still exhibited protein expression
for the respective protein and sequencing data also displayed unsuccessful gene editing
(data not shown). In order to improve CRISPR/Cas eﬃciency in human cell systems,
I targeted two diﬀerent exons of the respective gene in U-2 OS cells (Table 3.4). The
generation of at least one clone per genotype was achieved by CRISPR/Cas. Western
blot analysis conﬁrmed loss of protein expression (Figure 4.4), however, sequencing
data of the individual genes failed (data not shown). Although standard PCR did
yield the desired amplicon of WHAMM and JMY, DNA sequencing resulted in poor
results. Ampliﬁcation of human WASH failed and needs to be optimized.
Collectively, these ﬁndings conﬁrm the generation of diﬀerent murine cell lines carrying
either early abortive mutations on the coding sequence or sequence alterations that led
to misfolding and therefore protein degradation induced by the CRISPR/Cas method.
Gene KOs in human U-2 OS cells have been validated by western blotting indicating
a loss of targeted NPFs in a human cell system.
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Figure 4.4: Western blot analyses show absence of expression of WASH, WHAMM or
JMY in human U-2 OS clones. U-2 OS WT cells were transfected with pSpCas9(BB)-2A-GFP
containing a sgRNA targeting the respective NPF (each protein was targeted with two sgRNAs).
Single clonal strains were obtained by ﬂow cytometry or serial dilution and were sent for sequencing
after cell expansion. Cell lysates were harvested and protein expression was checked by western
blotting. GAPDH or Tubulin was used as loading control. (A-C) Representative images of western
blots. Western blot analysis revealed eﬃcient loss of WASH, WHAMM or JMY proteins in human
osteosarcoma cells. Data are representative of at least two independent experiments. Individual clones
are designated by numbers.
4.2 Cellular characterization of NIH/3T3 WHAMM KO cells
4.2.1 Morphology of WHAMM KO cells
Established NIH/3T3 WHAMM KO cells were utilized for further investigation
("Clones pooled" comprised all four WHAMM KO cell lines). Therefore, clones were
ﬁrst analyzed for morphological parameters, including cell area, cell volume, and cell
granularity. It was noted that on average WHAMM deﬁcient cells appeared larger and
I asked whether this may be due to an overall increased cell size or due to increased cell
spreading. Thus, I investigated the cell and nuclear area. As anticipated, WHAMM
deﬁciency caused an increase of the cell area and the nuclear area in ﬁxed, spread cells
(Figure 4.5, A-C, Supplementary data, Figure 6.6).
68
4 Results
Figure 4.5: Cells deﬁcient in whamm are larger in size and display larger cell nuclei. (A)
Representative immunoﬂuorescence images of WT cells and WHAMM KO clone #3. Cells deﬁcient
in whamm show an increase in cell size and larger cell nuclei. Giantin staining (green) was used to
label the position of Golgi. DAPI staining (blue) was used as a cellular nucleus marker. F-actin (red)
was stained by ﬂuorescent phalloidin. Scale bar: 20µm. (B-C) Quantitative analysis of WT cells
versus WHAMM KO clones conﬁrms signiﬁcantly larger cells and larger cell nuclei in KO cells. Data
are representative of three independent experiments. n = number of cells analyzed. **P  0.01,
****P 0.0001, Two-tailed Student's t-test. Error bars represent SEM.
I also analyzed the cells by ﬂow cytometry with the help of Stephanie Stahnke (HZI,
Braunschweig) to assess their cellular volume. Cells were grouped into four categories,
depending on cell size and cell granularity. For this measurement, sideward scatter SSC
and forward scatter FSC are plotted and gates are set to WT parameters (Figure 4.6,
A). The results clearly exhibited that WHAMM deﬁciency results in a shift from smaller
to larger granular cells (Figure 4.6, B). Moreover, it became evident that WHAMM
KO cells display a signiﬁcant increase in granularity (Figure 4.6, C), indicative of an
accumulation of light scattering material in the cell, such as protein aggregates or
vesicles.
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Figure 4.6: Eﬀect of WHAMM KO on cell size and granularity. (A) Cell size and cell
granularity were analyzed by ﬂow cytometry. Quadrant gates split the population into four adjacent,
discrete subpopulations. (B-C) Quantitative analysis of WT cells versus WHAMMKO clones conﬁrms
a shift in cell population from smaller to large cells in KO cells as well as to higher granularity. Data
are representative of two independent experiments. (B) *P  0.05, **P  0.005, ***P  0.0001,
One-way ANOVA, (C) *P  0.05, Two-tailed Student's t-test. Error bars represent SEM.
WHAMM is known to promote ERGIC-membrane tubulation in an actin- and micro-
tubule dependent fashion [20]. Therefore, I investigated with the help of Frieda Kage
(TU Braunschweig) whether WHAMM-deﬁciency impairs the general cytoskeletal or-
ganization or ER appearance. WT and KO cells were stained with probes to F-actin,
ER, and ERGIC. To this end, I found no eﬀects on stress ﬁber formation (Supplemen-
tary data, Figure 6.6), diﬀering from previous observations upon siRNA treatments in
BJ/SV40 T ﬁbroblasts [41]. F-actin bundles were organized into conventional stress
ﬁbers in both WT and KO cells. Total protein levels of actin were assessed via western
blotting and results exhibited similar expression levels in WT and WHAMM KO cells
(Figure 4.7, A). Next, CellTracker and phalloidin stainings were performed to mea-
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sure F-actin intensity in both WT and WHAMM KO cells. Quantiﬁcation analysis
displayed that intensity levels of WHAMM KO cells are similar to control levels mea-
sured in WT cells (Figure 4.7, B). These data imply that loss of WHAMM did not
aﬀect actin expression and stress ﬁber formation.
Figure 4.7: Total actin and F-actin intensity levels in WHAMM KO cells. (A) Represen-
tative image of western blots. Lysates of WT and WHAMM KO cells were separated on a SDS gel.
Membrane was blotted for actin and GAPDH was used as loading control. Total actin protein expres-
sion levels were quantiﬁed by densitometry analysis of western blot bands. Data were normalized to
WT protein levels. Data are representative of two independent experiments. (B) F-actin intensities of
WHAMM KO cells in comparison to WT cells were analyzed via CellTracker and phalloidin stainings.
Intensities were measured with ImageJ software and normalized to WT values. n = number of cells
analyzed. Data are representative of two independent experiments. Error bars represent SEM.
In addition, the ER and ERGIC region were also unaﬀected concerning general distri-
bution and network structure (Supplementary data, Figures 6.8 and 6.9), which also
contradicts current data [45]. Since it has been described that WHAMM interacts
with microtubules [20], WT and WHAMM KO cells were stained with an anti-tubulin
antibody. The microtubule pattern of KO cells was unaltered and virtually identical
to WT cells (Figure 4.8).
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Figure 4.8: Microtubules in WHAMM KO ﬁbroblasts are unaltered. Tubulin staining
(green) was used to label the position of microtubules. F-actin (red) was stained by ﬂuorescent
phalloidin. Scale bar: 10µm. Data are derived from one experiment.
WHAMM was described to facilitate and regulate vesicle transport between ER and
Golgi as well as to contribute to the maintenance of Golgi integrity and morphology
[20]. Therefore, I probed whether deletion of WHAMM might cause alterations of
the Golgi complex. To do so, I stained Giantin, a cis-Golgi matrix protein in WT
and WHAMM KO cells (Figure 4.9, A, Supplementary data, Figure 6.10). KO of
WHAMM resulted in noticeable scattering of the Golgi apparatus and an increase
of detectable Golgi fragments in all four clones (Figure 4.9, B-C), whereas WT cells
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expressing WHAMM showed a predominant compact Golgi pattern. While 70% of WT
cells showed a compact Golgi phenotype, only 30% of WHAMM KO cells exhibited a
normally compact Golgi structure. These data support a model, in which WHAMM
impacts on cis-Golgi integrity and organization.
Figure 4.9: Eﬀect of WHAMM KO on Golgi apparatus in NIH/3T3 cells. (A) Repre-
sentative immunoﬂuorescence images of WT cells and WHAMM KO clone #3. The majority of cells
deﬁcient for WHAMM show a disseminated Golgi complex. Giantin staining (green) was used to label
the position of Golgi. DAPI staining (blue) was used as a cellular nucleus marker. Scale bar: 10µm.
(B-C) Quantitative analysis of WT cells versus WHAMM KO clones conﬁrms a signiﬁcant dispersion
of Golgi apparatus in KO cells. Golgi structures were categorized as compact or disseminated. Num-
ber of particles has been assessed using the MosaicSuite tool. n = number of cells analyzed. Data
are representative of three independent experiments. **P  0.01, Two-tailed Student's t-test. Error
bars represent SEM.
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Due to the known involvement of WHAMM in vesicular traﬃcking [20], I aimed at an-
alyzing the dynamics of Golgi disassembly and assembly further. To do so, I conducted
a BFA washout assay in WT and KO cells examining the reassembly of the Golgi com-
plex. BFA is a fungal metabolite that causes disassembly of the Golgi compartment
within 30min of application [96]. To explore potential defects in Golgi reassembly in
WHAMM KO cells, BFA was washed out for various time points followed by Giantin
staining. BFA treatment caused a similar Golgi phenotype in both genotypes, with
the Golgi appearing disseminated (Figure 4.10, A). The number of Golgi fragments
is signiﬁcantly increased in WHAMM KO cells, as already observed earlier (Figure
4.9). Interestingly, in both WT and KO cells the Golgi apparatus reassembled to the
state before BFA treatment with comparable kinetics (Figure 4.10, B) indicating that
WHAMM is not involved in Golgi reassembly from ER membranes upon BFA washout.
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Figure 4.10: Loss of WHAMM leads to a more pronounced Golgi fragmentation but
does not aﬀect Golgi reassembly. (A) Representative immunoﬂuorescence images of WT cells
and two WHAMM KO clones untreated or treated with 2.5µg/mL BFA (+ BFA) for 35min, followed
by replacement of BFA-containing medium with complete culture medium (WO = washout) for the
times indicated. Giantin staining was used to label the position of Golgi. Note that untreated KO cells
display a less organized and less compact Golgi apparatus as compared to control cells, consistent with
previous experiments (Figure 4.9). Scale bar: 10µm. (B) Quantitative analysis of average number of
Golgi fragments in WT cells and WHAMM KO clones. KO clones were normalized to the average
number of Golgi fragments in control cells (Untreated). Both cell lines showed complete recovery from
BFA-treatment. Number of particles has been assessed using the MosaicSuite tool. n = number of
cells analyzed. Data are representative of two independent experiments. Error bars represent SEM.
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4.2.2 The contribution of WHAMM to autophagy
KO cells displayed a signiﬁcant increase in granularity, indicative of an accumulation
of granular particles (e.g. protein aggregates or vesicles) (Figure 4.6, C). WHAMM has
previously been reported to be an important regulator of endomembranes, acting not
only in the ERGIC region but also at the ER during autophagy [20, 44]. Moreover,
it has been shown that WHAMM is involved in autophagosome biogenesis through
an actin-comet tail motility mechanism [44]. An important facet of autophagy is the
production of autophagic vacuoles [97], which may explain increased intracellular gran-
ularity observed in WHAMM KOs. Thus, I aimed at further investigation of the role of
WHAMM during autophagy and examined this process in established WHAMM KO
cells. To explore the function of WHAMM in autophagosome assembly, I compared
WT and KO cells grown under nutrient-rich (fed or basal) versus starvation conditions,
the latter is a well-known inducer of autophagy via the mTOR pathway [68, 78]). I
investigated the mTOR pathway by western blotting and visualized the formation of
omegasomes, autophagosomes, and lysosomes by staining for the distribution of diﬀer-
ent autophagy markers, including DFCP1, ATG9, LC3, p62, and LAMP1.
As mTOR is a prominent inhibitor of autophagy, I ﬁrst examined expression of mTOR
and p-mTOR via western blotting. Interestingly, protein expression levels of mTOR
under basal conditions were signiﬁcantly reduced by about 20% in WHAMM KO cells
(Figure 4.11, A), but surprisingly displayed a clear upregulation of p-mTOR (Figure
4.11, B). This phenotype suggests that the absence of WHAMM increases active mTOR
levels together with a downregulation of total mTOR protein levels to counterbalance
overactivation.
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Figure 4.11: WHAMM KO cells exhibit lower expression of mTOR, but increased
mTOR phosphorylation. (A) Total mTOR protein expression levels were quantiﬁed by densitom-
etry analysis of western blot bands. Lysates of WT and WHAMM KO cells were separated on a SDS
gel. Membrane was blotted for mTOR and Tubulin was used as loading control. Data were normalized
to WT protein levels. (B) Total p-mTOR protein expression levels were quantiﬁed by densitometry
analysis of western blot bands. Lysates of WT and WHAMM KO cells were separated on a SDS gel.
Membrane was blotted for p-mTOR and Tubulin was used as loading control. Data were normalized
to WT protein levels. (A-B) One representative blot is shown of three independent experiments. **P
 0.01, Two-tailed One-Sample t-test. Error bars represent SEM.
Another interesting aspect with regard to autophagy was to investigate the number
and distribution of ATG9-positive vesicles, which are important membrane sources
during early steps of autophagy [81]. ATG9 mainly resides in the Golgi apparatus but
under starvation conditions, it partially colocalizes with markers of early endosomes
and recycling endosomes [98]. Since it is known that WHAMM associates with Golgi
membranes [20], I asked whether WHAMM might facilitate ATG9 transport. If so, I
expected an accumulation of ATG9 vesicles in WHAMM KO cells. So far, preliminary
analysis of immunoﬂuorescence images displayed small ATG9-containing structures in
WT cells under basal conditions, which were distributed in a normal fashion throughout
the cytoplasm, whereas WHAMM KO cells showed larger ATG9 clusters (Figure 4.12,
A). Moreover, the majority of ATG9 spots in WHAMM KO cells was positioned in the
perinuclear region (Figure 4.12, A) and their number was clearly reduced as compared
to WT cells (Figure 4.12, B).
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Figure 4.12: ATG9 distribution in WHAMM KO cells. (A) Representative immunoﬂuores-
cence images of WT and WHAMM KO cells. ATG9 was used to label ATG9-containing structures
(single-membrane vesicles). The majority of ATG9-positive structures accumulated in the juxta-
perinuclear region under fed conditions. Arrowheads indicate enlarged ATG9 dots in KO cells. Scale
bar: 10µm. (B) Quantitative analysis of WT cells versus WHAMM KO clones conﬁrms a decreased
number of ATG9 puncta per cell in WHAMM-deﬁcient cells under fed conditions. Number of particles
has been assessed using the MosaicSuite tool. n = number of cells analyzed. Data are derived from
one experiment. Error bars represent SEM.
Total ATG9 protein expression levels were tested by western blotting under both fed
and starvation conditions with the help of Silvia Prettin (HZI, Braunschweig). How-
ever, preliminary data uncovered strikingly diﬀerent protein expression levels of ATG9
among WHAMM KO clones (data not shown). To probe for RNA levels, I examined
the expression proﬁles of various ATG genes including ATG9 from GeneChip Arrays
with the help of Robert Geﬀers (HZI, Braunschweig), which are shown in Figure 6.19
(Supplementary data), however, with no signiﬁcant result.
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I also inspected the localization of DFCP1, an early autophagy marker found on omega-
somes, by transfecting ﬁbroblasts with EGFP-tagged DFCP1. EGFP-DFCP1-coated
omegasomes were formed in both genotypes. However, WHAMM depletion resulted in
a marked accumulation of enlarged EGFP-DFCP1-positive structures (Figure 4.13, A,
Supplementary data, Figure 6.11) under fed conditions. Strikingly, omegasomes tended
to accumulate in clusters in WHAMM KO cells, whereas singular structures predom-
inantly appeared in WT cells. Clustering of omegasomes was also conﬁrmed with
superresolution microscopy (data not shown). I quantiﬁed the number and size of clus-
tered DFCP1 structures aﬃrming a distinct increase in both parameters in WHAMM
KOs (Figure 4.13, B-C). These data suggest a defect in early autophagy upon ablation
of WHAMM. Omegasome formation was also visualized with live cell imaging to inves-
tigate whether DFCP1 spots in KO cells display alterated kinetics. Preliminary data
of EGFP-DFCP1 structures revealed no diﬀerence in DFCP1 puncta formation in fed
and starvation medium (data not shown). Omegasomes in both WT and WHAMM
KO cells appeared mobile and dynamic.
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Figure 4.13: WHAMM KO leads to an accumulation of omegasomes. (A) Representative
immunoﬂuorescence images of WT cells and WHAMM KO clone #2. EGFP-DFCP1 was used to
label the position of omegasomes. WHAMM KOs in general exhibited an accumulation of DFCP1-
positive structures under fed conditions. Scale bar: 10µm. (B) Accumulated DFCP1 structures
are increased in WHAMM KO cells under fed conditions. (C) WHAMM KO cells contain enlarged
DFCP1 structures under fed conditions. (B-C) n = number of cells analyzed. Data are representative
of three independent experiments. *P  0.05, ****P  0.0001, Two-tailed Student's t-test. Error
bars represent SEM.
Next, I determined whether WHAMMKO has an eﬀect on autophagosome maturation.
Therefore, I investigated the lipidated form of LC3, LC3-II, under fed and starved
conditions in WT versus KO cells by western blotting. However, results only showed
either a diﬀused or weak antibody staining, especially for LC3-I detection, which could
not be quantiﬁed (Supplementary data, Figure 6.12). To circumvent this, I performed
immunoﬂuorescence staining for LC3 (Figure 4.14, A). Interestingly, initial localization
analysis showed that autophagic vesicles in WHAMM KO cells are more frequently
found in the perinuclear region of the cell as compared to WT cells (Figure 4.14, B-C).
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Figure 4.14: WHAMM KO aﬀects distribution of autophagosomes. (A) Representative
immunoﬂuorescence images of WT cells and two WHAMM KO clones. LC3 was used to label the
position of autophagosomes. WHAMM KOs in general exhibited a perinuclear localization of LC3-
positive structures under fed conditions (indicated by arrow heads). Drawn circles indicate cell nuclei.
Scale bar: 20 µm. (B) Preliminary analysis of WT cells versus WHAMM KO clones indicates a per-
inuclear distribution of LC3 puncta in WHAMM-deﬁcient cells under fed conditions. (C) Preliminary
analysis of WT cells versus WHAMM KO clones show a perinuclear distribution of LC3 puncta in
WHAMM-deﬁcient cells under starvation conditions. (B-C) n = number of cells analyzed. Data are
derived from one experiment.
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Analysis of the total number of LC3 puncta per cell showed that the quantity of LC3
vesicles was similar in both WT and KO cells during fed conditions (Figures 4.15, A and
4.18, A), but decreases upon prolonged starvation in WT cells, indicative for increased
autophagic degradation of LC3-II-labeled structures. Whereas the basal level of LC3-
positive structures was almost identical in both genotypes, the number of LC3 puncta
per cell in KO cells was markedly higher upon starvation than that in WT cells (Figure
4.15, A, Supplementary data, Figures 6.13 and 6.14), leading to a drastic diﬀerence in
the number of LC3-vesicles between WT and KO cells. In fact, KO cells on average
showed a 50% - 75% increase of LC3 vesicles per cell in comparison to WT cells. The
increase of LC3 dots in WT cells upon starvation was very moderate in comparison
to that in KO cells, indicative of an accumulation of autophagosomes in WHAMM
KO cells due to impaired degradation during autophagic ﬂux. Also note that the
ratio between untreated and starved NIH/3T3 WT cells was not remarkably altered,
indicating that shorter starvation time points might be necessary to assess increased
autophagy due to amino acid deprivation. Moreover, the total area of autophagosomes
per cell was signiﬁcantly elevated in comparison to WT cells upon starvation (Figure
4.15, B, Supplementary data, Figures 6.13 and 6.14), suggesting a defect in vesicle
fusion or ﬁssion. In order to better understand the autophagic ﬂux in WT and KO
cells, I chose additional approaches to assess LC3 turnover.
Figure 4.15: WHAMM KO aﬀects number and total area of autophagosomes. (A)
Quantitative analysis of WT cells versus WHAMM KO clones conﬁrms an increased number of LC3
puncta per cell in WHAMM-deﬁcient cells under starvation conditions. (B) Quantitative analysis of
WT cells versus WHAMM KO clones shows no diﬀerences in the total area occupied by LC3-positive
vesicles under fed conditions, whereas starvation leads to larger LC3-positive vesicles in WHAMM-
deﬁcient cells. (A-B) Particle analysis has been performed with the Threshold function (see Materials
and Methods). n = number of cells analyzed. Data are representative of at least two independent
experiments. *P 0.01, **P 0.01, ****P 0.0001, Two-tailed Student's t-test. Error bars represent
SEM.
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Thus, autophagic activity in WHAMM KO cells was also measured by ﬂow cytome-
try. This methodology is based on the fact that LC3 serves as a potential autophagic
substrate for degradation. Therefore, changes in total intracellular LC3 ﬂuorescence
intensity were used as an indicator of cellular autophagic activity in WT and KO cells.
Representative plots of untreated cells are shown in Figure 6.17 A (Supplementary
data). As expected, WHAMM KO cells showed a higher ﬂuorescence intensity com-
pared to WT cells (Supplementary data, Figure 6.17, B) supporting my previous notion
that autophagic material preferentially accumulates in WHAMM KO cells, indicative
of dysregulated autophagy.
Another assay to monitor autophagic ﬂux is the inhibition of autophagosome degra-
dation. Therefore, cells were kept under starvation conditions and/or treated with
BafA1. This inhibitor is known to block the acidiﬁcation inside the lysosome as well as
autophagosome-lysosome fusion, thereby preventing LC3-II degradation [99]. Accord-
ingly, diﬀerences in the amount of LC3-II in the presence and absence of a lysosomal
inhibitor represent the amount of LC3 that is delivered to lysosomes for degradation
(i.e. autophagic ﬂux). Fed conditions with BafA1 resulted in no signiﬁcant diﬀerence
in the number and size of LC3 puncta in both WT and WHAMM KO cells (Figures
4.16, A-B and 4.19, A). However, KO cells showed a clear increase of autophagic vac-
uoles after starvation and BafA1 treatment compared to WT cells (Figure 4.16, A and
Supplementary data, Figures 6.15 and 6.16). In fact, data displayed more than 70
LC3-positive dots in KO cells, while WT ﬁbroblasts carried less than 40 LC3 vesicles
per cell. Furthermore, these particles were again increased in size (Figure 4.16, B).
However, NIH/3T3 WT and KO ﬁbroblasts in general displayed a somewhat untyp-
ical nucleus staining for LC3 making it partially challenging to monitor endogenous
LC3 by immunoﬂuoresence (see discussion). Nonetheless, autophagosomes strikingly
appeared to accumulate in WHAMM KO cells under starvation and BafA1 treatment,
exempliﬁed by signiﬁcant diﬀerences between WT and WHAMM KO cells. Moreover,
an accumulation of LC3-positive spots upon starvation plus BafA1 treatment corre-
sponds to the expected dynamics, indicative of impaired autophagic ﬂux and thereby
conﬁrming previous assumptions. In summary, these data suggest that WHAMM de-
ﬁciency leads to a stronger increase of autophagosomes under amino acid deprivation
and lysosomal block conditions.
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Figure 4.16: Eﬀect of WHAMM KO on autophagic ﬂux. (A) Analysis of WT cells versus
WHAMM KO clones conﬁrms an increased number of LC3 puncta per cell in WHAMM-deﬁcient cells
under starvation and/or BafA1 treatment. (B) Analysis of WT cells versus WHAMM KO clones leads
to larger LC3-positive vesicles in WHAMM-deﬁcient cells under starvation and/or BafA1 treatment.
(A-B) Particle analysis has been performed with the Threshold function (see Materials and Methods).
n = number of cells analyzed. Data are representative of two independent experiments. *P 0.05,
**P 0.01, ***P 0.001, ****P 0.0001, Two-tailed Student's t-test. Error bars represent SEM.
To clarify observed eﬀects of WHAMM KO on autophagy, I also examined the p62
level by both western blotting and immunoﬂuorescence. p62 is a carrier protein se-
lectively incorporated into autophagosomes through direct binding to LC3. Induction
of autophagy leads to its degradation [99, 100], which can be utilized as readout. In
fact, the steady-state p62 level is widely used as a marker of autophagy degradation
activity.
Strikingly, p62 protein expression levels in WHAMM KO cells were strongly increased
under both fed and starvation conditions compared to WT ﬁbroblasts (Figure 4.17, B).
Loss of WHAMM resulted in a 2.5-fold increase of p62 under nutrient rich conditions
compared to WT cells. During prolonged starvation, protein expression levels of p62
were slightly increased (early starvation time points), but not signiﬁcantly changed in
WT cells. In contrast, p62 was more abundant in KOs than in WT cells. In fact, a
signiﬁcantly higher amount of p62 was detected in WHAMM KOs upon starvation,
which initially increased and then dropped below starting levels. This result suggests
once more that material which is dedicated to autophagic degradation accumulates
faster and to a greater extent in WHAMM KO cells.
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Figure 4.17: Quantiﬁcation of p62 levels after HBSS treatment. (A) Representative image
of western blots. Cells were seeded and starved with HBSS for the indicated time points. Lysates
of WT and WHAMM KO cells were separated on a SDS gel. Membrane was blotted for p62 and
GAPDH was used as loading control. Data are representative of three independent experiments. (B)
Total p62 protein expression levels were quantiﬁed by densitometry analysis of western blot bands.
Data were normalized to untreated WT protein levels. Data are representative of three independent
experiments. *P 0.05, ***P 0.001, Two-tailed Student's t-test. Error bars represent SEM.
Western blot data were additionally veriﬁed by staining endogenous p62 by immunoﬂu-
orescence. Microscopic analyses showed a clear diﬀerence of p62 spots per cell between
WT and KO cells during fed conditions (Figure 4.18, A-B). Moreover, a signiﬁcant
increase of p62 puncta per cell was detected in both genotypes upon starvation, fol-
lowed by a reduction during prolonged starvation, most likely reﬂecting degradation
(Figure 4.18, B, Supplementary data Figures 6.13 and 6.14). However, also in this
assay the number of p62-positive structures was signiﬁcantly higher in WHAMM KO
cells, suggesting that loss of WHAMM impairs the autophagic process. The total area
of p62-positive structures per cell seemed to be not signiﬁcantly diﬀerent between the
genotypes and tended to decrease upon starvation (Figure 4.18, C, Supplementary
data, Figures 6.13 and 6.14).
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Figure 4.18: WHAMM KO aﬀects number of p62-positive spots. (A) Representative
immunoﬂuorescence images of WT cells and WHAMM KO clones. Basal level of autophagy was
studied with autophagy markers LC3 (red) and p62 (green). Scale bar: 20µm. (B) Quantitative
analysis of WT cells versus WHAMM KO clones conﬁrms an increased number of p62 puncta per cell
in WHAMM-deﬁcient cells under fed and starvation conditions. (C) Quantitative analysis of WT cells
versus WHAMM KO clones shows no diﬀerences in the total area occupied by p62-positive vesicles
under fed and starvation conditions. (B-C) Particle analysis has been performed with the Threshold
function (see Materials and Methods). n = number of cells analyzed. Data are representative of at
least two independent experiments. **P 0.01, ***P 0.001, ****P 0.0001, Two-tailed Student's
t-test. Error bars represent SEM. 86
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Finally, additional treatment with BafA1 resulted in further accumulations of p62
puncta in both genotypes, which was again more pronounced in WHAMM KO cells
(Figure 4.19, A). The number of p62-particles slowly decreased during prolonged star-
vation in WT ﬁbroblasts, whereas p62-accumulation in WHAMM KOs did not fade
and instead cells showed persistent p62-levels upon starvation. In addition, these ac-
cumulated p62 punctae were signiﬁcantly larger than those of WT cells (Figure 4.19,
B).
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Figure 4.19: Eﬀect of WHAMM KO on autophagic ﬂux. (A) The autophagic ﬂux was
further investigated by HBSS treatment in the presence of BafA1 and studied with autophagy markers
LC3 (red) and p62 (green). (B) Analysis of WT cells versus WHAMMKO clones conﬁrms an increased
number of p62 puncta per cell in WHAMM-deﬁcient cells under starvation and/or BafA1 treatment.
(C) Analysis of WT cells versus WHAMM KO clones conﬁrms a larger area occupied by p62-positive
vesicles in WHAMM-deﬁcient cells under starvation and/or BafA1 treatment. (B-C) Particle analysis
has been performed with the Threshold function (see Materials and Methods). n = number of cells
analyzed. Data are derived from one experiment. *P 0.05, **P 0.01, ***P 0.001, ****P 0.0001,
Two-tailed Student's t-test. Error bars represent SEM.
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p62 has a dual role in intracellular proteolysis: It can not only interact with ubiquiti-
nated proteins via its C-terminal ubiquitin-associated domain, but also binds directly
to LC3 and GABARAP family proteins via its LIR motif. Consequently, p62 shut-
tles ubiquitinated proteins to the autophagic machinery enabling their degradation in
the lysosome [101, 102]. Additionally, it is known that p62 is involved in ubiquitin-
dependent proteasomal degradation [103, 104]. Hence, an accumulation of p62 ob-
served in Figures 4.17, 4.18 and 4.19 might not only result from hindered autophagy
but also from an inhibition of the ubiquitin-proteasome pathway due to the intro-
duced gene KO. To analyze whether WHAMM KO aﬀects proteasomal degradation of
poly-ubiquitinated proteins, I performed western blotting of whole cell lysates of WT
and KO cells and probed for the abundance of poly-ubiquitinated proteins. Results
did not show any signiﬁcant diﬀerence in the pattern of poly-ubiquitinated proteins
(Figure 4.20) indicating that WHAMM KO more likely and more strongly aﬀects the
autophagic machinery than the ubiquitin-proteasome pathway.
Figure 4.20: Western blot analysis of total ubiquitin-bound protein levels in WHAMM
KO cells. Representative image of western blots. Lysates of WT and WHAMM KO cells were sepa-
rated on a SDS gel. Membrane was blotted for ubiquitin. Data are representative of two independent
experiments.
Lysosomes are the ﬁnal destination of the autophagic pathway [105]. Impaired au-
tophagy (see Figures 4.15 and 4.18) might be a result of lysosomal dysfunction in-
duced by the deletion of whamm. Although earlier work has implied WHAMM in
early autophagosome biogenesis [44], I aimed at formally excluding additional defects
in later steps of autophagy, such as autophagosome-lysosome fusion. An accumulation
of lysosomes might indicate impaired autophagosome-lysosome fusion and a block of
the autophagic ﬂux. Therefore, I visualized lysosomes with LAMP1 staining under
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basal and starvation conditions. Results revealed that the number of LAMP1 spots in
WHAMM KO cells is increased in comparison to WT cells (Figure 4.21, A). Moreover,
the number gradually increased in KO cells, whereas WT cells revealed similar amounts
of LAMP1 spots upon both fed and starvation conditions. I also found that WHAMM
KO cells contain a larger portion of bigger structures as compared to WT cells under
both basal and starvation conditions (Figure 4.21, B). Culturing both genotypes under
fed conditions resulted in virtually 50% more of enlarged LAMP1-spots in WHAMM
KOs as compared to WT cells. This eﬀect slowly faded upon starvation but WHAMM
KO cells contained still higher numbers of bigger lysosomes per cell in comparison to
WT cells. This data uncover that WHAMM ablation also results in enlarged lysosomes
(Figure 4.21, C) supporting the assumption of possible defects in vesicle fusion or ﬁs-
sion.
Collectively, the data on DFCP1, LC3, p62, and LAMP1 support the notion that au-
tophagosome formation and maturation as well as later fusion events are aﬀected due to
the absence of WHAMM pointing to a defect in membrane ﬁssion and/or fusion. This
might lead to an inhibited autophagic ﬂux and ﬁnally to a congestion of autophagic
material destined for degradation.
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Figure 4.21: WHAMM KO aﬀects number and size of LAMP1 spots. (A) Quantitative
analysis of WT cells versus WHAMM KO clones conﬁrms an increased number of LAMP1 spots
per cell in WHAMM-deﬁcient cells under fed and starvation conditions. (B) Quantitative analysis of
WT cells versus WHAMM KO clones shows diﬀerences in the number of larger lysosomes per cell
in WHAMM-deﬁcient cells under fed and starvation conditions. (A-B) Data are representative of
at least two independent experiments. *P 0.05, Two-tailed Student's t-test. Error bars represent
SEM. (C) Representative immunoﬂuorescence images of WT cells and two WHAMM clones under fed
conditions. Cells deﬁcient in whamm show enlarged lysosomal structures. Scale bar: 10µm.
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The quantitative power of ﬂow cytometry has also been used for a deeper LAMP1
analysis (Supplementary data, Figure 6.17). As performed for LC3, non-starved and
starved cells were analyzed for changes in their ﬂuorescence intensity. Preliminary
results exhibited an increase in ﬂuorescence in WHAMM KO cells (Supplementary
data, Figure 6.18). This data is consistent with previous data (see Figure 4.21) and
indicates once more that loss of WHAMM leads to an accumulation of lysosomes.
4.2.3 Gene regulation and cholesterol homeostasis in WHAMM KO cells
To get a deeper insight into WHAMM KO imposed cellular changes and the alter-
ations in autophagy described above, I performed cDNA microarray analyses of WT
and WHAMM KO cells with the help of Robert Geﬀers (HZI, Braunschweig). Two
diﬀerent WT samples (ran in duplicates) served as controls and were compared to
WHAMM KO clones #2, #3, #7, and #11. Heatmaps in Figure 4.22 display the
diﬀerential expression of the top 500 (A) as well as top 50 genes (B). WHAMM KO
cells revealed a distinct gene expression pattern compared to WT cells. All KO clones
clustered and deviated from WT samples, suggesting that loss of WHAMM has an
impact on the expression proﬁle. Interestingly, WT samples were more similar to each
other than KO samples, which might indicate that gene disruption of WHAMM posses
a signiﬁcant pressure on the surviving of cell clones. I searched for the top 50 genes
(done by Robert Geﬀers) and data analyses revealed two major gene clusters (indicated
by red and green boxes) (Figure 4.22, B). I analyzed both clusters and identiﬁed diﬀer-
entially expressed genes between WT and KO cells, such as acly and tm7sf2 or lrrk2.
The formers are known to be involved in lipid synthesis, whereas Lrrk2 is a positive
regulator of autophagy (Supplementary data, Table 6.1). Moreover, other interesting
genes diﬀerentially expressed in WHAMM KOs are involved in the budding of vesi-
cles from the Golgi apparatus (i.e. ap3s1 ps1/ps2 ), play a role in maintaining normal
plasma cholesterol levels (i.e. pdzk1ip1 ) or have been associated with remodeling of the
actin cytoskeleton (i.e. gmpr). Interestingly, WHAMM functions in ER to cis--Golgi
transport [20] and it was also connected to drive autophagy through a mechanism de-
pendent on actin assembly [44]. Therefore, a comparison between new data shown by
this and previous chapters as well as published studies indicates a direct link between
WHAMM, eﬃcient vesicle ﬁssion and/or fusion, and autophagy.
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Figure 4.22: Heat maps of gene expression in WHAMM KO cells. Heatmaps depicting
diﬀerential expression of top 500 (A) as well as top 50 genes showing two major clusters of genes
(indicated by red and green boxes) (B) between control and KO conditions. Each horizontal line
displays one of the top regulated genes. Red indicates higher expression and green indicates lower
expression. Microarray analysis was performed with the help of Robert Geﬀers (HZI, Braunschweig).
Data are derived from one experiment measuring WT control samples in duplicates and four WHAMM
KO cell lines.
I next examined whether WHAMM KO impairs the expression of WASH or JMY
genes. Indeed, WASH messenger RNA (mRNA) levels were decreased in cells lacking
WHAMM, whereas no changes in JMY mRNA levels were detected (Figure 4.23, A-
B). However, an additional analysis by western blotting revealed that neither WASH
protein levels nor JMY protein levels were altered in comparison to WT cells (Figure
4.23, C-D), indicating that loss of WHAMM does not aﬀect abundance of WASH or
JMY.
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Figure 4.23: WASH and JMY mRNA and protein levels in WHAMM KO cells. (A-B)
Relative mRNA expression of WASH and JMY in WHAMM KO cells. Gene expression was assessed
by microarray analysis and normalized to WT levels. Data are derived from one experiment. (C-D)
Total WASH and JMY protein expression levels were quantiﬁed by densitometry analysis of western
blots bands. Data were normalized to WT protein levels. Data are representative of two independent
experiments. (A-D) *P  0.05, Two-tailed Student's t-test. Error bars represent SEM.
The observations described in Chapter 4.2.2 suggest that autophagy is aﬀected due
to WHAMM deletion in NIH/3T3 cells. Therefore, expression pattern of several au-
tophagy markers were analyzed and are depicted in Figures 4.24 and 6.19. mRNA
Expression of DFCP1 and LC3B were signiﬁcantly downregulated in WHAMM KO
cells (Figure 4.24, A-B), whereas expression levels of p62 was unaltered (Figure 4.24,
C). Data also revealed that LAMP1 mRNA expression tends to be decreased compared
to WT levels (Figure 4.24, D). These results are suggestive of a compensatory restric-
tion/reduction of DFCP1 and LC3 transcription to counteract protein accumulation,
which might be due to an impeded autophagic ﬂux.
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Figure 4.24: mRNA levels of important autophagy markers. Relative mRNA expression of
DFCP1 (A), LC3B (B), p62 (C), and LAMP1(D) in WT and WHAMM KO cells. Gene expression was
assessed by microarray analysis and normalized to WT levels. Data are derived from one experiment.
*P  0.05, ****P  0.0001, Two-tailed Student's t-test. Error bars represent SEM.
Interestingly, expression cluster analysis of microarray data revealed a down- and up-
regulation of genes involved in cholesterol biosynthesis, such as DHCR7 and SOAT1
(Figure 4.25, A-C, Supplementary data, Figure 6.21), as well as an impact on genes
involved in adhesion signaling (Supplementary data, Figure 6.22). In order to validate
microarray data, qPCR was performed to assess gene expression levels of DHCR7 and
SOAT1. However, results depicted in Figure 6.20 (Supplementary data) showed dis-
crepancies in transcript levels determined by qPCR.
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Figure 4.25: Gene regulation in WHAMM KO cells. (A-C) Relative mRNA expression of
DHCR7 and SOAT1/2 in WHAMM KO cells. Gene expression was assessed by microarray analysis
and normalized to WT levels. Data are derived from one experiment. ***P  0.0005, ****P 0.0001,
Two-tailed Student's t-test. Error bars represent SEM.
Aside from this data, an intimate relationship between cholesterol content and integrin
adhesion has been described in detail [106,107]. Lipids also regulate lysosome function
and autophagy [108]. They stimulate covalent modiﬁcation of proteins to ensure proper
membrane targeting to initiate isolation membrane elongation and autophagosome clo-
sure. Finally, lipids directly aﬀect lipid bilayers by controlling their physicochemical
properties [109]. For instance, cholesterol contributes to membrane ﬂuidity and is cru-
cial in membrane traﬃcking as well as transmembrane signaling processes. De novo
cholesterol biosynthesis takes place in the smooth ER [110]. It was shown that deple-
tion of cholesterol activates autophagy in human ﬁbroblasts [111], whereas an overload
in total cellular cholesterol may aﬀect autophagosome clearance [112,113].
As shown by microarray analysis, cholesterol biosynthesis might be altered in WHAMM
KO cells. To test if this is also mirrored by cholesterol content or cholesterol distri-
bution in WHAMM KO cells, I employed ﬁlipin labeling (Figure 4.26, A). Filipin is
a naturally ﬂuorescent polyene antibiotic and a widely used tool for detection of free
cholesterol in vitro [114].
It should be noted, that cells cultured in regular FBS containing medium are constantly
exposed to a number of steroids as FBS itself carries large amounts of cholesterol.
Therefore, culturing under serum starvation condition was necessary. Cell culture
medium was supplemented with ITS-G to still enable optimal growth conditions for
ﬁbroblasts. However, both WT and WHAMM KO cells showed similar ﬁlipin staining
intensities per cell (Figure 4.26, B). Furthermore, the localization pattern of ﬁlipin
spots was also unchanged between WT and WHAMM KO clones (Figure 4.26, C).
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However, WT cells showed a spotted staining and clearly outlined vesicular structures,
whereas WHAMM-deﬁcient cells prevalently displayed a less deﬁned staining of ﬁlipin
spots (Figure 4.26, A).
Figure 4.26: Cholesterol analysis in WHAMM KO cells. (A) Representative immunoﬂuo-
rescence images of WT cells and WHAMM KO clones. Filipin staining was used to label unesteriﬁed
cholesterol. Scale bar: 20µm. (B) Intensities were measured with ImageJ software and normalized to
WT values. (C) Localization of ﬁlipin spots in WT and WHAMM KO cells. (B-C) n = number of
cells analyzed. Data are representative of three independent experiments. Error bars represent SEM.
I additionally analyzed the cholesterol levels in whole cell extracts using a commercial
Amplex® Red Cholesterol Assay Kit. Two diﬀerent lysis buﬀers were applied, but the
data obtained exhibited no signiﬁcant changes between WT and WHAMM KO cells
(Figure 4.27, A-B) suggesting that the cholesterol content was unaﬀected by WHAMM
KO.
97
4 Results
Figure 4.27: Cholesterol concentration in WHAMM KO cells. (A-B) WT and WHAMM
KO cells were lysed with Amplex lysis buﬀer I or Amplex lysis buﬀer II and cellular cholesterol
content was measured using AmplexTM Red Cholesterol Assay Kit. Data are representative of two
independent experiments. Error bars represent SEM.
Microarray analyses revealed that WHAMM KO impairs extracellular matrix (ECM)
and integrin alpha subunits (ITGA) signaling (Supplementary data, Figure 6.22), in
particular spp1 (encoding secreted phosphoprotein 1), itga10 (encoding integrin-10),
and adamts4 (encoding a disintegrin and metalloproteinase) gene expression was down-
regulated in WHAMM KO cells. Thus, I decided to analyze the adhesion pattern of
mutated ﬁbroblasts. WT and WHAMM KO cells were stained for the focal adhesion-
associated proteins vinculin and paxillin.
Important to note is that immunoﬂurescence images displayed partly a high background
staining as well as KO cells tended to depict a strong perinuclear signal after vinculin
staining. Both remarks made it challenging for the automated detection by Mosaic-
Suite to distinguish between positive and negative particles (i.e. to detect actual focal
adhesions). Therefore, I double-checked the quantiﬁcation procedure and recognized
that numerous false positive structures have been detected but I also false negative
structures that have not been considered (Figure 4.28, see Materials and Methods,
Figure 3.5).
So far, immunoﬂuorescence stainings of vinculin revealed that loss of WHAMM re-
sulted in similar numbers numbers of focal adhesions compared to WT cells, while the
length and the average intensity were signiﬁcantly decreased in WHAMM KOs (Figure
4.29, A-B). Further analyses showed that neither vinculin transcript (Figure 4.29, C)
nor protein expression levels (Figure 4.29, D) were signiﬁcantly up- or downregulated
in WHAMM KO cells.
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Figure 4.28: Analysis of vinculin-containing focal adhesions by MosaicSuite. Representa-
tive immunoﬂuorescence images of WT cells and two WHAMM KO clones. Vinculin was used to label
the position of focal adhesions. Number, length, and intensity of focal adhesions were investigated
in both NIH/3T3 WT and WHAMM KO cells. The MosaicSuite tool was applied to analyze focal
adhesions. Note that the second panel depicts a cropped image version. Scale bar: 20µm.
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Figure 4.29: Analysis of vinculin-containing focal adhesions in WHAMM KO cells. (A)
Representative immunoﬂuorescence images of WT cells and two WHAMM KO clones. Vinculin was
used to label the position of focal adhesions. Focal adhesions in WHAMM KOs appeared smaller
compared to WT cells. Scale bar: 20µm. (B) Preliminary analysis of WT cells versus WHAMM KO
clones revealed that both genotypes exhibited similar numbers of focal adhesions per cell. In addition,
length, and average focal adhesion intensity were decreased in KO cells. Number of focal adhesions
has been assessed using the MosaicSuite tool. n = number of cells analyzed. Data are representative of
two independent experiments. ****P 0.0001, Two-tailed Student's t-test. Error bars represent SEM.
(C) Relative mRNA expression of Vinculin in WHAMM KO cells. Gene expression was assessed by
microarray analysis and normalized to WT levels. Data are derived from one experiment. Error bars
represent SEM. (D) Total Vinculin protein expression level was quantiﬁed by densitometry analysis
of western blots bands. Data were normalized to WT protein levels. Data are representative of three
independent experiments. Error bars represent SEM.
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Immunoﬂuorescence, stainings were repeated with paxillin, a protein that also localizes
to focal adhesions. Preliminary experiments revealed a slight increase of focal adhesions
per cell in WHAMM KO cells (Figure 4.30, A-B). Consistent with previous vinculin
stainings, KO cells showed a signiﬁcant reduction in focal adhesions length as well
as intensity (Figure 4.30, B). Paxillin mRNA expression levels in WHAMM KO cells
were roughly equal to those in WT cells, but protein expression results showed a slight
decrease (Figure 4.30, C-D). Overall, these data suggest that genetic removal of whamm
leads to smaller adhesion sites that exhibit less intensity, but future work is necessary
in order to conﬁrm these assumptions.
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Figure 4.30: Analysis of paxillin-containing focal adhesions in WHAMM KO cells. (A)
Representative immunoﬂuorescence images of WT cells and two WHAMM KO clones. Paxillin was
used to label the position of focal adhesions. Focal adhesions in WHAMM KOs appeared smaller, but
cells exhibit an increased number compared to WT cells. Scale bar: 20µm. (B) Preliminary analysis
of WT cells versus WHAMM KO clones revealed increased adhesion numbers per cell. In addition,
length, and average focal adhesion intensity were decreased in KO cells. Number of focal adhesions
has been assessed using the MosaicSuite tool. n = number of cells analyzed. Data are representative of
two independent experiments. ****P 0.0001, Two-tailed Student's t-test. Error bars represent SEM.
(C) Relative mRNA expression of Paxillin in WHAMM KO cells. Gene expression was assessed by
microarray analysis and normalized to WT levels. Data are derived from one experiment. Error bars
represent SEM. (D) Total Paxillin protein expression level was quantiﬁed by densitometry analysis
of western blots bands. Data were normalized to WT protein levels. Data are representative of two
independent experiments. ***P 0.001, Two-tailed One-Sample t-test. Error bars represent SEM.
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4.2.4 Viral infection studies in WHAMM KO cells
WHAMM is known to allow Arp2/3 complex activation, which in turn forms actin
ﬁlament branches on endomembranes [3], which are utilized by viruses for their prop-
agation. Viruses have evolved highly varied strategies for manipulating the actin cy-
toskeleton, critical for viral replication at many stages of the viral life cycle such as
binding, entry, and traﬃcking [115]. A study from 2009 showed that VSV-containing
vesicles depend on actin for their internalization [116]. A crucial role for actin was
also reported for entry of HSV-1. Virus particles attached to human corneal ﬁbrob-
lasts and nectin-1-expressing CHO cells, activated both Cdc42 and RhoA, resulting in
ﬁlopodium-like protrusions. HSV-1 particles preferentially associated with these pro-
trusions and treating cells with actin-depolymerizing drugs such as Cyto D and Lat B
blocked HSV-1 internalization [65].
I asked whether altered endomembrane traﬃcking in WHAMM KO cells also aﬀects
virus propagation. Thus, the following experiments were meant to preliminarily test if
virus infections are suited to learn more about whamm deﬁciency in cells. I conducted
infection experiments with VSV and HSV-1 in cooperation with Mario Schelhaas (Uni-
versity Münster) and Ulrich Kalinke (Twincore, Hanover), respectively. In the ﬁrst
experiment, I assessed the eﬃcacy of infection by quantifying the number of infected
cells of all genotypes by ﬂow cytometry. A GFP reporter was used to provide in-
formation about uninfected and infected cells. Cells were mock infected or infected
with EGFP-VSV or EGFP-HSV-1 at a MOI of 5.5. The experiment revealed that
WHAMM KO cells tend to be less susceptible to both VSV and HSV-1 compared to
WT cells (Figure 4.31, Supplementary data, Figures 6.23 and 6.24). In the case of
HSV-1, WHAMM#3 even showed 50% less GFP-positive cells in comparison to WT
cells, indicating that WHAMM might be an interesting protein important for viral
infection processes.
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Figure 4.31: VSV and HSV-1 infection in WHAMM KO cells. (A) GFP-positive cells after
VSV infection. Cells were seeded, infected with VSV and inspected after 6 hpi and 12 hpi, respectively.
WHAMM#3 exhibited reduced VSV infection. (B) GFP-positive cells after HSV-1 infection. Cells
were seeded, infected with HSV-1 and inspected after 12 hpi, respectively. WHAMM#3 exhibited
reduced HSV-1 infection. (A-B) Mock infection was used as negative control. Vero cell line was
utilized as infection control. Data are derived from one experiment.
VSV and HSV-1 infection in WHAMM KO cells was additionally investigated using a
plaque assay. I already observed in preliminary experiments that WHAMM KO cells
showed less entry of VSV and HSV-1 compared to WT cells (data not shown). The
plaque assay was performed once with three WHAMM KO clones. However, the total
virus titer (PFU) of VSV was only diminished in two WHAMM KO cell lines (data
not shown). Infection with HSV-1 also resulted in opposite ﬁndings (data not shown).
Based on these observations, the entry mechanism of VSV and HSV-1 into WHAMM-
deﬁcient cells might be aﬀected but further experiments are necessary in order to revise
contradictory data.
Finally, I visualized the dynamics of infection using live cell imaging of EGFP-tagged
VSV particles (EGFP-VSV) in WT and KO cells. Preliminary data revealed that in-
creased green ﬂuorescent dot formations, indicative of virus production, were detectable
as early as 120 min after infection and became numerous by 5-6 hpi (data not shown).
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Time-lapse imaging showed that virus particle were mobile within the cytoplasm, mov-
ing toward the cell periphery. In both genotypes the virus could spread from cell to
cell indicating that the infection is progressing without obvious defects.
4.3 Preliminary data of NIH/3T3 JMY KO cells
WHAMM and JMY are two NPFs with similar domain architecture, which show
similar localization [44]. As previously described in this thesis, WHAMM binds micro-
tubules and is involved in ER to cis-Golgi transport [20]. Unlike WHAMM, JMY plays
a role in cytoskeleton remodelling and trans-Golgi transport [47]. Despite the diﬀerent
preferred localizations, the strong similarity between WHAMM and JMY suggest that
both NPFs might have partially overlapping functions. To gain deeper insights into the
distinct functions of JMY, I conducted preliminary experiments with JMY KO cells,
which are described below.
JMY is not only found in the cytosol, but also in the nucleus [44]. Therefore, I investi-
gated the nuclei in JMY KO cells. In fact, JMY deﬁciency resulted in a substantially
increased nuclear area (Figure 4.32). Moreover, KO cells appeared much larger com-
pared to WT cells as described above for WHAMM KO cells (data not shown). These
data suggest that JMY might aﬀect both nuclear area and cell size. Future measure-
ments, for instance by ﬂow cytometry, are required to uncover whether this phenotype
is due to excessive cell spreading or whether it reﬂects an increase in cell size.
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Figure 4.32: Cells deﬁcient in jmy display larger cell nuclei. (A) Representative immunoﬂu-
orescence images of WT and JMY KO clone #5. DAPI staining was used as a cellular nucleus marker.
Scale bar: 20µm. (B) Quantitative analysis of WT cells versus JMY KO clones conﬁrms signiﬁcantly
larger cell nuclei in KO cells. Data are representative of three independent experiments (Note that data
from JMY#2 and JMY#10 are from one experiment.) n = number of cells analyzed. ****P 0.0001,
Two-tailed Student's t-test. Error bars represent SEM.
A report from 2015 showed that JMY plays a role in autophagy through its nucleation
activity. They identiﬁed a N-terminal LIR motif, which is necessary to target JMY
to the autophagsome [85]. In addition, a recent study demonstrated that LC3 and
a regulator of JMY called STRAP regulate JMY´s actin activities in trans during
autophagy [117]. To learn more about the potential participation of JMY in autophagy,
I examined in preliminary experiments endogenous expression of LC3 and p62 under
basal conditions in WT and JMY KO cells (Figure 4.33). KO cells showed elevated
levels of both LC3 and p62-positive vesicles as well as a signiﬁcant increase in the total
area occupied by LC3 and p62 spots (Figure 4.34). These data contradict previous
depletion studies by siRNA, where a reduction in both the autophagosome number
and the total autophagosome area has been observed [85].
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Figure 4.33: Loss of JMY aﬀects autophagy. DAPI staining was used as a cellular nucleus
marker. Basal level of autophagy was studied with autophagy markers LC3 (red) and p62 (green).
Scale bar: 20 µm.
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Figure 4.34: JMY KO aﬀects number and total area of autophagosomes and p62-
positive spots. (A) Quantitative analysis of WT cells versus JMY KO clones conﬁrms an increased
number of LC3-positive vesicles per cell in JMY-deﬁcient cells under fed conditions. The total area
occupied by LC3-positive vesicles was signiﬁcantly increased. (B) Quantitative analysis of WT cells
versus JMY KO clones conﬁrms an increased number of p62-positive vesicles per cell in JMY-deﬁcient
cells under fed conditions. The total area occupied by p62-positive vesicles was signiﬁcantly increased.
(A-B) n = number of cells analyzed. Data are derived from one experiment. **P 0.01, ***P 0.001,
****P 0.0001, Two-tailed Student's t-test. Error bars represent SEM.
Flow cytometry analysis as well as in vivo monitoring of EGFP-VSV was also con-
ducted with NIH/3T3 JMY KO clones. First, I assessed the number of infected cells
by ﬂow cytometry. Data revealed that JMY KO reduced the viral infection by 65%
(Figure 4.35, A). Next, I performed time-lapse videomicroscopy to gather additional
information on the altered infection dynamics in JMY KO cells. The results clearly
show that both infected WT and KO cells produced viruses as they became more and
more green 4.35, B). Interestingly, WT cells released the virus at some point, leading to
infection of neighbouring cells. This was rarely observed in JMY KO cells, suggesting
that traﬃcking of the virions to the cell periphery or virus egress may be altered.
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Figure 4.35: VSV infection in JMY KO cells. (A) Quantitative ﬂow cytometry analysis of
JMY KO cells after VSV infection. Cells were seeded, infected with VSV and inspected after 6 hpi.
GFP ﬂuorescence provided a sensitive and accurate measure of the proportions of infected cells. Mock
infection was used as negative control. Data are derived from one experiment. ***P 0.001, Two-
tailed Student's t-test. Error bars represent SEM. (B) WT and JMY KO clone #5 were infected with
EGFP-VSV at a MOI of 5.5 and maintained at 37°C with 5% humidiﬁed CO2. Images were taken
8 hpi. Scale bar: 40 µm.
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5.1 CRISPR/Cas9-mediated gene KO of WASH, WHAMM and
JMY
Targeted genome modiﬁcation based on the CRISPR-associated RNA-guided en-
donuclease Cas9 is a leading genome engineering technique. The simplicity of this tool
to modify speciﬁc targets resulted in multiple applications, such as deleting, silencing,
enhancing, or targeting genomic loci in mammalian cell lines and several species, in-
cluding monkeys, mice, and rats [89].
In this study, the CRISPR/Cas9 technology was used to generate KO cell lines of the
three NPFs WASH, WHAMM, and JMY in order to dissect their roles during various
processes. The conducted methodology oﬀers a simple and broadly applicable frame-
work for generating KO cell lines. The workﬂow has been adapted from previously
published methods [89] and can be divided into four steps: 1) sgRNA design and con-
struction, 2) sgRNA screening, 3) clone isolation, and 4) clone screening and validation.
This approach could be applied to any cell culture model that easily receives foreign
DNA by transfection and tolerates ﬂow cytometry.
As mice and humans share many genetic similarities, I established both murine NIH/3T3
ﬁbroblasts and human osteosarcoma cells (U-2 OS) lacking the respective NPF (see
Figures 4.2 and 4.4). These two diﬀerent cell systems will aid to gain insights and in-
formation that can be used to better understand how the selected genes may cause
or contribute to biological mechanisms, as well as may provide information about
species/cell-speciﬁc diﬀerences in the utilization of these NPFs. Importantly, both
cell lines are commonly used to study many aspects of cell biology and are widely ap-
plied in biomedical research.
The results in Chapter 4.1 demonstrate the capability of a CRISPR/Cas9-based ap-
proach to rapid targeted gene KO in cultured NIH/3T3 as well as U-2 OS cells. Cus-
tomizable sgRNAs programmed to an exon of the wash, whamm, and jmy gene trig-
gered sequence-speciﬁc Cas9-mediated NHEJ and resulted in the ablation of WASH,
WHAMM and JMY protein expression, respectively.
sgRNAs were suﬃcient to lead to homozygous or heterozygous gene mutations in
NIH/3T3 cells after a single transient CRISPR/Cas9 treatment (see Table 4.1). In
my experience, this straightforward approach can be used to generate gene-edited
NIH/3T3 clones within a matter of weeks. CRISPR/Cas9 also provides a distinct ad-
vantage, since it permits the study of endogenous genes that are embryonically lethal
when knocked out in vivo, such as wash [24, 25].
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Gene editing in human cell systems has emerged to be much more challenging than the
application of murine cells. Targeting the gene of interest with a single sgRNA did not
allow robust and eﬃcient gene KO. Functional disruption of wash, whamm, and jmy
required disruptive indels in all (or most) alleles of the gene. Since U-2 OS cells are
known to be polyploid [118], it is likely that indels occured at one or more alleles but
were not suﬃcient to disrupt the gene of interest to the desired extent. To overcome
this limitation, two sgRNAs that target diﬀerent regions of the gene of interest were de-
signed. For future considerations, it should be noted that human wash was discovered
within subtelomeric regions, which are duplication-rich, structurally variable regions
situated near chromosome ends [21]. They are typically composed of various repeated
elements, pseudogenes, and retrotransposons and provide low eﬃciency of target site
cleavage by Cas9 [119]. Subtelomeric regions are also enriched in epigenetic marks
that are characteristic for heterochromatin [120], that can negatively aﬀect Cas9 bind-
ing and functioning [121]. A second important limitation of the CRISPR/Cas9 system
which might explain initial issues in human cells, is the generation of oﬀ-target cleavage
sites as a result of complexing of the sgRNA with mismatched complementary target
DNA within the genome [122]. To date, eﬀorts to improve the Cas9 enzyme have
been performed to increase speciﬁcity and reduce oﬀ-target cleavage. Mali et al. engi-
neered a sgRNA:Cas9 system by tethering transcriptional activation domains to either
a nuclease-null Cas9 or to sgRNAs mitigating the eﬀects of oﬀ-target sgRNA:Cas9 ac-
tivity [123]. Furthermore, a study from 2014 also described an improved DNA cleavage
speciﬁcity by fusion of FokI nuclease to an inactive Cas9 (fCas9) [124]. They showed
that fCas9 modiﬁed target DNA sites with >140-fold higher speciﬁcity than WT Cas9
and with an eﬃciency similar to that of paired Cas9 nickase. Another strategy to min-
imize oﬀ-target eﬀects is to increase the PAM length [122]. Cas9 orthologs from bacte-
rial species show diﬀerences in their PAM repertoire. For instance, the CRISPR/Cas9
system derived from Neisseria meningitidis represents a safer alternative for precision
genome engineering in human cells. It recognizes an 8-mer PAM sequence that can
improve target speciﬁcity and reduce potential oﬀ-target cleavage [125]. Another ap-
proach to speciﬁcally target NPFs in human cell systems could be the CRISPR nickase
system. It utilizes a single Cas9 nickase to ensure precise base editing up to 53 bp from
the nicking site. Intriguingly, this technology showed no oﬀ-target editing and provides
a versatile and powerful technology for rapid, site-speciﬁc, and precise base editing in
eukaryotes [126].
To validate gene editing of potential WASH, WHAMM, and JMY KO clones, I per-
formed both western blotting and DNA sequencing. KOs for WASH and JMY in
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NIH/3T3 and U-2 OS cells could easily be determined. In the case of WHAMM, I
was facing protein detection issues regardless of the applied cell line (see Figures 4.2
and 4.4). WHAMM is known to be expressed at very low levels in NIH/3T3 cells [47].
Even loading more protein per lane and including protease inhibitors in the lysis buﬀer
did not improve WHAMM detection. Furthermore, I also tried to generate an own
WHAMM antibody in cooperation with Jan Faix (MHH, Hanover). Yet it appeared
that the produced antibody nonspeciﬁcally interacted in both murine and human cells
indicating a cross reactivity against homologous epitopes (data not shown).
Furthermore, in human cells introduced KOs could not be conﬁrmed by sequencing
analysis because of poor sequencing data. Since WHAMM mutation in NIH/3T3 KO
cells produced a distinct phenotype, it would be interesting whether similar ﬁndings
will appear in an alternative cell system such as U-2 OS. To assess whether these ob-
servations are not oﬀ-target related phenotypes, recovery experiments will be valuable
for validation of CRISPR/Cas9 KO gene activity in human cells. Design of a HDR
strategy for genomic tagging or generation of constructs for ectopic re-expression of the
targeted gene may additionally contribute to eﬃcient validation of the phenotype. An
alternative approach would be to transiently transfect WASH, WHAMM, and JMY
into human KO cells and compare transfected KO cell lines to WT controls.
So far, indels in human KO cells were diﬃcult to detect by Sanger sequencing. A simple
procedure for quantifying point mutations and indels is the Surveyor nuclease assay,
which detects genome editing in a cell pool without the need for clonal expansion prior
to analysis [127129]. The Surveyor nuclease is a DNA endonuclease, which cleaves
with high speciﬁcity at the 3´ side of any mismatch side in both DNA strands [130].
Finally, deep sequencing of human KO cells would be a comprehensive gold standard
to guide study interpretation. It seems advisable to pursue such characterization in
U-2 OS cells as edited cells are diﬃcult to sequence by Sanger sequencing.
5.2 WHAMM KO signiﬁcantly alters NIH/3T3 morphology
WHAMM, a protein uniquely expressed in vertebrates, was identiﬁed to be a canon-
ical Arp2/3 activator that interacts with both the actin and the microtubule cytoskele-
ton [20,43]. It localizes to the cis-Golgi and ERGIC making it an interesting example
for the coordination of vesicle traﬃc between ER and Golgi [20].
The cellular studies presented here highlight the importance of WHAMM in regulating
cell and nucleus size, as well as for the organization of the Golgi apparatus. I observed
signiﬁcant increases of both cell size and nucleus size in WHAMM KO cells (see Figure
4.5). There are conﬂicting reports regarding the factors that determine nuclear size.
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On the one hand, there is evidence that the DNA content inﬂuences the volume of the
nucleus, which in turn has an impact on the cell size [131, 132]. In contrast, investi-
gations of yeast showed that a 16-fold increase in nuclear DNA content did not aﬀect
nuclear size [133]. Even though NIH/3T3 cells generally exhibit higher aneuploidy lev-
els [134], propidium iodide staining to estimate nuclear DNA content did not conﬁrm
diﬀerences between WT and KO cells (data not shown). On the other hand, previ-
ous studies support the notion that nuclear size is determined by cytoplasmic volume
rather than DNA content. A cytoplasmic factor that might determine nuclear size is
an intact ER. In vitro data of mammalian cells uncovered an interaction between the
ER and nuclear envelope formation and expansion [135]. However, results showed a
normal ER distribution as well as network structure in both WT and WHAMM KO
cells (see Appendix, Figure 6.8). Consequently, increased nucleus size is presumably
not ER-associated.
WHAMM is a classically cytosolic protein, but other NPFs such as WASH and JMY
have been described to localize in the nucleus [136,137], which has not yet determined
for the WHAMM protein. It was shown that WASH interacts with B-type lamin and
functions in the nucleus to modulate global nuclear organization [136]. According to
this, enlarged nuclei in WHAMM KO cells might occur due to a loss of nuclear struc-
tural integrity, such as by disrupting lamins or nuclear actin. Lamins belong to the
intermediate ﬁlament protein family and represent the main components of the nuclear
lamina. Nuclear actin may exist in conformations distinct from actin ﬁlaments in the
cytoplasm [138]. It is tempting to speculate that WHAMM may be involved in the
regulation of nucleoskeletal structures and may contribute to maintenance of the nu-
clear shape.
Another interesting notion to explain increased nucleus size in WHAMM KO cells is
the involvement of mTOR signaling. The mTOR pathway has been considered to be a
molecular regulator of cell size [139]. Moreover, there is growing evidence that mTOR
localizes to the nucleus, where it directly regulates gene expression [140]. Since active
mTOR levels are increased in WHAMM KO cells (see Figure 4.11), future investiga-
tions will include a potential role of mTOR in nucleus size regulation in these cells.
Compared to WT cells, WHAMM mutant cells also exhibited increased cell size (see
Figure 4.5). This phenotype may also be associated with the mTOR pathway. I
reported that active mTOR protein expression is increased in WHAMM KO cells
(see Figure 4.11). mTOR is known to stimulate cell growth, thereby increasing cell
size [139]. In particular, mTORC1 activity promotes cell size upon activation in mam-
malian cells [141]. Of great interest would be to dissect the role of mTOR during cell
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size regulation in WHAMM KO cells and if mTOR-dependent downstream signaling
pathways are involved in cell size control. First insights into whether mTOR is involved
in cell size regulation in WHAMM KO cells may come from rapamycin treatments.
It primarily inhibits mTORC1, but long-term exposure also inhibits mTORC2 [142].
Moreover, I would also hypothesize that dysfunctional autophagy and cell size are con-
nected. This degradation pathway might be critical for increased cell size of WHAMM
KO cells. I observed a clear accumulation of autophagy markers such as p62 and
LAMP1 during fed conditions (see Figures 4.18 and 4.21). Therefore, I would propose
that WHAMM KO disturbs the clearance of (abnormal) proteins, which in turn might
also result in an enlargement of cell size.
Changes in WHAMM KO cells size may additionally be caused by altered adhesion
and spreading patterns. Cell adhesion was not investigated during this study but a pre-
vious report showed that knockdown of WHAMM did not aﬀect cell attachment [41].
WHAMM KO cells spreaded smoothly on coated plastic surfaces. However, microarray
data generated in this thesis identiﬁed impaired signaling of the ECM and ITGA (see
Appendix, Figure 6.22) (i.e. downregulation of spp1, itga10, and adamts4), indicating
that focal adhesion formation or more speciﬁcally adhesion turnover may be aﬀected
(see discussion below).
In this study, I have not tested yet whether also altered cell spreading plays a role
in increased cell size of WHAMM KO cells. Cell spreading requires an interaction
between membrane-based integrins with their corresponding ECM proteins and the
engagement of the cytoskeleton, which initiates a complex cascade of signaling events.
When cells are plated onto artiﬁcial surfaces coated e.g. with ﬁbronectin or gelatin,
they ﬁrst attach, then ﬂatten, and spread [143]. It is known that binding of integrins
to speciﬁc ECM epitopes leads to the recruitment of anchor proteins to the adhesion
site and ultimately induces the assembly of focal complexes and focal adhesions and
the associated cytoskeleton [144]. Focal adhesions are dynamic actinintegrin links
that lie at the convergence of integrin adhesion, signaling, and the actin cytoskele-
ton [145, 146]. WHAMM KO cells exhibited smaller focal adhesions compared to WT
cells (see Figures 4.29 and 4.30), which points to changes in cell attachment. Stud-
ies showed that focal adhesion disassembly was impaired in autophagy-deﬁcient cells
leading to abnormally large focal adhesions as well as impairment in autophagy-driven
focal adhesions turnover [147]. Interestingly, WHAMM KO cells exhibited dysregu-
lated autophagy, in particular I could observe an increase of autophagic markers under
basal conditions (e.g. p62 or LAMP1; see Figures 4.18 and 4.21). Even though my
results revealed smaller focal adhesions in the absence of WHAMM, it still would be
interesting whether there is a relationship between defective autophagy and focal ad-
hesion number/length in KO cells.
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Ablation of WHAMM also resulted in increased cell granularity as inspected by ﬂow
cytometry (see Figure 4.6). This phenotypic change may implicate a higher number
of protein aggregates or vesicles. Interestingly, WHAMM KO cells exhibit an increase
of autophagy markers (see Figures 4.18 and 4.21, see discussion below), which would
correspond to the observed phenotype. Increased cell granularity is indeed often as-
sociated with enhancement of autophagy, since one important facet of this process is
the production of autophagic vacuoles [97]. A report from 2009 showed that senescent
keratinocytes die as a result of high autophagic activity and also revealed higher granu-
larity [148]. Additionally, WHAMM KO cells showed an increased number of lysosomes
upon fed and starved conditions (see Figure 4.21). It was shown in several cancer cells
that accumulation of lysosomes presumably contributed to higher granularity [149],
which is a considerable overlap with my results and would also explain increased cell
granularity in KO cells.
WHAMM ablation is additionally associated with a genetic disorder named the GMS.
It is characterized by various developmental and physical abnormalities, including mi-
crocephaly, developmental delay, and nephrotic syndrome. Patient harbor homozygous
mutations in wdr73 as well as the closely linked whamm gene. Patient cells showed
abnormal stress ﬁbers organization and an enlarged ERGIC morphology [45]. Inter-
estingly, ﬁndings in WHAMM KO ﬁbroblasts contradict these observations. Cultured
KO cells displayed normal, prominent bundles of F-actin as found in WT cells (see
Figures 4.5 and 6.6), which is not consistent with previous data [41, 45]. Although
WHAMM facilitates membrane tubulation and traﬃcking on the ER, cis-Golgi, and
ERGIC [45], ablation of WHAMM did not alter ER or ERGIC appearance (see Ap-
pendix, Figures 6.8 and 6.9). In contrast, Mathiowetz et al. claimed that the ERGIC
appeared larger in patient ﬁbroblasts [45]. This speciﬁc phenotype may result through
the coincident wdr73 mutation in these patients. Moreover, there might be diﬀerences
in the gene expression proﬁles between primary and immortalized cell culture systems
and utilizing mouse cells instead of human cells also might explain these disparities.
On the other hand, four WHAMM KO cell lines have been included in this study, each
arosen from a single cell in order to get reliable results and exclude clonal variance.
All subclones showed low clonal variation with high consistency in growth, transcript
levels and phenotypic observations, indicating that whamm deletion might cause the
described phenotype.
In accordance with a previous study, WHAMMKO cells displayed a disseminated Golgi
apparatus (see Figures 4.9 and 6.10). WHAMM is crucial for controlling a compact
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and stacked Golgi structure and VSV-G transport assays stated that it functions in
membrane traﬃcking from the ER to the Golgi [20]. The Golgi complex receives pro-
teins and lipids from the ER, where they are further processed and sorted for their ﬁnal
destinations through the secretory pathway. Proteins are sorted in and bud from the
TGN and eventually deliver their content to various cellular locations, including plasma
membrane, lysosomes, and for secretion [150]. This anterograde traﬃc is balanced by
a transport pathway, known as retrograde traﬃc that runs in the opposite direction.
Cargo proteins or lipids are transported from endosomes to secretory compartments
such as TGN or cis-Golgi [151]. Scattered membrane structures in the Golgi appara-
tus observed for WHAMM KO cells might aﬀect intracellular transport mechanisms.
Previous depletion experiments showed that VSV-G progression from the ER to the
Golgi, and the amount of VSV-G reaching the cell surface was diminished suggesting
that WHAMM is important for anterograde transport [20]. It is also likely that in
the absence of WCA-Arp2/3-mediated tubulation events or F-actin networks near the
Golgi, proteins in general are transported more rapidly via small tubular transport
intermediates rather than large tubular structures [152].
To explore the role of WHAMM in Golgi function and transport mechanisms in more
detail, I conducted a BFA washout assay (see Figure 4.10), constituting a standard
assay for examining the assembly of the Golgi apparatus. BFA is a fungal metabo-
lite that induces a redistribution of Golgi enzymes to the ER compartment [153]. It
shuts down anterograde transport, whereas retrograde transport of Golgi components
to the ER still takes place. Based on BFA washout results, WHAMM is not involved
in reformation of Golgi stacks from ER membranes and does not aﬀect retrograde
transport.
5.3 WHAMM impairs autophagy
Autophagy involves highly dynamic membrane organization as well as vesicular
traﬃcking from diﬀerent subcellular compartments to the forming autophagosome
[154, 155]. Such traﬃcking must be tightly regulated by various intra- and extra-
cellular signals [44, 45]. Membrane shaping and remodeling events are mediated by
lipid modifying enzymes, membrane sculpting and remodeling proteins, lipid-binding
eﬀector proteins, protein kinases, and phosphatases [156]. WHAMM has been impli-
cated in mammalian autophagy, in particular it connects actin assembly via the Arp2/3
complex at sites of autophagosome formation [44,45]. Indeed, several studies revealed
a colocalization of actin ﬁlaments with autophagic markers, demonstrating a link be-
tween actin assembly and autophagy [83,157]. In addition, it has been suggested that
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mouse knockout of Atg7 prevents autophagosome formation but also revealed disorga-
nized F-actin ﬁbers as well as a loose F-actin net. The authors suggest a link between
impaired autophagy and morphological changes in F-actin in Atg7-deﬁcient primary
cells [158]. However, established WHAMM KO cells did not show changes in stress
ﬁber formation or organization as previously observed in primary cells [45]. However,
the Golgi apparatus was clearly dispersed in the absence of WHAMM (see Figure 4.9
and 6.10) and it is known that ER-Golgi membrane transport and autophagy consti-
tute intersecting traﬃcking pathways [159].
Aligning the ﬁndings of this study with the literature, I suggest dysregulated autophagy
in response to WHAMM ablation. KO cells clearly revealed increased levels of au-
tophagy markers such as LC3, p62, and LAMP1 upon starvation (see Figures 4.15,
4.18 and 4.21. These results imply that WHAMM likely plays a role in early stages of
autophagy (i.e. autophagosomal biogenesis) in addition to maturation of autophago-
somes (see discussion below).
Total protein levels of mTOR, a known regulator of autophagy under-nutrient rich con-
ditions [68, 78], were downregulated by about 20% in WHAMM KO cells (see Figure
4.11). However, its activated form, p-mTOR, displayed a clear upregulation in KO
cells (see Figure 4.11). Typically, mTOR activity is high under fed conditions which
in turn leads to the phosphorylation of the ULK1 complex and accordingly to an in-
hibition of autophagy [160]. In response to starvation, reduced mTOR activity results
in an activation of the ULK1 complex and ﬁnally in an activation of autophagy [161].
Future work will be needed to further determine the levels of mTOR and p-mTOR, for
instance by immunoﬂuorescence stainings or qPCR.
In previous studies, WHAMM has been detected adjacent to LC3-positive vesicles as
well as omegasomes, PI3P-enriched structures that form at sites of the ER [44,45,91].
Omegasomes are cupshaped structures marked by the protein DFCP1, which asso-
ciate with actin ﬁlaments upon starvation [45, 91]. Dynamic localization studies of
EGFP-DFCP1 in WHAMM KOs revealed a strong defect in omegasome formation
which is inconsistent with the normal ERGIC morphology (see Appendix, Figure 6.9).
This compartment is required for membrane recruitment of DFCP1 and ﬁnally for
omegasome generation [162]. WHAMM KO actually induced clustering of DFCP1-
positive omegasomes around the nucleus (see Figure 4.13). I therefore propose that
the progression of omegasome to autophagosome maturation partially depends on the
presence of WHAMM. Hence, it would be interesting to visualize DFCP1-structures
upon starvation to gain information, whether there is a delay in phagophore formation
due to the accumulated omegasomes. Thus far, I can also not exclude the possibil-
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ity that the scattered Golgi inﬂuences this phenotype, even though DFCP1-positive
omegasomes normally appear to localize near the connected mitochondria-associated
ER [163]. Disruption of the Golgi architecture with e.g. BFA followed by a visualization
of omegasomes would clarify the possibility of Golgi contribution. Another interesting
future aspect is to evaluate the morphological membrane properties of omegasomes in
KO cells by electron microscopy. Identifying the structural features (e.g. thickness,
topology of the isolation membrane) may provide important insights into the charac-
teristics of these clustered structures.
Phagophore elongation and closure is a dynamic process that is regulated in a cargo-
speciﬁc manner. A protein, that functions in phagophore assembly, is the multi-
spanning integral membrane protein ATG9. It possibly participates in the forma-
tion of phagophore curvature since induction of autophagy results in a distribution of
ATG9 from the Golgi into tubo-vesicular compartments [156], where it co-localizes with
LC3 [164]. Since WHAMM regulates the Golgi structure, its absence might aﬀect traf-
ﬁcking of ATG9-containing vesicles which again is indicative of an involvement of the
Golgi complex in the autophagic pathway. More precisely, the observed ATG9 accumu-
lation at the perinuclear region (see Figure 4.12) suggests a defect in the transport of
ATG9-containing membranes for expansion of the phagophore membrane. Colocaliza-
tion studies of both ATG9 and the phagophore membrane marker such as ULK1 would
help to shed light on this question. Interestingly, altered distribution of ATG9 did
not aﬀect autophagosome development in WHAMM KO cells. However, a study from
2009 showed that ﬁbroblasts deﬁcient in ATG9 did not properly induce autophago-
some formation and exhibited impaired degradation of long-lived proteins as well as
p62 [165]. The latter would be consistent with my observations since WHAMM KO
cells displayed a clear increase of p62 vesicles upon fed and starvation conditions (see
Figure 4.18).
LC3 is a model substrate essential for autophagosome biogenesis/maturation. After
translation, its preform is cleaved by ATG4 family proteases to form cytosolic LC3-I.
Subsequently, LC3-I is conjugated to PE to become LC3-II, which localizes to isolation
membranes and autophagosomes. The amounts of LC3-I and LC3-II and their ratio
under diﬀerent conditions and/or over time are therefore indicative of autophagosome
formation, but turned out to be technically too demanding. Generally, the number of
autophagosomes increases during nutrient starvation such as HBSS treatment and ac-
cordingly the amount of LC3-II increases [166]. Unfortunately, immunoblotting of LC3
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was problematic in both WT and WHAMM KO cells. A band for LC3-I could not be
detected at all or was very faint (see Appendix, Figure 6.12). A known issue regarding
the detection of the ratio of LC3-I to LC3-II conversion is the diﬀerent immunoreac-
tivity of the antibody, which preferentially binds LC3-II [167]. In general, LC3-I tends
to be less sensitive to detection [168], especially when performing semi-try transfer of
proteins as I applied in my studies. Moreover, it was reported that the signal ratio
between LC3-I and LC3-II may not always reliably reﬂect the actual ratio of cytosolic
and membrane-bound LC3 [166], thus it is recommended for future experiments to
compare the amount of LC3-II among samples [167].
Autophagic activity may also be measured by immunoﬂuorescence (see Figures 4.18
and 4.19 as well as Appendix, Figures 6.13   6.16). This method provides information
about the number as well as size of LC3-positive puncta. Knockdown of WHAMM
was proposed to reduce autophagosomal size and movement, and a WHAMM point
mutation that should have a reduced aﬃnity for Arp2/3 also decreased the number
of LC3-positive structures [44]. Measuring LC3 vesicles under fed conditions revealed
that both genotypes showed similar amounts of autophagosomes (see Figure 4.15, A),
but diﬀered in the total area of LC3 puncta per cell (see Figure 4.15, B). Accordingly,
WHAMM KO does not aﬀect the number of autophagosomes under basal conditions,
but strikingly led to higher levels of LC3-positive structures upon starvation (see Fig-
ure 4.15), indicative for an accumulation of autophagosomes. This accumulation may
be caused by impaired degradation of autophagy substrates, which in turn could be ex-
plained by defective lysosomal fusion with autophagosomes. WHAMMKO cells showed
enlarged lysosomes (see Figure 4.21, see discussion below), which might result in de-
fects in autophagosome-lysosome fusion and consequently to the observed phenotype
in WHAMM KO cells upon nutrient deprivation. In order to prove obtained results as
well as the idea of aﬀected autophagosome-lysosome fusion events, I recommend visu-
alizing autophagic structures in an alternative cell system, such as U-2 OS WHAMM
KO cells. Studying another biological system will provide evidence of the reproducibil-
ity of dysregulated autophagy due to the absence of WHAMM. However, counting the
amount of autophagosomes remained challenging in both WT and WHAMM KO as
the applied threshold function of ImageJ software (see Material and Methods) was not
easy to adapt to the need of the approach. Especially the high background and in par-
ticular the high background in nuclei made it somewhat complicated to ensure reliable
LC3 detection in both WT and WHAMM KO cells. Recently however, in the course
of two independent Master´s Theses, LC3 stainings were further optimized. It may be
worth to repeat the stainings shown here with an optimized staining procedure, which
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includes the addition of low concentrations of a permeabilizing agent such as Triton
X-100. Another quantiﬁcation strategy might also be considered in order to measure
LC3 vesicles in WT and KO cells more reliably. For instance, the threshold function
may be replaced by a tool called MosaicSuite which tracks single particles in 2D and
3D and has already been utilized in this study for diﬀerent sets of experiments (see
Materials and Methods) [169,170].
p62 was an alternative marker to monitor autophagic activity because it directly binds
to LC3, thereby serving as a selective substrate of autophagy [166, 167]. Most in-
terestingly, p62 levels appeared signiﬁcantly higher in WHAMM KOs upon fed and
starvation conditions as compared to WT cells (see Figures 4.17 and 4.18). Upon 4 h
starvation, the amount of p62 decreased in both genotypes (see Figure 4.18), suggesting
that p62 degradation occurs in response to starvation. Together, these data indicate
an inhibition of the autophagic ﬂux in WHAMM KO cells. Generally, activation of
autophagy results in a decrease of p62 expression due to faster degradation of the
protein and, contrarily, an accumulation of p62-positive structures reﬂects a decline
in the autophagic ﬂux [171]. Interestingly, elevated p62 levels after starvation (early
time points) have also been observed in WT cells (see Figures 4.17 and 4.18). Thus, it
might be that p62 transcriptional levels in these cells are upregulated upon 1 h and 2 h
starvation resulting in higher protein expression. Nonetheless, the speed of autophagic
degradation appears decreased in WHAMM KO cells, which is in line with my hypoth-
esis that autophagy is delayed or inhibited in WHAMM KO cells.
In order to determine the lysosome-dependent degradation of autophagic vessels, it
was important to measure the amount of LC-II and p62 with the concomitant use of
a compound that blocks autophagy (e.g. BafA1). The diﬀerence in the amount of
LC3-II or p62 in the presence and absence of such a selective inhibitor is indicative of
the autophagic ﬂux [166]. BafA1 is a vacuolar-type ATPase inhibitor, which blocks the
fusion between autophagosome and lysosome, and leads to a block in lysosomal degra-
dation [168]. Usually, the number of LC3-positive structures increases upon BafA1
treatment, indicating that lysosomal degradation of LC3 is inhibited. I expected a
pronounced accumulation of LC3-positive vesicles in non-starved plus BafA1 treat-
ment conditions compared to control cells. This has indeed been observed for both
WT and WHAMM KO cells (see Figures 4.15 and 4.16). Furthermore, WHAMM KO
cells showed signiﬁcantly increased levels of LC3 upon 2 h and 4 h starvation in the
presence of BafA1 compared to WT cells (see Figure 4.16). This conﬁrms once more
that LC3-positive particles accumulate due to the loss of WHAMM. In fact, WHAMM
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deletion presumably leads to a defect in autophagosome formation and/or degradation
and I would propose that WHAMM KO rather delays than fully abrogates autophagy.
This study also demonstrated that WHAMM KO cells showed a marked increase in
the amount of p62 upon BafA1 treatment for all tested time points and/or treatment
conditions (see Figure 4.19). Interestingly, KO cells treated either with HBSS alone or
with HBSS and BafA1 (see Figures 4.15 versus 4.16 and 4.18 versus 4.19) exhibited
similar trends in the amount of LC3 and p62 dots, respectively. Both treatment of KO
cells with HBSS or HBSS plus BafA1 succeeded to observe a clear diﬀerence compared
to WT cells by revealing a strong accumulation of LC3-vesicles and p62 particles. To-
gether, these data conﬁrm dysregulated autophagy due to WHAMM deﬁciency and
strengthen the assumption of a degradation defect in WHAMM KO cells.
Apart from the potential structural function of WHAMM during autophagy, it is also
likely that it plays a speciﬁc role during mTOR signaling. Steady state levels of p62
measured by western blotting were increased in KO cells (see Figure 4.17) and most
likely resulted in the higher number of p62 vesicles upon fed conditions observed during
immunoﬂuoresence stainings (see Figure 4.18). p62 has been previously linked to the
mTOR pathway, where Duran et al. uncovered an interaction between both proteins
and showed that p62 is required for mTORC1 activation [172]. Since active mTOR
levels are increased upon WHAMM KO (see Figure 4.11), it is tempting to speculate
whether WHAMM is involved in mTOR signaling by increasing p62 levels.
Another direct method to measure autophagic ﬂux and to assess any changes between
WT and KO cells was ﬂow cytometry. Preliminary measurement of endogenous LC3
indicated an increase in WHAMM KO cells upon both fed and starvation conditions
(see Appendix, Figure 6.17), which is consistent with the previous assumption that
loss of WHAMM leads to an accumulation of LC3 due to dysregulated autophagy (see
Figure 4.15). Future work will include ﬂow cytometry in combination with inhibitors of
degradation (e.g. BafA1), which will additionally provide information about changes
in the autophagic ﬂux of the system.
Moreover, a second approach to measure autophagic activity in cultured cells will be
based on the ﬂuorescent probe GFP-LC3-RFP-LC3G [166]. This fusion protein is
cleaved by endogenous ATG4 proteases generating equimolar numbers of GFP-LC3 and
RFP-LC3G in the cytosol. When autophagy is induced, GFP-LC3 is PE-conjugated
and localizes to the autophagosomes followed by degradation within autolysosomes,
while RFP-LC3G remains in the cytosol. Finally, the autophagic ﬂux is estimated
by calculating the GFP/RFP ratio, which precisely determines the cumulative GFP-
LC3 degradation [166,173]. Using this probe may circumvent LC3 detection problems
I faced in NIH/3T3 ﬁbroblast.
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The last stage of autophagy comprises the fusion of the autophagosome with the lyso-
some, when the cargo is released into the acidic and hydrolytic lumen of these or-
ganelles [174]. Lysosome size is regulated by a balance between lysosomal membrane
fusion and ﬁssion [175]. This study provides evidence that WHAMM KO leads to
changes in lysosomal size and number (see Figure 4.21). Functional lysosomes are
critical for the maturation process of autophagosomes and for the degradation of the
cytoplasmic material [105]. First, I suspected that WHAMM KO aﬀects a process
called lipophagy because of the analysis of regulated pathways upon GeneChip Arrays
(see discussion below). It literally is the degradation of lipids via autophagy, which is
particularly relevant in the context of genetic lysosomal storage disorders. Perturba-
tions of the autophagic ﬂux, which I could observe for WHAMM KO cells, have been
suggested to contribute to the disease aetiology [176]. However, with two methods
I could not detect any defect in cholesterol amount or distribution in WHAMM KO
cells (see Figures 4.26 and 4.27). Therefore, I assumed that the observed lysosomal
phenotype might be more likely caused by the dispersed Golgi apparatus. Vesicle size
is normally regulated by the rate of fusion versus the rate of ﬁssion [175], indicating
that inhibited lysosomal fusion/ﬁssion may explain the increased number and size of
lysosomes observed in WHAMM KO cells (see Figure 4.21). Moreover, the formation of
enlarged lysosomes might be connected to the accumulation of autophagosomes as well
as p62-positive structures. An interesting future aspect will be to test the degradative
capacity of lysosomes in WHAMM KOs. Impaired hydrolytic function might impair
the degradation of LC3- and p62-positive vesicles in WHAMM KOs. Future work will
also focus on the determination of the kinetics of fusion and ﬁssion of vesicles, but also
on a deeper analysis of lysosomal structures using super-resolution microscopy.
Studying the SNARE syntaxin 17 will also be considered since it is crucial for the last
maturation step of autophagosomes [177]. This protein is required for the fusion of
autophagosomes with lysosomes to form autolysosomes [178] and it would be interest-
ing to examine whether its expression or turnover is impaired due to loss of WHAMM.
Another important future aspect, that has not yet been tested in this study, is to
investigate the mechanism underlying WHAMM's normal function during autophagy.
Thus, localization of endogenous WHAMM as well as its dynamics during autophagy
would be of great interest. However, WHAMM is a low abundant protein and reagents
available at present are not suited to detect it by immunoﬂuoresence. GFP-tagged
WHAMM, which easily induces overexpression artefacts, could be a helpful tool when
optimizing the experimental conditions.
In summary, WHAMMKO leads to an accumulation of LC3 and p62 as well as enlarged
lysosomal structures, implying dysregulated autophagy due to its loss.
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5.4 Gene regulation in WHAMM KO cells
The study of gene expression proﬁling of cells has become a major tool in biol-
ogy and allows for simultaneous assessment of the expression level of thousands of
genes [179, 180]. cDNA microarray analysis was performed to determine which genes
are transcriptionally inﬂuenced by the absence of WHAMM to gain information about
its cellular role in general and its function in autophagic and infectious processes in
particular. So far, gene expression proﬁles of cells lacking WHAMM protein have not
been published. This thesis now reports on speciﬁc genes, which play important roles
in biological processes to be signiﬁcantly regulated upon WHAMM KO. Heat maps
clearly demonstrated the diﬀerential gene expression pattern in WT and WHAMM
KO cells (see Figure 4.22). Transcriptom analysis revealed that ablation of WHAMM
slightly decreases WASH mRNA expression, whereas JMY levels appeared unaltered
(see Figure 4.23). However, analysis of protein quantity via western blotting showed
that the expression levels of both NPFs were unchanged in WHAMM KO cells (see
Figure 4.23). KO of WHAMM represents a genetic perturbation, which is apparently
not functionally compensated by WASH or JMY. Genetic compensation in response to
a KO is a widespread phenomenon, in particular of related genes, whereby the loss of
one gene may be compensated by another with overlapping functions [181]. WHAMM
and JMY share a similar domain architecture and it was shown that both colocalize
and comigrate with LC3 and the ER-resident protein VAP-A pointing to some degree
of overlap [44]. However, whether WHAMM and JMY perform similar or overlapping
roles is not substantiated by this study.
In addition, microarray analysis has been used to potentially identify altered genes asso-
ciated with autophagy (see Figure 4.24). Interestingly, the amount of DFCP1 mRNA
was signiﬁcantly downregulated upon WHAMM KO (see Figure 4.24, A). However,
WHAMM KO cells showed an increase of accumulated DFCP1-positive structures un-
der basal conditions (Figures 4.13 and 6.11). Moreover, previous data (see discussion
above) demonstrated a strong increase of diverse autophagic markers and I already
proposed a degradation defect in WHAMM KO cells. Thus, microarray data might
implicate a cell-speciﬁc regulation of DFCP1 mRNA levels due to defects in lysosomal
degradation. Since omegasomes are still formed, it might be worth to inspect DFCP1
protein expression levels by western blotting.
WHAMM has been closely linked to autophagy and its inactivation inhibited LC3 lipi-
dation as well as clearance of ubiquitinated protein aggregates [44,45]. LC3 is a suitable
marker for detecting autophagic structures, in particular, it reﬂects the number of au-
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tophagosomes and autophagy-related structures [166]. As observed for DFCP1, mRNA
analysis of LC3 showed less LC3 mRNA expression in WHAMM KO cells (see Figure
4.24, B). On the other hand, KO cells exhibited a higher amount of LC3-positive par-
ticles under starved conditions compared to WT cells (see Figure 4.15), indicative of
again slower protein turnover. Thus, WHAMM KO cells might try to compensate the
degradation defect of LC3-positive vesicles by downregulating mRNA levels. In mam-
malian cells, 30-40% of the variation in protein concentration may be explained by
mRNA abundance [182]. Apart from other factors such as (post-)translational mod-
iﬁcations and measurement errors [182, 183], the most common reason in regulating
protein stability is by protecting it from or driving it into degradation. The relation-
ships between the rates of the processes producing and degrading the participating
molecules determine the abundances of mRNA and proteins.
Finally, with the help of Robert Geﬀers (HZI, Braunschweig), I performed meta ex-
pression analysis to understand if the regulated genes in WHAMM KO versus WT
belong into distinct pathways. KEGG pathway analysis implicated a deregulation of en-
zymes involved in cholesterol biosynthesis, in particular, it showed a downregulation of
DHCR7 and an upregulation of SOAT1 and SOAT2, respectively (see Figures 4.25 and
6.21). Since lipid synthesis/degradation is also associated with autophagy [108, 109],
the cholesterol content in WT and WHAMM KO cells was investigated. However,
analysis of cholesterol content via ﬁlipin staining or Amplex assay did not conﬁrm that
absence of WHAMM aﬀects cholesterol levels (see Figures 4.26 and 4.27). Thus, a
direct validation of gene expression of DHCR7 and SOAT1 has been determined by
qPCR (see Appendix, Figure 6.20). In contrast to microarray analysis, qPCR results
actually showed unchanged mRNA expression levels in WHAMM KO compared to
WT cells. These ﬁndings highlight that microarray results might vary considerably
and need to be validated by further methods.
5.5 WHAMM KO impairs VSV and HSV-1 infection in
NIH/3T3 cells
Viral infections hijack normal functions of a cell, including reconﬁguration and re-
organization of cellular actin. The extent and degree of cytoskeletal rearrangement
varies among diﬀerent viruses [59]. The Arp2/3 complex, a know actin nucleator, has
weak actin nucleation activity, which in turn requires an activation by NPFs leading to
robust actin nucleation. Both bacteria and viruses developed sophisticated strategies
to exploit the power of Arp2/3-mediated actin polymerization to promote cell-to-cell
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spread [184]. Reorganization of the actin cytoskeleton accompanies all stages of the
viral life cycle (i.e. entry, replication, assembly, and egress) [185]. Viruses such as
VSV require the actin system for their uptake (clathrin-mediated actin-assisted endo-
cytosis) and also take advantage of the actin cytoskeleton for intracellular nucleocapsid
mobility [186, 187]. HIV-1, as another example, exploits and modulates the actin cy-
toskeleton to facilitate its entry into, transport within, and egress from host cells [188].
To this end, I investigated virus infection in WHAMM KO cells and found distinct
defects in VSV and HSV-1 infections (see Figure 4.31). Flow cytometric analysis of
virus infection was aimed at the measurement of EGFP-VSV and EGFP-HSV-1, re-
spectively, in order to identify infected cells (see Appendix, Figures 6.23 and 6.24).
Interestingly, the infection rate decreased for both viruses (i.e. by about 20% for VSV
and 50% for HSV-1) in WHAMM KO compared to WT cells, implying an impact on
both viruses due to loss of WHAMM. On the basis of these results, I cannot clearly
conclude which stages of the viral life cycle (i.e. entry, replication, assembly, and/or
egress) are impaired. However, I could observe that entry of VSV was not completely
blocked by WHAMM KO. Flow cytometry data showed a GFP signal in cells deﬁcient
in whamm (see Appendix, Figure 6.23), thereby reﬂecting that cells still got infected.
Hence, I would suggest that viruses were obviously internalized despite the lack of
WHAMM. Indeed, a possible consequene of absence of WHAMM could be that VSV
replication and/or assembly are aﬀected. Growth inhibition of VSV by BFA revealed
that interference with membrane traﬃc leads to the inhibition of viral protein glycosy-
lation and also blocks virus genome replication [189]. WHAMM is known to function
in ER to Golgi transport and WHAMM KO cells exhibit a dispersed Golgi pheno-
type (see Figures 4.9 and 6.10). Thus, it is tempting to speculate that inhibition of
viral progression/maturation is connected to alterations of this cellular compartment
and that the Golgi is actively involved in VSV assembly in WHAMM KO cells. A
similar connection between Golgi and virus assembly was found in studies performed
with vaccinia virus. Data revealed that the intracellular mature virus becomes en-
wrapped by a cellular cisterna to form ﬁrst the intracellular enveloped virus and ﬁnally
the extracellular enveloped virus. The origin of this wrapping cisterna is derived from
the TGN [190]. Another report dealing with hepatitis C virus showed by transmis-
sion electron microscopy as well as confocal microscopy that viral proteins appeared
located in the Golgi complex and ER, underlining the supposed involvement of these
compartments in viral assembly and morphogenesis [191]. Moreover, transport and
release of newly-assembled japanese encephalititis virus particles utilize the host mem-
brane transport systems, including the ER to the classic secretory pathway (via the
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Golgi apparatus), by using viral structural proteins [192]. In order to visualize ER-
to-Golgi transport in the future, ﬂuorescently tagged viral glycoprotein VSV-G could
be applied [20]. Cells harboring siRNA to WHAMM showed that VSV-G transport to
the Golgi was reduced by 40% as compared to control cells and also exhibited a 50%
reduction in plasma membrane localization of VSV-G. These data would support the
notion of impaired virus assembly due to the absence of WHAMM.
In comparison, a previous report identiﬁed a role for the WASH complex in Salmonella
entry [193]. In particular, it accumulated at sites of Salmonella entry in ﬁbroblasts
and RNA interference studies revealed an impaired pathogen uptake [193]. Further-
more, the WASH complex has been described to accumulate on phagosomes and
macropinosomes in Dictyostelium, where it has an important role in protein recycling
to the plasma membrane [33]. It remains to be determined with the help of established
WASH KO cell lines whether WASH has a similar function during virus uptake or
whether it plays a distinct role in actin-dependent virus entry.
Interestingly, autophagy has not only been described in cellular homeostasis, cellular
stress responses, and immune pathways, but also to be involved in pathogenesis of virus
infections. It either plays a pro-viral or anti-viral role, depending on the virus, the cell
type, and the cellular environment. During cell infection, viral proteins are initially
targeted for degradation via autophagy. However, many viruses are able to escape
autophagy-induced lysosomal degradation. Indeed, certain viruses even utilize the au-
tophagy machinery by replicating themselves in autophagosome-like structures, well
protected from the overall immune response and other intracellular degradation path-
ways [194]. On the other side and noteworthy for my studies is that invasion of host cells
by DNA viruses activates autophagy, illustrated for instance by Herpesviruses [195].
HSV-1 is a member of the human Herpesviridae family [196] with a double-stranded
DNA genome protected by a capsid and a proteinaceous tegument [195]. Early HSV-1
infection has been associated with autophagic changes in the host cell, speciﬁcally it in-
duces an interaction of the cyclic GMP-AMP synthase (cGAS) with the autophagy pro-
tein Beclin 1. During robust immune responses, cGAS acts as an intracellular pattern
recognition receptor (PRR) sensing cytosolic pathogen DNAs, producing the second
messenger cGAMP to initiate the STING pathway and subsequently interferon pro-
duction [197]. During HSV-1 infection, the above mentioned interaction between cGAS
and Beclin 1 inhibits the production of cGAMP, allowing the activation of PtdIns3K,
thereby increasing autophagy and targeting viral DNA for degradation [195, 197]. In
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myeloid cells, autophagy is activated already upon viral entry, thus independent of viral
gene expression [198]. Apart from cytosolic PRR, surface receptors such as toll-like re-
ceptor (TLR)2 and TLR4 are also able to interact with viruses and induce autophagy.
They can interact with multiple viral components, for instance with the VSV-G vi-
ral glycoprotein for TLR2 or HSV glycoproteins gH/gL/gB for TLR2 [195]. However,
WHAMM-deﬁcient cells showed a clear defect in the autophagic process, more pre-
cisely loss of WHAMM resulted in an accumulation of autophagic markers such LC3
or p62 (see Figures 4.15 and 4.18), likely inhibiting this process. From those data I
would assume that decreased autophagy should likely lead to higher levels of HSV-1
infection. However, loss of WHAMM in NIH/3T3 cells lead to reduced GFP-positive
cells, thus to lower levels of HSV-1 infection (see Figure 4.31, B).
On the other side, it has been shown that autophagy can have diﬀerent eﬀects on
HSV-1 infection depending on the cell type [199]. For instance, it has been reported
that autophagy is critical for viral control in primary neurons, whereas being dispens-
able in mouse embryonic ﬁbroblasts [200, 201]. In my study it is well possible that
reduced HSV-1 infection in KOs results from a defect in transport, not directly related
to autophagy. It is known that cytoplasmic envelopment of HSV-1 virions is followed
by their vesicular transport to the cell surface and secretion by fusion of the vesicle
membrane with the plasma membrane [202]. I hypothesize that the dispersed Golgi
phenotype might lead to dysfunctional traﬃcking of viral components or virions bud-
ding from this compartment. Future analyses must focus on the eﬃciency of virus
entry, capsid transport to the nucleus, as well as virus assembly and egress in the
absence of WHAMM, preferably using GFP-HSV-1 and super-resolution microscopy.
5.6 Characterization of NIH/3T3 JMY KO cells
JMY was initially discovered as a p300 cofactor that facilitates the p53 response
by augmenting p53-dependent transcription and apoptosis [48]. It is a dual function
protein as it nucleates actin ﬁlaments in the presence and absence of Arp2/3 com-
plex [18]. Interestingly, domain organization and sequence alignments showed that
JMY is roughly 35% identical and 50% similar to WHAMM. Moreover, both NPFs
have been linked to autophagy [44,45,85,117]. Aside from its ability to regulate actin
ﬁlament assembly, JMY is capable of translocation to the nucleus in response to DNA
damage, where it promotes transcription by p53 and enhances apoptosis [50].
As I could clearly show for WHAMM KO cells (see Figure 4.5), JMY KO cell lines
also exhibited an increase in the nuclear area (see Figure 4.32). JMY´s WH2 domain
harbors a bipartite nuclear localization signal motif that controls JMY´s subcellular
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localization. Decreases in the concentration of monomeric actin in the cytoplasm in-
duced JMY to accumulate in the nucleus [50]. Moreover, knockdown of JMY by siRNA
decreased the cytoplasmic concentration of ﬁlamentous actin [46]. Interestingly, actin
itself has also been found to translocate to the nucleus. Unlike cytoskeletal actin, nu-
clear actin does not polymerize into persistent ﬁlaments. Instead, it exists as monomers
and probably as highly dynamic polymers and has been implicated in a variety of pro-
cesses such as regulation of transcription factors, the nuclear lamina, and as a crucial
component of multiple chromatin remodeling complexes [203]. JMY KO in NIH/3T3
cells might cause a disruption of cytoskeletal attachments to linkers of the nucleoskele-
ton to the cytoskeleton at the nuclear envelope. These complexes physically connect
the nucleus to the endomembrane and the cytoskeletal system. They are required to
maintain nuclear size and shape in mammalian cells as well as to maintain structure
and integrity of the nuclear envelope. However, no formal evidence is provided here to
support these notions and further experiments are required.
In general, NPFs have been linked to autophagy [25, 44, 45, 117]. It was previously
demonstrated that JMY localizes to autophagosomes and inﬂuences their formation.
Furthermore, JMY has been described to induce actin assembly needed for the expan-
sion of the phagophore membrane [76] and to increase autophagosome number and
size [85, 204]. Interestingly, JMY contains a LIR motif, which is required to target it
to the autophagosome, where it might contribute to autophagosome formation [85].
A novel study showed that JMY partially coincides and comigrates with DFCP1 and
ATG9. Most interestingly, JMY can be enforced to lysosomal compartments when
endo-lysosomal fusion is blocked with BafA1 [117]. In addition, JMY has been shown
to partially localize to the ER, a compartment linked to the formation of early au-
tophagic structures [46,47,70,74].
siRNA studies performed in human U-2 OS exhibited that downregulation of JMY
aﬀected autophagosome number and size upon drug treatment [85]. However, pre-
liminary assessment of LC3 and p62 particle number and size under fed conditions
revealed that loss of JMY led to a strong increase of these two parameters (see Figure
4.34). It would be interesting to address the autophagic ﬂux under nutrient depri-
vation, however, the dramatic increase of LC3 and p62 vesicles at steady state may
point to a higher activity level of the autophagic machinery in JMY KO cells. Since
JMY localizes to the ER and the TGN where it functions in vesicle traﬃcking [47],
JMY KO in NIH/3T3 cells might also lead to decreased autophagosome motility and
consequently to an accumulation of autophagic markers such as LC3 and p62. There-
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fore, further experiments such as starvation and/or BafA1 treatment are necessary to
obtain a better understanding of the contribution of JMY in autophagy regulation in
cultured cells. Super-resolution imaging of early and late autophagic structures will
also be interesting, as well as live-cell imaging applications in order to uncover JMY´s
role during autophagy.
As mentioned above, cytoplasmic JMY localizes to the ER and the TGN and has been
shown to inﬂuence cell motility and invasion [46,47,205]. Further, it was described that
its overexpression aﬀects both Golgi integrity and VSV-G transport to the plasma
membrane [47]. Interestingly, JMY KO cells described here were less susceptible to
VSV infection and displayed a clear defect in virus release (see Figure 4.35), indicating
an involvement of JMY in the life cycle of VSV. One current idea is to investigate
transport mechanisms via the secretory pathway. Studies of the traﬃcking of viral
integral membrane proteins such as RSV-F protein may lead to a better understanding
of intracellular transport mechanisms in JMY KO cells. RSV-F traﬃcs through the
secretory pathway and has an ER signal sequence. Moreover, it is responsible for viral
fusion with the host cell membrane as well as for the induction of the characteristic
syncytia produced in RSV infections [206]. I anticipate that JMY KO might lead to
aberrant localization of RSV-F. Another future experiment would be to quantify virus
infection via a plaque assay. Plaques result from the infection of a cell layer by virions
followed by the virus replication and the death of the infected cells. This assay may
be used as a complementary method to ﬂow cytometry and video microscopy in order
to conﬁrm previous results.
In this work presented here, I report a simple and rapid approach that used pro-
grammable CRISPR/Cas9 nucleases to generate speciﬁc KO cell lines. I could gener-
ate four individual WHAMM KO clones by this method, among others. Recent evi-
dence indicates an intriguing relationship between WHAMM, vesicle traﬃcking, and
autophagy. In-depth analysis showed a distributed Golgi apparatus in all WHAMM
KO clones. Furthermore, WHAMM KO led to abnormal accumulation of autophagic
markers such as DFCP1, LC3, and p62 that can be associated with impaired au-
tophagosome maturation as well as lysosomal fusion dysfunction. In addition, this
study shows for the ﬁrst time the relevance of key molecular players (e.g. WHAMM
or JMY) involved in VSV and/or HSV-1 infection processes. These novel data will
provide a further piece of understanding of the viral infection route and will improve
our idea by which mammalian cells are harnessed by VSV or HSV-1 and thereby how
to protect the host against these potential invaders.
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6.1 Supplementary data
6.1.1 Sequencing alignments of NIH/3T3 cells deﬁcient in WASH, WHAMM
or JMY
DNA from generated NIH/3T3 KO cell lines was isolated and sent for sequencing.
Reads were aligned to NIH/3T3WT cells using Clustal Omega and are shown in Figures
6.1  6.3. Sequencing gaps indicate indels and are underlined in red. Sequencing results
revealed both homozygous and heterozygous gene mutations depending on the targeted
gene. Respective amino acid translations of NIH/3T3 WASH and JMY KO cells are
depicted in Figures 6.4   6.5. Amino acids labeled in red indicate positions that diﬀer
from the WT sequence. Protein sequence alignments of JMY also show positions of
premature stop codons (designated by stars) due to the introduced frameshifts.
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Figure 6.1: DNA alignments of NIH/3T3 WT and WASH KO cells. All WASH KO clones
exhibit heterozygous gene mutations (indicated by two diﬀerent alleles). WASH#22 displays three
diﬀerent alleles which might indicate a mixture of clones. Sequencing gaps (underlined in red) in the
WASH locus implicate indels. Upper lane = WT sequence, lower lane = KO sequence.
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Figure 6.2: DNA alignments of NIH/3T3 WT and WHAMM KO cells. WHAMM#7
bears two diﬀerent alleles (heterozygous mutation), whereas WHAMM#11 has exactly the same two
alleles (homozygous mutation). Sequencing gaps (underlined in red) in the WHAMM locus implicate
indels. Upper lane = WT sequence, lower lane = KO sequence.
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Figure 6.3: DNA alignments of NIH/3T3 WT and JMY KO cells. All JMY KO clones
exhibit heterozygous gene mutations (indicated by two diﬀerent alleles). JMY#10 displays three
diﬀerent alleles which might indicate a mixture of clones. Sequencing gaps (underlined in red) in the
JMY locus implicate indels. Upper lane = WT sequence, lower lane = KO sequence.
Figure 6.4: Protein alignments of NIH/3T3 WT and WASH KO cells. In this study, I
established NIH/3T3 deﬁcient in wash. Three clonal cell lines were generated by using one sgRNA
targeting the coding region of wash, which produced indels that abolished WASH protein expression.
Amino acids labeled in red indicate positions that diﬀer from the WT sequence.
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Figure 6.5: Protein alignments of NIH/3T3 WT deﬁcient in jmy. In this study, I estab-
lished NIH/3T3 deﬁcient in jmy. Three clonal cell lines were generated by using one sgRNA targeting
the coding region of jmy, which produced indels that abolished JMY protein expression. Amino acids
labeled in red indicate positions that diﬀer from the WT sequence. Horizontal dash indicates missing
amino acid(s). Protein sequence alignments show positions of premature stop codons (designated by
stars) due to the introduced frameshifts.
6.1.2 Cell size and actin pattern in WHAMM KO cells
Immunoﬂuorescence stainings of NIH/3T3 WHAMM KOs are displayed in Figure
6.6, A. DAPI staining (blue) was used as a cellular nucleus marker. F-actin (red) was
stained by ﬂuorescent phalloidin. Note that KO cells appeared larger in comparison
to WT cells. Additionally, the cell area was examined 5 h after cell seeding (Figure
6.6, B). These data show that WHAMM KO causes cell enlargement and consequently
conﬁrm previous experiments shown in Figure 4.5.
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Figure 6.6: NIH/3T3 cells deﬁcient in WHAMM expression display unaltered stress
ﬁbers but are larger in size. (A) DAPI staining (blue) was used as a cellular nucleus marker.
F-actin (red) was stained by ﬂuorescent phalloidin. Scale bar: 20µm. (B) Cells were stained with
CellTracker, seeded onto ﬁbronectin-coated coverslips and ﬁxed after 5 h. Quantitative analysis of WT
and WHAMM KO cells conﬁrms an impact of whamm deletion on cell area. Data are representative
of two independent experiments. n = number of cells analyzed. Error bars represent SEM.
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6.1.3 Granularity in WHAMM KO cells
Cells were analyzed by ﬂow cytometry with the help of Stephanie Stahnke (HZI,
Braunschweig) to assess their cellular volume (Figure 6.7, A). Cells were grouped into
four categories, depending on cell size and cell granularity. For this measurement,
sideward scatter SSC and forward scatter FSC are plotted and gates are set to WT
parameters. The results show that loss of WHAMM results in a shift from smaller to
larger cell populations as well as to big granular cells (Figure 6.7, B-C).
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Figure 6.7: Eﬀect of WHAMM KO on cell size and granularity. (A) Cell size and cell
granularity were analyzed by ﬂow cytometry. Quadrant gates split the population into four adjacent,
discrete subpopulations. (B-C) Quantitative analysis of WT cells versus WHAMMKO clones conﬁrms
a shift in cell population from smaller to large cells in KO cells as well as a higher number of big
granular cells. Data are representative of two independent experiments. **P  0.005, ***P 
0.0001, One-way ANOVA. Error bars represent SEM.
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6.1.4 ER and ERGIC pattern in WHAMM KO cells
Immunoﬂuorescence stainings of NIH/3T3 WHAMM KO cells are displayed in Fig-
ures 6.8 and 6.9. F-actin ﬁlaments were visualized with phalloidin, ER was uncovered
with GFP-tagged VAP-A, and ERGIC was targeted with EGFP-ERGIC.
Figure 6.8: Subcellular localization of VAP-A in WT and WHAMM KO cells. Represen-
tative immunoﬂuorescence images of WT and WHAMM KO cells. EGFP-VAP-A (green) was used to
label the position of ER. F-actin (red) was stained by ﬂuorescent phalloidin. Enhanced contrast was
utilized to improve visualization of the ER. Scale bar: 10µm. Data are derived from one experiment.
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Figure 6.9: ERGIC staining in WT and WHAMM KO cells. Representative immunoﬂuo-
rescence images of WT and WHAMM KO cells. EGFP-ERGIC (green) was used to label the position
of ERGIC elements. F-actin (red) was stained by ﬂuorescent phalloidin. Scale bar: 10µm. Data are
derived from one experiment.
6.1.5 Golgi pattern in WHAMM KO cells
Immunoﬂuorescence stainings of NIH/3T3 WHAMM KO cells are displayed in Fig-
ures 6.10. Golgi apparatus was visualized with Giantin and DAPI was used to visualize
nuclear DNA.
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Figure 6.10: Eﬀect of WHAMM KO on Golgi apparatus in NIH/3T3 cells. Represen-
tative immunoﬂuorescence images of WT and WHAMM KO cells. The majority of cells deﬁcient for
WHAMM expression show a disseminated Golgi complex. Giantin staining (green) was used to label
the position of Golgi. DAPI staining (blue) was used as a cellular nucleus marker. Scale bar: 20µm.
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6.1.6 WHAMM KO aﬀects autophagy
Early autophagy was investigated with EGFP-DFCP1. Figure 6.11 displays EGFP-
DFCP1-coated omegasomes under basal conditions.
Figure 6.11: WHAMM KO leads to an accumulation of omegasomes. Representative
immunoﬂuorescence images of WT and WHAMM KO cells. EGFP-DFCP1 was used to label the
position of omegasomes. WHAMM KOs in general exhibited an accumulation of DFCP1-positive
structures under fed conditions. Scale bar: 10µm.
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Autophagy was induced in both WT and WHAMM KO cells by HBSS treatment.
Moreover, the autophagic ﬂux was further examined by HBSS and/or BafA1 treat-
ment. Level of autophagy was monitored and measured by LC3 and p62 westerm blot
analyses as well as immunoﬂuorescence stainings. A representative image of LC3-I and
LC3-II detection in WT and two WHAMM KO cells starved with HBSS is shown in
Figure 6.12. Immunoﬂuorescence stainings of NIH/3T3 WT and WHAMM KO cells
treated with HBSS are displayed in Figures 6.13 and 6.14. Immunoﬂuorescence stain-
ings of NIH/3T3 WT and WHAMM KO cells treated with HBSS and/or BafA1 are
displayed in Figures 6.15 and 6.16.
Figure 6.12: Western blot analysis of LC3-I and LC3-II after HBSS treatment. Rep-
resentative image of western blots. Cells were seeded and starved with HBSS for the indicated time
points. Lysates of WT and WHAMM KO cells were separated on a SDS gel. Membrane was blotted
for LC3-I and LC3-II as well as GAPDH was used as loading control. Western blot analysis revealed
a diﬀuse or weak antibody staining, especially for LC3-I detection. Data are representative of at least
three independent experiments.
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Figure 6.13: Loss of WHAMM does aﬀect autophagy. Autophagy was induced by HBSS
treatment and studied with autophagy markers LC3 (red) and p62 (green). Scale bar: 20µm.
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Figure 6.14: Loss of WHAMM does aﬀect autophagy. Autophagy was induced by HBSS
treatment and studied with autophagy markers LC3 (red) and p62 (green). Scale bar: 20µm.
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Figure 6.15: Loss of WHAMM does aﬀect autophagy. The autophagic ﬂux was further
investigated by BafA1 treatment and studied with autophagy markers LC3 (red) and p62 (green).
Scale bar: 20 µm.
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Figure 6.16: Loss of WHAMM does aﬀect autophagy. The autophagic ﬂux was further
investigated by HBSS treatment in the presence of BafA1 and studied with autophagy markers LC3
(red) and p62 (green). Scale bar: 20µm.
A ﬂow cytometry-based assay was applied as further method to analyze and quantify
the amount of LC3 in WHAMM KO cells. Cells were untreated or treated with HBSS
for the indicated time points followed by ﬂow cytometry analysis. Representative ﬂow
cytometry gating plots of untreated cells are depicted in Figure 6.17, A. Quantiﬁcation
of ﬂuorescence intensity in WT and WHAMM KO cells is shown in Figure 6.17, B.
Calculations are based on population 3 (P3).
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Figure 6.17: Quantiﬁcation of LC3 by ﬂow cytometry. (A) Representative ﬂow cytometry
plots of untreated cells. Texas Red A (LC3) vs. FITC A (LAMP1) channels are plotted. Cells were
split into three populations (P3 consists of P1 and P2). (B) Preliminary results conﬁrm a higher
ﬂuorescence intensity in WHAMM KO cells under basal and starvation condition. Data are derived
from one experiment. Error bars represent SEM.
Flow cytometry has also been applied to quantify the amount of LAMP1 present in
WHAMM KO cells. Cells were untreated or treated with HBSS for the indicated
time points followed by ﬂow cytometry analysis. Representative ﬂow cytometry gating
plots of untreated cells are depicted in Figure 6.17, A. Quantiﬁcation of ﬂuorescence
intensity in WT and WHAMM KO cells is shown in Figure 6.18. Calculations are
based on population 3 (P3).
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Figure 6.18: Quantiﬁcation of LAMP1 by ﬂow cytometry. Preliminary results conﬁrm a
higher ﬂuorescence intensity in WHAMM KO cells under basal and starvation condition. Data are
derived from one experiment. Error bars represent SEM.
6.1.7 Gene regulation in WHAMM KO cells
Microarray analysis of WHAMM KO cells was performed with the help of Robert
Geﬀers (HZI, Braunschweig). Top 50 genes are shown in Table 6.1. Note that the ﬁrst
genes (acadsb - 6430550D23Rik) are downregulated, whereas all others are upregulated
in comparison to WT cells. Expression patterns of several ATGs were analyzed and
are depicted in Figure 6.19.
Table 6.1: Top 50 genes
Gene Function
Acadsb Catalyze dehydrogenation of acyl-CoA derivatives in the metabolism
of fatty acids or branch chained amino acids
Acat2 Plays a role in lipoprotein assembly and dietary cholesterol absorption
Acyltransferase and ligase activity
Acly ATP-citrate synthase
Synthesis of cytosolic acetyl-CoA
Central role in de novo lipid synthesis
Aldh4a1 Dehydrogenase
Conversion of delta-1-pyrroline-5-carboxylate to glutamate
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Aox3 Oxidizes aromatic azaheterocycles, aldehydes
Involved in the regulation of reactive oxygen species homeostasis
Catalyzes nitric oxide production
Ap3s1 ps1/ps2 Part of AP-3 complex that facilitates the budding
of vesicles from the Golgi
May be directly involved in traﬃcking to lysosomes
Bmf May play a role in apoptosis
Ccr7 Receptor for MIP-3-beta chemokine
Cebpd Transcription activator regulating the expression of genes
involved in immune and inﬂammatory responses
Cped1 Cadherin Like And PC-Esterase Domain Containing 1
Cyba Critical component of membrane-bound oxidase of phagocytes
Superoxide generation
Dact1 Plays a role in canonical and/or non-canonical Wnt signaling
Galnt15 Catalyzes initial reaction in O-linked oligosaccharide biosynthesis
Gas1 Growth arrest protein involved in growth suppression
Blocks entry to S phase
Gdpd2 Glycerophosphoinositol inositolphosphodiesterase activity
Hydrolyzes glycerophosphoinositol
Remodeling of the actin cytoskeleton
Gmpr Catalyzes the irreversible NADPH-dependent deamination of GMP
Functions in the conversion of nucleobase,
nucleoside and nucleotide derivatives of G to A nucleotides,
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and in maintaining the intracellular balance of A and G nucleotides
Gm12060 Involved in ER-associated degradation of misfolded, glycosylated proteins
Has a role in the protection of cells from ER stress-induced apoptosis
Gxylt2 Glycosyltransferase, elongates O-linked glucose attached to
EGF-like repeats by catalyzing the addition of xylose
Iﬁ27l2a Localizes at the inner nuclear membrane in transfected cell lines,
inhibits function of the NR4A1 nuclear receptor,
downregulated NR4A1-target genes
Mitochondrial protein
Limd2 Cell motility
Lrrk2 Positively regulator of autophagy
Activation of CaMKK/AMPK signaling pathway
Plays a role in retrograde traﬃcking pathway for recycling proteins
Lurap1 Activates NF-kappa-B pathway
Drives production of proinﬂammatory cytokines
Involved cell protrusion and migration
Mgp Associates with the organic matrix of bone and cartilage
Acts as an inhibitor of bone formation
Nﬁl3 Transcriptional regulator
Nr4a2 Transcriptional regulator
Iimportant for diﬀerentiation and maintenance of meso-diencephalic
dopaminergic neurons
Osmr Cytokine binding
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Cytokine receptor activity
Growth factor binding
Oncostatin-M receptor activity
Pde8b Hydrolyzes second messenger cAMP
Regulator of many important physiological processes
Pdzk1ip1 Scaﬀold protein that connects plasma membrane proteins
and regulatory components
May be involved in the coordination of a diverse range of
regulatory processes for ion transport and second messenger cascades
Plays a role in maintaining normal plasma cholesterol levels
Pmvk Involved in mevalonate pathway
Ptgir Prostacyclin receptor
Rassf2 Potential tumor suppressor
Acts as a KRAS-speciﬁc eﬀector protein
May promote apoptosis and cell cycle arrest
Rbbp9 May play a role in the transformation process
Scd1 ER enzyme
Catalyzes rate-limiting step in formation of monounsaturated fatty acids
Slc25a35 Transmembrane transporter activity
Stat3 Transcription factor involved in interleukin 6 signaling
Tm7sf2 Involved in cholesterol biosynthesis
6430550D23Rik -
A930033H14Rik -
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Apobec1 Essential component of the apolipoprotein B mRNA
editing enzyme complex
Cav1 Mediates entry of calcium ions
Involved in calcium-dependent processes (e.g. muscle contraction,
cell motility, cell division and cell death)
Isoc1 Catalytic activity
Slc25a22 Involved in transport of glutamate across the
inner mitochondrial membrane
Zfpm1 Transcription regulator
Plays a role in erythroid and megakaryocytic cell diﬀerentiation
152
6 Appendix
Figure 6.19: mRNA levels of various ATGs. Relative mRNA expression of ATG2a, ATG3,
ATG4a, ATG4b, ATG4c, ATG5, ATG7, ATG9, ATG13, ATG16L1, and ATG16L2 in WT and
WHAMM KO cells. Gene expression was assessed by microarray analysis and normalized to WT
levels. Data are derived from one experiment. *P  0.05, ***P  0.001, Student's t-test. Error bars
represent SEM. 153
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DHCR7 and SOAT1 transcript levels in WHAMM KO cells were additionally deter-
mined by qPCR and are shown in Figure 6.20. qPCR was conducted with the help of
Silvia Prettin (HZI, Braunschweig).
Figure 6.20: Transcription levels of dhcr7 and soat1 quantiﬁed by qPCR. (A-B) Target
genes expressed in WT and WHAMM KO cells. The relative expression levels were normalized to
the expression levels of rps9. Data are representative of three independent experiment. Error bars
represent SEM.
KEGG pathway diagrams represent the relationships of genes or gene products in the
pathway of steriod biosynthesis (Figure 6.21) and adhesion signaling (Figure 6.22).
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Figure 6.21: Impact of WHAMM KO on steriod biosynthesis. The pathway model was
obtained from KEGG pathway. Red boxes indicate upregulated, whereas green boxes downregulated
genes.
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6.1.8 VSV and HSV-1 infection in WHAMM KO cells
Flow cytometry was utilized to assess the number of infected WT cells and one
WHAMM KO clone. A GFP reporter was used to provide information about nonin-
fected versus infected cells. Preliminary data showed that WHAMM#3 tends to be
less susceptible to both VSV and HSV-1 compared to WT cells (Figures 6.23 and 6.24).
Figure 6.23: Flow cytometry analysis of WHAMM KO cells after VSV infection. Cells
were seeded, infected with VSV and inspected after 6 and 12 hpi. GFP ﬂuorescence provided a sensitive
and accurate measure of the proportions of infected cells. The amount of cells infected is expressed
as percentage. Mock infection was used as negative control. Vero cell line was utilized as infection
control. Data are derived from one experiment.
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Figure 6.24: Flow cytometry analysis of WHAMM KO cells HSV-1 infection Cells were
seeded, infected with HSV-1 and inspected after 12 hpi. GFP ﬂuorescence provided a sensitive and
accurate measure of the proportions of infected cells. The amount of cells infected is expressed as
percentage. Mock infection was used as negative control. Vero cell line was utilized as infection
control. Data are derived from one experiment.
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